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Abstract 
Cancer continues to grow globally, exerting serious financial and emotional strain on 
individuals, families, associations and health systems. Early detection is crucial in 
order to control the spread of the disease and improve chances of survival. Despite the 
significant intellectual and financial efforts worldwide, there are currently no blood-
based biomarkers that are suitable for the non-invasive early detection of cancer. 
MicroRNAs/miRNAs are a family of non-protein-coding small RNAs which regulate 
the expression of nearly one third of all human genes. Over the past decade, significant 
evidence has emerged showing that miRNAs and modulation of their levels in human 
body are involved in the pathogenesis of cancer at its early stages. 
The main consideration when selecting methods of detection for miRNAs is the 
requirement for high-sensitivity and selectivity due to their low concentrations in 
blood. This thesis investigates a new method of electrochemical detection which is 
distinctive due to its sensitivity together with its simple, rapid and reliable design. The 
first experimental study investigates the role of artificial oligonucleotide probes for 
selective recognition of miRNAs. Upon using Peptide Nucleic Acid (PNA) probes, 
highly-sensitive and direct electrochemical detection of a pancreatic cancer-specific 
miRNA has been achieved with no additional labelling steps. The second study 
examines the adoption of magnetic beads for separation of target miRNAs from 
complex solutions (e.g. blood). This strategy addresses the major problem of non-
specific interactions that arises upon direct subjection of sensor surfaces to complex 
solutions. The final study concentrates on the use of redox active self-assembled 
monolayers (SAMs) on electrode surface for direct capacitive-based detection of 
miRNAs. Such methodology eliminates the need for pre-doping of the measurement’s 
solution or labelling of target and is highly desirable characteristic for a point-of-care 
device to be used for the analysis of clinical samples.  
Together, this thesis aims to serve as a potential guidance for overcoming the 
shortcomings of the current miRNA sensing, add value to the development of 
oligonucleotide-based biosensors for detection of circulating miRNA and hopefully 
enable the early detection of cancer state. 
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 Introduction  
 
The core objective of this thesis is to develop oligonucleotide hybridisation-based 
detection of circulating microRNAs (miRNAs) that are cancer-specific. Prior to the 
fabrication of such a platform it is crucial to understand the issues related to the current 
procedures for cancer diagnosis, and the diagnostic potential of extracellular miRNAs 
and their origin. Hence, this chapter is an introduction to the problems of cancer, the 
current tests and procedures for cancer diagnosis, and the broad range of studies in the 
literature which have identified serum (and plasma) miRNAs as candidate biomarkers 
for early detection of a range of cancers. Finally, the chapter will introduce 
electrochemical biosensors and the hybridisation-based recognition of miRNAs by 
oligonucleotide functionalised capture probes, which will form the foundation of this 
doctoral thesis. 
 
1. 1 What is cancer? 
Cancer is a disease state caused by uncontrolled cell division leading to the growth of 
abnormal tissue (Herrera et al. 2008; Burgio & Migliore 2015). The genetic basis of 
cancer was first introduced by the German zoologist Theodor Boveri who suggested 
that the mutations of the chromosomes in cell nucleus could result in cell generation 
with unlimited growth potential that could be transferred onto its descendants (Holland 
& Cleveland 2009; Burgio & Migliore 2015). If the spread is not controlled, it can lead 
to death. There are various external factors that can initiate cancer such as tobacco use, 
being overweight, radiation exposure, physical or chemical insults or pathogenic 
microorganisms (Blot et al. 1988; Grant 2002; Key et al. 2002; Burgio & Migliore 
2015). The internal factors include inherited genetics, immune conditions and 
hormones. Cancer has been referred to as a genetic disease and despite the introduction 
other models (Soto & Sonnenschein 2014), the somatic mutation theory (SMT) 
remains the dominant model of carcinogenesis (Blagosklonny 2005). According to 
SMT, carcinogenesis is a multistep process that includes initiation, promotion and 
progression, and is characterised by an accumulation of genetic and cytogenetic 
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Figure 1. 1 Schematic for somatic mutation theory of cancer (Burgio & Migliore 2015) 
 
1. 2 Cancer: A global burden 
Every year, more than 14 million people develop cancer with the majority living in 
low- and middle- income countries (Ferlay et al. 2014; World Health Organization 
2019; Cancer Research UK 2019b). The number of deaths in the low/middle class 
regions due to cancer exceeds the number of deaths due to HIV/AIDS, tuberculosis, 
and malaria all combined. Breast cancer is estimated to be the most frequently 
diagnosed amongst all cancer diseases in the US (Figure 1.2), with 268,600 new cases 
expected in 2019. This number is to be followed by prostate cancer, with an estimated 
174,650 new cases in 2019. The reported figures are also similar in UK, with cancer 
being the leading cause of death above heart disease and dementia (Department of 
Public Health England 2017). In 2014, there were 55,379 reported cases of breast 
cancer in UK and the incident rate is expected to rise by 27% (up to 70,670 cases) by 
2035 (Cancer Research UK 2019a). Prostate cancer had the second highest occurrence, 
with 47,343 new cases in 2014 (Cancer Research UK 2019a). As the figures suggest, 
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cancer continues to grow globally and exerts significant emotional and financial strain 
on individuals, families, communities, and health systems. As described by WHO 
Cancer control: knowledge into action series, one of the core components of cancer 
control is the early detection module (World Health Organization 2017). Patients 
diagnosed at an early stage are more likely to survive cancer (John & Broggio 2019). 
This is partly because patients have different treatment options when diagnosed in an 
early stage of cancer, compared to those diagnosed at a later stage. Hence, there is a 
need for the general population to understand the crucial role of early diagnosis, as 
many patients miss out on curative treatment because of their late diagnosis. At the 
same time, researchers should further explore the development of non-invasive 
approaches for the earliest possible identification of cancer. 
 
      
 
Figure 1. 2 New cases of cancer and deaths – Estimates for 2019, sourcing from 




1. 3 Current diagnosis of cancer: Tests and procedures 
Diagnosing cancer usually follows the same few steps. A person displays a symptom, 
or screening results might suggest cancer. Then the doctor has to find out if the 
abnormality is due to cancer or some other cause. There are various types of tests the 
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doctor can order for accurate diagnosis, these are: blood tests, imaging procedures, and 
biopsies (Kok et al. 2004; Saslow et al. 2007; Fass 2008; Ciatto et al. 2012). 
Blood tests are important tools, as high or low levels of certain cancer biomarkers 
within the bloodstream can be a sign of the disease. A few examples of these 
biomarkers are: alpha fetoprotein (AFP) in the screening for hepatocellular cancer 
(Ellis & Angeles 1988; Daniele et al. 2004), cancer antigen 125 (CA-125) for ovarian 
cancer (Bell et al. 1998; Jacobs et al. 1999), human epidermal growth factor receptor 
2 (HER2) for the identification of women with breast cancer, and prostate specific 
antigen (PSA) for the screening of prostate cancer (Duffy 2013). Although widely 
used, the efficacy of PSA screening in reducing prostate cancer mortality remains to 
be shown (Duffy 2007). 
However, due to the limited sensitivity and specificity of available markers, these tests 
cannot be solely used for the accurate diagnosis of cancer (Duffy 2001; Duffy 2007). 
Markers are observed to be elevated only in a proportion of patients (at highest 70-
80%) with a particular tumour/cancer type and are rarely elevated in the serum of 
patients who experience early or primary stages of cancer (Duffy 2001). Apart from 
PSA, which is mainly prostate specific, none of the other clinical markers are organ 
specific. 
Currently, the main uses for cancer biomarkers are prevention, aiding the diagnosis, 
and making predictions on the likely response to a given therapy (Duffy 2001). 
Therefore, there is still a requirement for combining lab tests with other clinical 
methods such as imaging of the suspected internal organs (Khalkhali et al. 1994; Fass 
2008). Some imaging methods that are currently used include MRI scans, 
Mammography, X-rays, PET scans, and Ultrasound screening (Duffy 2001; Fass 
2008). 
Although imaging tests are quite helpful in detecting masses and areas of abnormality, 
they may not differentiate cancerous cells from non-cancerous cells. As a result, the 
majority of patients are asked to undergo a biopsy in order to collect cells for 
histological analysis. A biopsy is the procedure of removing a piece of tissue or cells 
from a target site in the body for further investigation in the laboratory. The procedure 
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varies depending on the region of abnormality observed in the patient. For instance, 
bone marrow biopsies (Contreras et al. 1972; Brunning et al. 1975) are carried out by 
a doctor collecting a sample of bone marrow out of the back of the hipbone, with the 
aid of a needle. All of the needle biopsies collect tissues from internal organs by 
inserting needles/tubes through an orifice or by making a small incision in the skin 
(Reid et al. 2000; Mohamad A Eloubeidi. et al. 2003). Such an endoscopic biopsy 
requires the use of an endoscope (flexible tube) with a light on the end in order to 
visualise structures inside the body. However, such procedures are uncomfortable 
experiences for the patients and there is a preference for non-invasive or minimally 
invasive tests that also make the early stage diagnosis of cancer possible (Ferracin et 
al. 2011). Hence, the detection of cell-free (circulating) biomarkers in plasma or serum 
could serve as a ‘liquid biopsy’ which would be extremely useful in various diagnostic 
applications, and eliminate the need for tumour tissue biopsies (Schwarzenbach et al. 
2011). Such a technique would allow one to take repeated blood samples and 
continuously monitor the changes in the cell-free biomarkers during the natural course 
of the disease, and its treatment. 
 
1.4 microRNAs: Candidate biomarkers for cancer 
diagnosis 
Being first discovered in C. elegans in 1993 and soon after in all living organisms 
(Ferracin et al. 2011), microRNAs (miRNAs) are a class of non-coding RNA 
molecules, which are between 19-24 nucleotides in length, (Ambros 2004; Bartel 
2004; Iorio & Croce 2011), which regulate the expression of nearly one third of all 
human genes by targeting their 3’ untranslated region (UTR) (He et al. 2015). At the 
time of this study, thousands of miRNAs have been identified (~total of 38,589) within 
animals, plants, and viruses. The current version of miRBase (release 22) holds 
information on about 2,656 mature miRNAs in the human genome 
(http://mirbase.org/; Release 22.1: October 2018). Within the context of cancer disease 
development and progression, epigenetic alterations are considered one of the key 
drivers. Epigenetic alterations are shown to take place far more frequently than genetic 
mutations, and often appear in the early stages of tumorigenesis (Kaiser 2010; 
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Schwarzenbach et al. 2011). The term “epigenetic” refers to all heritable changes in 
gene expression, but excludes the alterations in a DNA sequence. To date, miRNAs 
remain the most common epigenetic alteration in circulation, a property which makes 
it of great interest in the search for diagnostic and prognostic biomarkers. Moreover, 
miRNA is shown to be quite stable in blood due to its packaging into exosomes which 
protect it from degradation, while other circulating nucleic acids, such as DNA, are 
cleared from circulation rapidly. The other types of epigenetic alterations involve 
aberrant DNA methylation, histone modifications, and dysregulated expression of 
non-coding RNAs. In the case of DNA methylation, the main drawback is the 
significant volume of serum/plasma that is required to obtain appropriate amounts of 
DNA in order to detect the process of methylation (Schwarzenbach et al. 2011). In this 
section we will primarily be looking into miRNAs which are shown to have great 
potential as cancer biomarkers in circulating blood. 
The initial evidence of miRNA as cancer biomarkers was accidental: in search for the 
tumour suppressor gene involved in chronic lymphocytic leukemia (CLL), Calin and 
colleagues (Calin et al. 2002) found that the smallest common area of deletion encoded 
two miRNAs: miR-15a and miR-16-1. The work suggested the roles of these two 
miRNAs as tumour suppressor genes in CLL. This was followed by studies in 2005, 
stating that each miRNA when it targets several mRNAs, can directly or indirectly 
regulate the expression of thousands of proteins (Lim et al. 2005), suggesting that the 
regulation of a single miRNA can in turn lead to substantial biological consequences. 
Although the major mechanism of miRNA leads to down-regulation of target genes, it 
was reported that in some cases miRNA acts by activating translation (Vasudevan et 
al. 2007), or even modulating transcription (Ferracin et al. 2011). In 2011, more 
tumour suppressor microRNAs were discovered, such as the let-7 family which is 
down-regulated in the case of cancer disease that leads to the upregulation of specific 
proto-oncogenes (Ferracin et al. 2011) (Figure 1.3). 
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Figure 1. 3 Family of miRNAs acting as tumour repressors or oncogenes. Genetic 
(deletion, point mutations, amplification) or epigenetic (DNA methylation) changes, 
various stress stimuli or abnormal transcription factor expressions may lead to 
deregulation of miRNAs in cancer cells. This variation in miRNA levels can in turn 
affect the levels of target genes. As a result, cells may undergo various situations 
representing hallmarks of cancer (no differentiation, undergoing apoptosis, increased 
proliferation and invasion, etc.) (Ferracin et al. 2011). 
 
MiRNAs are a particular area of interest for oncology research since their discovery 
and following evidence suggest that they are involved in the pathogenesis of cancer, 
in most cases by controlling the translation of oncogenes and tumour suppressors 
(Calin & Croce 2006; Esquela-kerscher & Slack 2006; Cho 2010). 
A Web search (Figure 1.4) reveals the breakthrough of disease specific miRNAs, first 
in 2002, which was followed by their detection studies in 2003. The number of 
publications indicates the limitation of the detection studies, although proved to be 
candidate biomarkers of various diseases. 
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Together with their crucial role in gene regulation, in 2008 the levels of miRNAs in 
circulating blood were discovered to show fluctuations in cancer state (Lawrie et al. 
2008). In the upcoming sections, we will be investigating the cancer specific 
circulating miRNAs in human plasma/serum for the development of non-invasive 
detection methodologies as the core objective of this thesis. 
 








































Figure 1. 4 Number of articles published on “microRNA” and “detection of 
microRNA” in the past 16 years (source: Web of Science™) 
 
 
1. 5 Extracellular microRNAs for early detection of 
cancer 
1.5. 1 Origin and diagnostic potential 
It was not long ago that significant amounts of circulating miRNAs were detected in 
various biological fluids that include plasma, urine, saliva, tears, semen, breast milk, 
amniotic fluid and cerebrospinal fluid (Alton Etheridge 2013). Surprisingly, these 
circulating miRNAs were observed to be very stable and survive extreme conditions 
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where the common RNA species (e.g. mRNA, rRNA and tRNA) would fail to survive 
and degrade within several seconds (Chen et al. 2008; Turchinovich et al. 2011). In 
this section, we will outline the actual theories regarding the origin and the transport 
of these intracellular miRNAs to extracellular environments and the mechanisms 





Figure 1. 5 From cell nucleus to circulating blood, the biogenesis of miRNAs. Re-
created from (Turchinovich et al. 2013). 
 
As the biogenesis model in Figure 1.5 suggests, all miRNAs are initially generated in 
the cell nucleus where they exist in the form of long primary miRNAs (pri-miRNAs) 
transcripts containing a 5’cap and a 3’polyA tail   (Lee et al. 2004). Then these are 
further cleaved by a microprocessor complex consisting of Drosha and DGCR8 
proteins, into ~70 nucleotide (nt) hairpin precursor pre-miRNAs (Lee et al. 2003; 
Landthaler et al. 2004). This is in turn followed by the active transport of the pre-
miRNAs into cytoplasm where they are further chopped into ~22 base pair (bp) 
miRNA/miRNA duplexes by the Dicer/TRBP enzyme complex (Zhang et al. 2002; 
Chendrimada et al. 2005). Eventually, miRNA duplexes separate leaving one of the 
strands associated with an Argonaute (AGO) protein (Okamura et al. 2004; Ender & 
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Meister 2010). Although an Argonaute family of four different proteins (AGO1, 
AGO2, AGO3, AGO4) were associated with mediating the translational repression of 
mRNA on ribosomes and mRNA decay in P-bodies, only AGO2 is capable of direct 
cleavage of mRNA in the cytoplasm. It is important to also note that neither pre-
miRNAs nor mature miRNAs were found to be in non-protein bound forms within the 
cells. 
On the other hand, the extracellular microRNAs are found to be in various forms such 
as, the in additional encapsulation of the protein-bounded form in microvesicles, HDL 
particles, or apoptotic bodies. Hence, these shielded forms of extracellular miRNAs 
protect the miRNA from RNase degradation as most reports suggest (Turchinovich et 
al. 2013). 
The exact mechanism by which the exosomes/microvesicles are released by the cell 
still remains unclear, however the release is modulated by extracellular signals. 
Although some early studies referred to the extracellular vesicles as “garbage bags” of 
the cells, they are now gaining increasing recognition for intercellular communication. 
In this manner, they produce a pathway for the intercellular transfer of information 
that resembles direct cell-cell contact but acting at a distance. However, in some cases 
this information transfer was observed to be in favour of tumour growth, the 
extracellular vesicles were observed to be protective for tumour cells by clearing away 
molecules such as the membrane attack complex from tumour cell membranes. In a 
similar way, it was proposed that they educate the host environment to re-model a 
supportive niche for tumour growth and the spread of metastasis (Peinado et al. 2012). 
Also, some studies argued that miRNAs delivered by extracellular vesicles play a role 
in immune system regulation (Taylor et al. 2013). 
With the proposal of the concept of “liquid biopsy” (Murtaza et al. 2013) the 
circulating miRNAs started getting more attention as good candidates for liquid 
biopsy, as the quantities and sequences of miRNAs convey information for diagnosis. 
Although circulating miRNAs were previously thought to be “garbage” from cells, it 
is now proposed that the “garbage” actually serves as a communication tool and should 
be referred to as “gold”. Such that we shall provide a detection method that is based 
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on the mechanism of secreted miRNAs in cancer development and that “listens” to 
this cell-cell communication. 
 
1.5. 2 Serum and plasma microRNAs as candidate biomarkers  
Following the discovery of miRNAs as potential cancer biomarkers, various methods 
have been adopted for the quantification of their levels within the human body. By 
using techniques such as quantitative reverse transcription-polymerase chain reaction 
(qRT-PCR), miRNA cloning, microarray, and bead-based profiling methods, the 
variations of miRNA profiles can be detected in a wide spectrum of haematological 
malignancies and solid tumours (Lu et al. 2005; Volinia S, Calin GA, Liu CG 2006; 
Yanaihara et al. 2006; Cummins et al. 2006; Iorio & Croce 2011). However, there is 
still the requirement for non-invasive or minimal invasive methods of cancer 
diagnostics. One solution to this problem could be the detection of miRNA levels in 
the bloodstream. However, the question is: could the circulating miRNAs levels within 
human serum, plasma, saliva or other body fluids be related to the presence of any 
tumour or cancerous disease within the body? 
The first suggestion was made in 2008 by Lawrie et al. who reported circulating 
tumour-related miRNAs as non-invasive diagnostic markers for cancer (Lawrie et al. 
2008). The study compared the levels of tumour-related miR-155, miR-210 and miR-
21 in serum taken from 43 healthy controls and 60 diffuse large B-cell lymphoma 
(DLBCL) patients. Lawrie et al. reported high serum levels of miR-21 in patients, and 
the levels were interestingly found to be related with the relapse-free survival of these 
patients. The study gave the first description of circulating miRNAs and suggested 
miRNAs as non-invasive biomarkers for DLBCL and possibly for other types of 
cancer. 
Later, another study conducted by Mitchell et al. (2008) reported miRNAs to be 
remarkably stable in human plasma and protected from endogenous RNase activity. 
The same study also reported miRNAs to be entering the bloodstream from human 
prostate cancer xenografts and their levels could be measured readily from plasma. 
From distinguishing xenografted mice from controls, the concept was applied to cancer 
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in humans, where serum levels of miR-141 (prostate cancer specific miRNA) can 
distinguish prostate cancer patients from healthy controls. 
 
            
 
Figure 1. 6 Class of circulating miRNAs that relate with different types of cancers 
(Lautner & Gyurcsá 2014) (Refer to Table 1.1 for further references). 
 
A recent study, in 2017, suggested a wide profile of miRNAs present in human plasma 
have significant diagnostic value for early stages of non-small cell lung cancer 
(NSCLC) (Zhang et al. 2017). By using reverse transcription-quantitative polymerase 
chain reaction, the study validated the over expression of plasma miR-145, miR-20a, 
miR-21 and miR-223 in 129 NSCLC patients compare to 83 healthy controls. 
In 2019, Gablo et al. gave evidence that plasma miR-21, miR-210, miR-155, and miR-
196a levels in blood can distinguish with high sensitivity and specificity pancreatic 
ductal adenocarcinoma (PDAC) patients from healthy controls (Gablo et al. 2019). 
Following that, in 2019, another study reported plasma miR-195 to be significantly 
under-expressed in patients with metastatic breast cancer, compared to healthy 
controls (Mcanena et al. 2019). 
The most recent study, in 2020, analysed 102 breast cancer patients at diagnosis and 
after treatment together with 15 healthy women (Anwar et al. 2020). By using 
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quantitative reverse transcription polymerase chain reaction (qRT-PCR), over 
expression of circulating miR-155 from patients’ plasma was reported. The study 
uncovered the potential use of circulating miR-155 as a clinical biomarker in breast 
cancer (Anwar et al. 2020). References to other cancer-related circulating miRNAs are 
displayed in Table 1.1, which presents groups of miRNAs in serum/plasma and their 
relation to different cancer cases. Once thought to be unstable, miRNAs proved their 
stability in serum/plasma such that establishing an extremely promising approach for 
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1. 6 Key challenges to detection of circulating miRNA 
Prior to the implementation of miRNA sensing technology for clinical applications, 
there are a number of technical challenges to be addressed. The most critical one is the 
low and undefined level of miRNA in blood to detect (Gillespie et al. 2019). The 
literature review in previous chapter reveals the fact that the changes to specific 
miRNA levels in serum/plasma were defined as up- or down regulation between 
healthy controls and patients with disease state. There are no records stating the actual 
concentration of miRNA in healthy biological samples and the change of this 
concentration in disease state. This could be attributed to the lack of standardised 
protocols for separation of miRNAs, their processing and quantification. Hence, this 
makes it extremely difficult to carry out quantitative comparisons between the studies 
reported in literature due to the slightly different conditions of each study. Although, 
there is no reliable answer to the question of what the exact quantity of miRNA in 
blood is, the method of normalisation could be of extreme help for the quantification 
of miRNA as biomarkers. Upon defining a strict level of control (mean value of 
miRNAs in blood derived from healthy controls that would take into account the 
miRNA fluctuations influenced by diet, physical activity, etc.) more reliable analysis 
could be made by evaluating the variations of the miRNAs compared to the normalised 
levels. Other challenges are the short sequence length of miRNAs and the high 
sequence homology within the family of miRNAs. Hence, there is the requirement for 
highly specific sensors that can distinguish between miRNAs that possess single base 
mismatch. 
 
1. 7 Sensors and biosensors 
A sensor, in its broadest definition, is a device that detects or measures a physical 
property or change, and provides a resulting output/measurement in return (OED 
2019). Sensors can be classified into three types: chemical, physical and biosensors. 
Physical sensors deal with measure of physical quantities such as weight, temperature, 
length, electricity, pressure, etc. A chemical sensor on the other hand, has a chemical 
or molecular target to measure. Chemical sensors are defined as “devices which 
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respond to a particular analyte in a selective way through chemical reaction and can 
be used for qualitative or quantitative determination of the analyte” (Sang et al. 2013). 
Biosensors are considered as a sub-set of chemical sensors, however, they are most 
often regarded as a topic in their own right. A biosensor is a device that detects an 
analyte and in doing so it combines a biological component with a physiochemical 
detector component. The general biosensor architecture is represented in Figure 1.7 
which can be divided into three main bodies (Sang et al. 2013): 
1. Bioreceptor: The sensitive biological recognition layer that can selectively 
bind to analyte. This is usually achieved by functionalisation of an electrode 
surface with a bio-receptor molecule. The bio-receptor molecule (e.g. DNA, 
aptamer, antibody) acts as a capture probe that binds to a target. 
2. The transducer: The detector element that can work in optical (Haes 2002), 
mass sensitive (Janshoff et al. 2000), electrochemical (Cass et al. 1984), and 
many other ways that can convert the signal induced by the biological 
interactions into a measurable signal. 
3. The signal processor: This is the part that enhances the signal and generates 




Figure 1. 7 Biosensor Architecture. Typically, the analyte is recognised by a specific 
biological recognition layer (bioreceptor) at the sensor interface. A transducer 
element converts the change in the properties of a recognition layer into quantifiable 
signal. The signal is further amplified and converted into readable signal by the 
output device (Sang et al. 2013; Jolly 2016). 
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A broad range of methods can be adopted for the development of biosensors and the 
biosensor efficiency can be assessed by important parameters listed in Table 1.2. 
 
Table 1. 2 Parameters for biosensor performance assessment (Hammond 2017) 
Parameter Statement 
Sensitivity Ratio between the output signal and measured 
property 
Selectivity Capability of the biosensor to selectively 
distinguish the analyte in a mixture of 
biomolecules. 
Limit of detection (LOD) Expressed in units of concentration, LOD 
indicates the smallest concentration of analyte 
that can be reliably distinguished by the sensor 
from a sample without the analyte. 
Dynamic range Range between the minimum and maximum 
levels of detection. 
Reliability Functioning correctly with predictable 
performance at specified conditions. 
Size/Miniaturisation The sensor must have applicable size for 
transport, point-of-care use and storage.  
Ease of use Ease of operation leads to dramatic reduction on 
the risk of user error  
Sample preparation Minimum requirement for sample preparation 
reduces cost, sample loss, time and 
experimental difficulty 
Cost Crucial factor for the viability of the product 
 
An example of a commonly used electrochemical set up comprises of a cell with a 
three-electrode configuration, which are the working electrode (WE), reference 
electrode (RE) and a counter electrode (CE), placed in an electrochemical solution. 
The WE is the recognition interface which is functionalised with a biological probe 
that specifically binds to the target molecules. Voltage potentials are set between the 
WE and the RE and the current flow is monitored between the WE and the CE. The 
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main benefit of introducing the RE is for stabilizing the voltage between the WE and 
the RE. Hence, such a configuration allows the establishment of the potential of the 
WE against the RE without compromising the RE stability by passing a current 
through it (Wang 2006). 
 
                               
 
Figure 1. 8 Electrochemical cell in three-electrode configuration. RE, WE and CE 
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1.7. 1 The ideal biosensor for microRNA sensing 
Before the definition of the ideal miRNA biosensor, a clear definition is required for 
its use. The requirements of a biosensor for point-of-care use varies significantly from 
laboratory use. There are many compelling laboratory methods that already exist for 
miRNA detection. Quantitative reverse transcription PCR (RT-qPCR) is known as the 
gold standard (Gillespie et al. 2019), together with other powerful techniques such as 
northern blotting and next generation sequencing. PCR-based technologies are well 
established with their ability to detect sequences of various lengths, and any new 
technology must therefore possess significant advantages in order to compete with 
current technology.  
On the other hand, for point-of-care use, an optimal biosensor should be easily usable 
by someone who has minimal training, require no sample preparation, have a long 
shelf life, be easy to store, and fit for diagnostic purposes. The most crucial 
requirement is the validation of the fabricated miRNA biosensor with clinical samples, 
which reflects the actual ability to transfer the biosensor into a technology that is usable 
within the field. In this thesis, the main focus will be given on the development of a 
point-of-care device for miRNA sensing. 
 
1. 8 Hybridisation based recognition of miRNA 
Molecular recognition is commonly adopted in electrochemical detection and the 
molecular recognition of miRNA is most generally achieved by adopting 
deoxyribonucleic acid (DNA) oligonucleotide or synthetic mimics of DNA, and the 
recognition is achieved through complementary Watson-Crick base-pairing. The 
chemical structure of an oligonucleotide is composed of phosphodiester (phosphate 
group) linkage between its bases and the backbone is made up of alternating phosphate 
and sugar (ribose in RNA and deoxyribose in DNA) residues (Rothenberg et al. 1989). 
However, the unmodified/natural DNA has several limitations that prevent their use in 
medical applications. Their phosphate group that forms the bridge between bases is a 
substrate for DNases and is usually cleaved before even reaching the target, they also 
lack target specificity. Moreover, DNA is not able to enter cells rapidly due to its large 
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and highly charged nature (Pierre Murat et al). Hence, the studies were targeted on 
solving these issues and synthetic analogues of DNA were developed where the 
phosphate backbone was subjected to a variety of chemical modifications. Synthetic 
oligonucleotide analogues represent a valuable alternative to standard DNA or RNA 
(Bala & Gorski 2016). 
Such DNA mimics offer the opportunity for rebuilding the specificity and affinity of 
hybridisation with natural DNA and RNA. The modifications can enhance the desired 
signal against a background of competing interactions which is of a strong interest for 
medical applications (Levicky et. al). In this section we will be introducing selective 
probes that include locked nucleic acids (LNAs), peptide nucleic acids (PNA), 





Figure 1. 9 Structures of natural and modified oligonucleotide backbones: (A) 
natural phosphodiester, DNA; (B) morpholino; (C) locked nucleic acid (LNAs); (D) 
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1.8. 1 Locked nucleic acids (LNA) 
One nucleic acid analogue that is known for displaying extraordinary hybridisation 
affinity towards complementary DNA and RNA is locked nucleic acid (LNA). Several 
reports have revealed LNA as promising tool for the development of oligonucleotide-
based detection particularly for the recognition of RNA (Petersen & Wengel 2003; 
Kaur et al. 2006; Natsume et al. 2007b; Natsume et al. 2007a). The melting 
temperatures (Tm) of LNA-RNA and LNA-DNA hybrids are respectively 2–10˚ C and 
1–8˚ C higher than those of DNA–RNA and DNA–DNA (Natsume et al. 2007a). The 
enhanced affinity is a result of the modified chemical structure of LNA, in which the 
furanose ring of the ribose sugar is chemically locked by the introduction of a 
methylene linkage between O2 and C4′ (Laschi et al. 2009). Hence, the resulting 
covalent bridge ends up to be an effective lock of the ribose in the N-type (3-endo) 
conformation that is dominant in A-form DNA and RNA. The improved affinity 
results from the conformation that enhances base stacking and phosphate backbone 
pre-organisation. These properties make LNA well suited for miRNA detection and 
analysis for cancer diagnostics. Hence, LNA probes were successfully applied for the 
optimisation of miRNA northern blot analysis, allowing sensitive and highly specific 
detection (Valoczi et al. 2004; Varallyay et al. 2007). A sensitive microarray platform 
for genome-wide profiling of mature miRNAs (miChip) was developed by utilising 
LNA modified capture probes (Castoldi et al. 2006). Moreover, LNA-probes were 
successfully applied for in situ detection of miRNA accumulation in developing 
animal embryos and in tissue sections (Wienholds et al. 2005; Silahtaroglu et al. 2007; 
Obernosterer et al. 2007; Sempere et al. 2007). 
 
1.8. 2 Peptide nucleic acids (PNA) 
Peptide Nucleic Acid is another class of DNA mimic which comes with neutral charge 
and a high affinity for hybridisation with single strand DNA (Egholm et al. 1992; 
Wang 1998; Nelson et al. 2000). Being first invented by a group of researchers from 
the University of Copenhagen in 1991 (Nielsen et al. 1991) their charge neutrality was 
achieved by replacing the negatively charged specific backbone phosphate groups of 
DNA by a polyamide backbone. This model of protein-induced bending for neutrality 
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of DNA, has also been tested by several later studies in 1997/98 (Strauss-Soukup et al. 
1997; Strauss-soukup & Maher 1998), where strategically placed polyamide 
backbones could induce bends of 3–4° per base pair in DNA. Such that the charge-
neutralisation-induced DNA bending provides significant contribution to the binding 
energetics of protein recognition processes (Strauss-soukup & Maher 1998; Okonogi 
et al. 2002). The higher binding energetics is a result of the lack of electrostatic 
repulsion present in the hybridisation of PNA: DNA compared to DNA: DNA or DNA: 
RNA. In addition, PNA displays excellent stability (chemical, biochemical, thermal) 
when used as probes, making them ideal capture tools. 
Providing a shift from a completely neutral platform to a negatively charged one upon 
hybridisation, PNA became an ideal candidate for electrochemical detection assays. 
These studies that use the surface charge variations of hybrid assays as their detection 
methodology, produced excellent results when adopting PNA as the capture probes for 
DNA recognition; e.g. field effect transistors (FET) (Aoki et al. 2000), electrochemical 
impedance spectroscopy (EIS) (Keighley et al. 2008), nanopore sensors (Jagerszki et 
al. 2007; Ali et al. 2010), and channel sensors (Aoki et al. 2000). It was not long ago 
that the same strategy was adopted by Jolly et al. (Jolly et al. 2016) for the development 
of a sensitive electrochemical detection platform for miRNA detection where fM 
detection limits were achieved. 
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Figure 1. 10 Chemical structure model of PNA (sequence N-GTA-C) hybridised in 
antiparallel orientation with its complementary DNA (sequence 5-TAC-3) (Nielsen 
et al. 1991) . 
 
 
1.8. 3 Morpholinos (MOs) 
First discovered in 1985, morpholinos are another a class of synthetic nucleic acid 
mimics with an uncharged nature (Summerton & Weller 1993; Summerton et al. 
1997). Such a property is anticipated to strongly affect the hybridisation rules that 
construct their emerging applications based on solid-phase hybridisation for diagnostic 
applications (Tercero et al. 2009; Gao & Ting 2009; Wang & Smirnov 2009; Zhang et 
al. 2010). The subunit of a morpholino comprises of a nucleic acid base, a morpholino 
ring, and a non-ionic phosphorodiamidate intersubunit linkage. In contrast to PNA that 
is also neutrally charged, Morpholino comes with a flexibility in length synthesis. The 
reduced constraint on sequence length provides essential flexibility for applications in 
gene expression or pathogenic identification which adopt lengths of up to 70 nt 
(Hughes et al. 2001; Bodrossy & Sessitsch 2004). Additional properties that make it 
excel include; stability, nuclease-resistance, long-term activity, efficacy, water 
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solubility, low toxicity, and exquisite specificity in comparison to PNA and DNA 
(Zhang et al. 2010). In 2009 Tercero et al. reported the construction of Morpholino 
monolayers on a gold surface and the hybridisation of Morpholino with DNA on the 
surface (Tercero et al. 2009). The same year, Gao & Ting adopted a Morpholino 
oligomer as a capture probe and in combination with a redox polymer for the 
ultrasensitive detection of DNA achieving a detection limit of 1 pM (Gao & Ting 
2009). Recently, in 2017, one study demonstrated a phosphorodiamidate morpholino 
oligos (PMO)-functionalised nanochannel biosensor for the label-free detection of 
miRNAs (Zhang et al. 2010; Liao et al. 2017). The nanochannel-based biosensor 
attained a reliable and low limit detection in PBS followed by a 10 fM limit of 
detection in serum. Hence, it is expected that such a new methodology will benefit 
miRNA detection in clinical diagnosis. 
 
1.8. 4 Hexitol nucleic acids (HNA)  
When compared to DNA, the chemical structure of hexitol nucleic acid (HNA) is 
modified by inserting an extra methylene group in the backbone between C1′ and O4′ 
of the â-D-2′-deoxyribose unit (Declercq et al. 2002). Hence, HNAs end up forming 
quite stable self-complementary duplexes as well as stable duplexes with their natural 
components (Hendrix et al. 1997). The resulting duplexes have the nucleic acid A 
structure with complementary DNA or RNA oligomers and the experiments 
investigating the melting temperatures and the gel shift analysis revealed the following 
order of duplex stability: HNA-HNA > HNA-RNA > HNA-DNA (Kozlov et al. 1999). 
The study of HNA duplex structure offers new insights into how sugar modifications 
can lead to the stabilisation of duplex structures, and provides valuable information for 
the design of various backbone modifications for innovative properties. The interest in 
such properties arises especially because of the capability to induce selective inhibition 
of gene expression for diagnostic applications. Furthermore, the promising structural 
modification of HNAs makes them an interesting tool for nucleic acid diagnostics. The 
enhanced hybridisation properties with DNA and RNA targets makes it worthwhile to 
investigate their use more meticulously. Moreover, such properties make them an 
exciting tool for the development of innovative methodologies for high mismatch 
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discrimination within the field of electrochemical detection of target DNA and RNA 
(Abramov et al. 2008). 
 
1. 9 Electrochemical sensing methodologies for 
microRNAs 
As of now, the most common methods of miRNA detection have been via; cloning, 
northern blotting, microarray or qRT-PCR, and next-generation sequencing (Chen et 
al. 2005; Lautner & Gyurcsµnyi 2014; Lee et al. 2010). However, most of these 
methods come with drawbacks, such as having either low throughput, low sensitivity 
of detection, or requiring   considerable time and effort for sample handling and 
detection protocols (Lautner & Gyurcsá 2014). 
Electrochemical detection is considered to be a cost-effective alternative to today’s 
well-established methods due to their high sensitivity and adoption of simple 
instrumentation that is applicable to microfabrication technology (Zayats et al. 2002; 
Ruan et al. 2002; Yang et al. 2004; Xu et al. 2005). A typical electrochemical biosensor 
consists of an electrode surface immobilized with short-single stranded nucleotides, 
that are complementary to the target, and electroactive hybridisation indicators. The 
performance of the electrochemical biosensors is dependent on the hybridisation 
efficiency between the probe and the complementary target sequence (Hamidi-asl et 
al. 2013). The novel approach of electrochemical detection platforms for miRNA only 
started in 2009 (source: Web of Science™) and has showed an increasing trend in 
publications since the first breakthrough. All of the electrochemical miRNA detection 
studies presented in the literature rely on hybridisation. 
Owing to their cost effectiveness, very high sensitivity and proven compatibility with 
point-of care devices, electrochemical detection presents a clear niche for miRNA 
detection (Hamidi-asl et al. 2013; Lautner & Gyurcsµnyi 2014; Jolly et al. 2015; Jolly 
et al. 2016). The following sections, will introduce some methodologies that are 
adopted in electrochemical detection for enhancement of nucleic acid (e.g. miRNA) 
detection. 
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 1.9. 1 Electroactive intercalators 
Intercalators are molecules that selectively insert themselves into base pairs of double-
stranded oligonucleotides (Gillespie et al. 2019). This property of intercalators is 
utilised in electrochemical detection for the recognition of hybridised duplexes and as 
an amplification step after the capture of the target oligonucleotide (Gaiji et al. 2017). 
The hybridised duplex (Figure 1.11) is monitored by an electroactive intercalator that 
can be easily reduced/oxidised on the surface. Some examples of intercalators that 
were used for miRNA sensing are: oracet blue, methylene blue and toluidine blue (Li 
et al. 2015; Azimzadeh et al. 2016; Rafiee-Pour et al. 2016; Guo et al. 2018a; Tian et 
al. 2018a). On the other hand, our study of the literature reports on the adoption of a 
naphthalene diimide intercalator bearing ferrocene moieties (FND) for the recognition 
of DNA (Figure 1.11). The electrochemical signal of the ferrocene molecules tagged 
on the FND intercalator were utilised to monitor the DNA recognition after selective 
binding of the intercalator with the PNA-DNA duplex (Gaiji et al. 2017). Differential 
pulse voltammetry was adopted to evaluate the oxidation potential of the FND 
intercalator related to its interaction with a complementary PNA-DNA hybrid. The 
oxidation peaks of the ferrocene, demonstrated a good linear dependence on DNA 
concentration in the range 1 fM to 100 nM of target DNA, with a low detection limit 
of 11.68 fM. The selectivity of the response was approved by an investigation with a 
non-complementary DNA sequence, which indicated the selective response of the 
FND intercalator to the target PNA-DNA duplex. Similar methodology can be adapted 
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Figure 1. 11 Schematic representation of the Fc-tagged intercalator based biosensor 
for detection of DNA by using PNA-probe. (a) Steps for PNA-DNA hybridisation (b) 
FND binding with PNA-DNA duplex (Gaiji et al. 2017). 
 
1.9. 2 Redox Labelling 
The concept of redox labelling a target sequence prior to detection has been an 
alternative approach in electrochemical detection of miRNA. Such methodology is 
carried out in a couple steps and requires the labelling of miRNA prior to analysis. In 
a representative study, miRNA was initially labelled with the electroactive complex of 
osmium(VI) and 2,2′-bipyridine (Os(VI)bipy) which specifically attaches to the ribose 
at the 3′-end of the miRNA (Bartosik et al. 2014). This was then followed by the 
hybridisation of the labelled miRNA target with a DNA capture probe that is 
complementary to target. The detection of miRNA was then carried out at hanging 
mercury drop electrode at the femtomole level (fM, 10-15 M) as a result of the 
electrocatalytic nature of the peak from the electroactive complex (Os(VI)bipy) 
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(Bartosik et al. 2014). However, such methodologies come with a significant drawback 
of the requirement for sample preparation that is not ideal for point-of-care 
applications. 
 
1.9. 3 Modifications with nanoparticles 
Metal nanoparticles possess unique physiochemical properties depending on their size 
and material, easy and simple functionalisation, conductance and a high surface to 
volume ratio (Jolly et al. 2017).  All noble metals, heavy metals, iron and metal oxides 
such as titanium dioxide are examples for metal nanoparticles. Gold nanoparticles 
(AuNPs) are the highlighted examples as they are the most extensively studied 
nanomaterial, and led to the development of numerous methods for molecular diagnostics, 
imaging, drug delivery and therapeutics because of their unique properties (Doria et al. 
2012). Although there are many applications for nanoparticles, their use in 
electrochemical sensing can be classified into a couple of categories based on their 
mode of action: expanding the electrode surface area, binding to biological probes for 
signal enhancement and acting to raise the concentration of the analyte (Jolly et al. 
2017). 
Expanding the surface area is an effective method to increase the amount of probes 
immobilised. For example, AuNPs can be immobilised on different carbon-based 
matrices such as a carbon nanotube, graphene or graphene oxide; gold surfaces or others 
polymers (Sardar et al. 2009). This raises the amount of probes immobilised, especially 
thiol molecules which have a high affinity to bind with AuNPs. Due to increased amount 
of probe, the amount of biomolecules anchored are raised resulting in an amplification of 
signal. Furthermore, AuNPs or other metal NPs can be used to mediate reactions 
amplifying the signal. For instance, capture probes can be initially immobilised on a 
substrate and then AuNPs modified with target probes are introduced for specific 
recognition, resulting in signal amplification (Jolly et al. 2016). 
On the other hand, magnetic micro- and nanoparticles are other frequently used nano-
particles in order to pre-concentrate target miRNAs from a sample (Li et al. 2015; 
Azimzadeh et al. 2016; Rafiee-Pour et al. 2016; Guo et al. 2018a; Tian et al. 2018a; 
Wang et al. 2013a; Zhu et al. 2014; Bartosik et al. 2014; Zhang et al. 2016; Koo et al. 
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2016; Islam et al. 2018; Boriachek et al. 2018). Magnetic beads are particles that are 
under the control of a magnetic field (Yáñez-sedeño et al. 2016; Gómez-pastora et al. 
2017). They are released into a biological sample, where time is allowed for 
hybridisation with target miRNA and then the beads are separated by the use of a 
magnet. Then the target miRNA is removed from the surface of magnetic beads either 
by heating or utilizing a magnetic electrode in order to concentrate magnetic beads at 
the surface. Hence, magnetic beads offer a valuable and effective method for sample 
preparation and separation of miRNA from complex samples. 
 
1.9. 4 Enzyme-based detection 
Electrochemical biosensors that are based on enzymes, are the oldest and most 
established biosensors following their commercialisation after the first glucose test in 
PoC format. For the case of miRNA detection, enzymes are employed as an 
amplification step via a sandwich sensor design. Recently, several studies reported the 
adoption of an enzymatic reaction for the recognition of a hybridisation event between 
the probe and miRNA targets. A representative study in literature initially immobilized 
a capture probe 1 on a gold electrode through Au—S (Gold-thiol) interaction (Mandli 
et al. 2017). In the presence of target miRNA, the capture probe 1 hybridised with part 
of the target. The second part of the target, on the other hand, hybridised with a 
biotinylated capture probe 2. This was followed by the immobilisation of a 
streptavidin-conjugated enzyme (such as alkaline phosphate) on the biotinylated 
capture probe 2 via biotin-streptavidin interaction (Mandli et al. 2017). The miRNA 
detection was achieved through monitoring the variations in α-naphtol 
oxidation signals, as the enzyme (SA-ALP, streptavidin-conjugated alkaline 
phosphatase) catalyses the electro-inactive α-naphtyl phosphate to an electro-active α-
naphtol (Mandli et al. 2017). Under the optimal detection conditions, the fabricated 
biosensor performed selective and sensitive detection with a detection limit of 100 pM. 
There are many other similar studies that adopt various types of enzymes such as 
horseradish peroxide (HRP), alkaline phosphatase and glucose oxidase (Gao 2012; 
Bettazzi et al. 2013; Campuzano et al. 2014). 
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Figure 1. 12 Principle of the enzyme-based electrochemical biosensor for miRNA 
detection. Re-created from (Mandli et al. 2017). 
 
 
1.9. 5 Electrocatalytic oxidation of guanine 
The label-free electrochemical detection of miRNA (or DNA) hybridisation based on 
a guanine moiety oxidation signal of the probe (or target) in electrochemical sensors, 
seems to be simple, faster, and more applicable in comparison to other methods 
(Hamidi-asl et al. 2013). In the most commonly adopted label free oligonucleotide 
biosensors, there is no guanine base in the probe sequence, they are replaced by several 
cytosines. Hence, the electrochemical signal is enhanced during hybridisation with 
targets containing several guanine bases (Raoof et al. 2011). An inventive 
electrochemical approach was reported in 2009 for the early detection of miRNAs, it 
presented an electrochemical detection based on guanine oxidation which is a 
consequent of the hybrid formation between the miRNA and its inosine substitute 
capture probe (Lusi et al. 2009). Differential pulse voltammetry was adopted for 
generating an electrical signal for the oxidation of guanine during the hybrid formation 
on the surface of the electrode. Such a method is label free and does not require 
labelling of miRNA with any substances. However, the sensitivity of the assay was 
poor with a detection limit of 0.1 pmol. 
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Intercalator    
DPV 1.5 x 10-17 Spiked in 
plasma 
(Guo et al. 2018b) 
DPV 3.3 x 10-17 Serum (Tian et al. 2018b) 
DPV 8.4 x 10-14 - (Rafiee-Pou et al. 2016) 
Redox Labelling    
SWV 1 x 10-17 50% diluted 
blood 
(Tavallaie et al. 2018) 
DPV 
 




(Zhang et al. 2018) 
 
CV 5x 10-16 - (Mohammadniaei et al. 
2017) 
DPV 10-15 - (Bartosik et al. 2013) 
Modification  with nanoparticles   
DPV 3.7 x 10-16 - (Jolly et al. 2016) 
DPV 1.92 x 10-15 Cell lysates (Wang et al. 2017) 
Enzyme-based    
CV & CA 2.2 x 10-19 Spiked 
saliva 
(Wang et al. 2013b) 
DPV 10-15 - (Mandli et al. 2017) 
CV 0.4 x 10-15 - (Campuzano et al. 
2014) 
Guanine oxidation    
DPV 10-12 - (Li et al. 2014) 
DPV 6.82 x 10−10 - (Raoof et al. 2011) 
DPV 7.27 x 10-12 - (Eksin & Erdem 2018) 
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With the current technology, many novel electrochemical detection methodologies are 
developed upon exploiting exciting molecular mechanisms as listed in Table 1.3. Most 
of these techniques are quite sensitive, however they incorporate different ideas in 
order to achieve low limits of detection. This adds up in the number of experimental 
steps required and it becomes more challenging to justify the advantage of each step. 
On the other hand, some of these methods require pre-labelling of target sequence that 
is not applicable for clinical use and point-of-care applications. Creating a simple 
electrochemical biosensing design which yields an ultrasensitive and direct detection 
of miRNA still remains a challenge. 
 
1. 10 General overview of the project 
This particular thesis is based on a project entitled “Electrochemical detection of 
microRNAs for cancer diagnosis”. The principal aspect of the current work is to study 
circulating miRNAs as cancer biomarkers, then investigate the design and 
immobilisation techniques of oligonucleotide-based capture probes for the 
development of direct electrochemical detection platforms. The study draws attention 
to the availability of a broad range of miRNAs in circulating blood as cancer 
biomarkers. Particular attention is given to miR-21-5p throughout our study, which is 
a pancreatic cancer specific circulating miRNA. In parallel, this thesis investigates the 
efficient separation of miRNA from biological samples and the design of redox active 
self-assembled monolayers that offer label-free detection. 
The following points will be highlighted with this thesis: 
1. In Chapter 3, use of electrochemical impedance spectroscopy for the 
development of highly sensitive and direct detection platforms for miRNA, 
which requires no additional amplification steps, is investigated. Chapter 3 
also investigates the adoption of Peptide Nucleic Acids as capture probes for 
improved affinity (and specificity) to target miRNA and the crucial role of 
surface chemistry optimisation for highly sensitive and direct (label-free) 
detection. 
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2. Chapter 4 presents a new method for efficient separation/fishing of target 
miRNA from complex solutions prior to detection. Such a strategy is crucial 
for pre-concentration of the target, hence for further amplification of the 
detection that is presented previously in Chapter 3. 
3. In Chapter 5, redox active self-assembled monolayers and their adoption in 
design of oligonucleotide-based detection probes for label-free detection is 
investigated. Such a methodology comes with a major advantage of 
eliminating the need for doping of the measurement solution that is required 
for the measurements presented in previous chapters. Hence, the final results 
chapter investigates further improvement of the methodologies presented in 
chapters 3 & 4. 
 
All in all, a highly-sensitive and direct electrochemical detection of miRNA is 
presented in Chapter 3. This is followed by a new method that is demonstrated in 
Chapter 4 in order to overcome the difficulty of direct detection of miRNA from 
serum. Hence, Chapter 4 looks into further improving the direct electrochemical 
detection presented in Chapter 3. Finally, in Chapter 5 a redox active self- assembled 
monolayer is investigated for label-free and capacitive based detection. If successfully 
implemented, such biosensor eliminates the need for doping of the measurement 
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Chapter 2 Principles and Methods 
 
This chapter provides an insight into the immobilisation of oligonucleotide based 
probes on the electrode surface, and particular attention is given to the self-assembled 
monolayers that are extensively adopted in our experimental work. In addition, this 
chapter presents the technical details behind electrochemical techniques, with a focus 
to the ones adopted in our experimental studies (Cyclic Voltammetry, Electrochemical 
Impedance Spectroscopy and Differential Pulse Voltammetry). Part of the work 
presented in this chapter is published in Jolly et al. (Jolly et al. 2017) where the main 
contributions to the study were made in the analysis of different strategies available 
for immobilisation of bio-recognition probes on the electrode surface, and the adoption 
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2. 1 Methods of immobilisation 
One of the key factors to account for in order to construct a successful biosensor is the 
design of the surface chemistry. The success of the fabricated biosensor highly 
depends on the surface engineering that is the initial step of the fabrication process. 
The design of the surface chemistry requires a decision being made on an 
oligonucleotide-based probe that is specific to the target, hence resulting in high-
affinity binding. This is followed by the immobilisation of this probe on the electrode 
surface. An appropriate control of the immobilisation of the probe is crucial for 
establishing a good sensitivity, selectivity, and stability of the biosensor (Campuzano 
et al. 2006). Immobilisation methodologies can be classified into four groups: physical 
adsorption, covalent binding, affinity, and entrapment. An insight into the advantages 
and drawbacks of these techniques are provided in Table 2.1. There have been many 
reported studies on the utilisation of different electrode surfaces for immobilisation, 
such as graphene, glassy carbon, carbon nanotubes, gold nanoparticles etc. However, 
the work in this thesis adopts a gold electrode surface for the fabrication of the 
biosensor. 
 
2.1. 1 Self-assembled monolayer 
A broad range of methods have been reported for the immobilisation of 
oligonucleotide-based probes, depending on the electrode surface and application. 
However, the most commonly reported techniques specifically for gold electrode 
surfaces are self-assembled monolayers (SAM), due to their highly controlled density 
and thicknesses on the transducer surface (Hong et al. 1999). The key condition to take 
into consideration for the immobilisation of oligonucleotide-based probes on a gold 
electrode surface is to have an optimum density (Keighley et al. 2008). Thiols, 
sulphides and disulphides have demonstrated a very high affinity for gold by forming 
a covalent bond between the sulphur and gold atoms, making alkane thiol-based SAMs 
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When sulphur comes in close contact with gold, the following reaction takes place:
   
                                      RSH + Au ↔ RS ─ Au + H+ + 𝑒 - 
The reaction is spontaneous leading to 80%-90% coverage in the first few minutes. 
However, the formation of a well organised layer takes up to 12-16 hours (Schreiber 
2000). The formation of well-organised SAMs is not only dependent on factors such 
as the presence of contaminants, and surface quality (roughness and purity), but also 
on the length of alkanethiols (Finklea 1996). The better kinetics for longer alkyl thiols 
could be attributed to amplified van der Waals interactions (Darling et al. 2002). The 
maximum density of alkane thiol on a gold surface was defined to be 4.64 × 1014 




Figure 2. 1 Schematic representation of SAM formation on gold electrode surface. 
Re-created from Love et al. 2005. 
 
The formation of a well-organised SAM undergoes two main steps. There is 
spontaneous assembly within the first couple minutes. Initially, alkane thiols lie flat 
on the gold electrode surface through physical adsorption, this is referred to as the 
‘lying-down’ phase (Camillone et al. 1994). This is followed by a chemisorption 
process where a crystalline or a semi-crystalline structure is formed due to van der 
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Waals forces resulting in lateral movement until a tilt angle of about 30° between the 
hydrocarbon chains is achieved (Love et al. 2005). The ability of thiols to move 
laterally along the gold surface leads to the formation of well-ordered layering, and the 
healing of defects (Ulman 1996). In such a process, the properties of the SAM are 
highly affected by the terminal groups of the alkanethiol that define the SAM’s 
interactions with biological molecules. For instance, a carboxylate group can be used 
to covalently bind an antibody by using ethyl (dimethylaminopropyl) carbodimiide 






Figure 2. 2 The chemical reaction scheme for the coupling of a ligand to the surface 
of a gold electrode. At the first step (Step 1), the terminal carboxyl group of the SAM 
that is immobilised on gold electrode surface is activated by EDC/NHS. This is 
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followed by the covalent attachment of the ligand by its primary amine, NH2 (Step 2). 
In this scheme R stands for oligonucleotides or aptamers (Sam et al. 2010). 
 
 
SAMs allow researchers to engineer novel and controlled biosensor designs as a result 
of offering the opportunity of having diverse functional terminal groups. SAMs have 
been adopted to immobilise various molecules from DNA aptamers (Jolly, Formisano, 
et al. 2019), peptides  (Laurent et al. 2008), biological enzymes (Fang et al. 2003) to 
metals such as gold nanoparticles (Bertok et al. 2013), copper (Nishizawa et al. 1997) 
etc.) and more. Furthermore, in Chapter 5 we will discuss the adoption of a ferrocene 
tagged SAM on the gold substrate to fabricate biosensors. The modification of SAM 
layers have resulted in the establishment of such mixed SAMs (composed of a redox 
layer with an antibody receptive component) which offers direct capacitive analysis of 
target recognition (Santos et al. 2015). The effect of DNA probe density on 
hybridisation efficiency by using co-immobilised binary SAMs on gold electrodes was 
demonstrated in 2008 (Keighley et al. 2008a). Moreover, in 2010 studies (Wu et al. 
2010) reported a ternary SAM on screen printed gold electrodes as a potential 
antifouling SAM for amperometric detection of oligonucleotides. Careful selection of 
the spacer molecules within a SAM would lead to the desired hydrophobicity or 
hydrophilicity as well as significant chemical reactivity. Therefore, such an approach 
could block non-specific binding and enhance the electrochemical signals (Herne & 
Tarlov 1997). 
 
2. 2 Electrochemical techniques 
2.2. 1 Electrode-solution interface 
Before describing electrochemical set ups and measurements it is crucial to understand 
what happens at the electrode/solution interface. Two types of processes are observed 
at the electrode surface, one in which charges (electrons) are transferred across the 
metal-solution interface (Faradaic process), and the other one where there is no transfer 
of charges but charge is progressively stored in the metal-solution interface (non-
Faradaic process) (Bard & Faulkner 1980). The processes of oxidation and reduction, 
which are electron transfer based reactions, take place at charge-transfer electrodes. 
C h a p t e r  3                                            P a g e  | 51 
 
   
Since these reactions are controlled by Faraday’s law (the amount of chemical reaction 
caused by the flow of current is proportional to the amount of electricity passed), they 
are called Faradaic processes. Under some conditions, the charge transfer reactions are 
thermodynamically or kinetically unfavourable at a range of potentials. However, 
there will still be adsorption and desorption processes and these are called non-
Faradaic processes. 
For an ideal polarised electrode, no charge transfer across the metal-solution interface 
would take place regardless of the potential applied by an outside source of voltage. 
As a result, it is characterised by an absence of net current between the electrode 
surface and the electrolyte (Bard & Faulkner 1980). Since, no charge can pass across 
the interface when the potential is altered, the behaviour of the electrode-solution 
interface is comparable to that of a capacitor. A capacitor, in its most basic form, is an 
electrical circuit element that consists of two parallel conductive (metal) plates which 
are separated by a dielectric material. The behaviour is governed by the following 
equation; 




 = C                                  Equation 2. 1 
Where q is the charge on the capacitor (in coulombs, C), E is the potential across the 
capacitor (in volts, V) and C is the capacitance (in farads, F). The capacitors ability to 
store charge, q, between its metal plates is proportional to the applied voltage E, for a 
known capacitance in Farads. A current, referred as charging current, will flow during 
this charging process. The interface of the electrode and solution has been presented 
experimentally to behave like a capacitor (Bard & Faulkner 1980). Hence, the 
interfacial region can be modelled resembling a capacitor. The specific capacitance C 
of an electric double-layer capacitor is evaluated analogous to a plate capacitor and is 
describe with the equation: 
 
C =  
εrε0 A
d
                                          Equation 2. 2 
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Where A is the electrode surface area, d is the charge separation distance (i.e., the 
distance between the adsorbed ion and the electrode surface), ɛr is the dielectric 
constant of the electrolyte and ɛ0 is the permittivity in vacuum, respectively. The 
charge on the metal, whether it is going to be negative or positive with respect to the 
solution, is dependent on the potential across the interface and the composition of the 
solution. At the contact interface of two different phases of electrode surface and 
liquid, positive and negative charges are arrayed at counter positions with an extremely 
short distance (e.g. atomic distance). Such charge layers are referred to as the electric 
double layer. Since the first introduction of the double layer model, referred to as the 
Helmholtz model (Helmholtz 1879) (Figure 2.3a), there has been a significant 
evolution of the theories in history that reflect the model of a double layer that we 
acknowledge today. Helmholtz, who was the first to think about charge separation at 
interfaces, proposed the first model of the double layer (Bard & Faulkner 1980). The 
model considered the ordering of positive and negative charges in a rigid fashion on 
the two sides of the interface and recognised no interactions stretching into solution. 
Such a structure is similar to a parallel-plate capacitor where the relation between the 





 V                                          Equation 2. 3 
Where 𝜀 is the dielectric constant of the medium, 𝜀0is the permittivity of free space 
and d is the distance between the two plates. Hence, differential capacitance (Cd) is; 
                                                                                                                                                                                                              
                                        
𝜕σ
𝜕𝑉
 = Cd = 
εε0
d
                        Equation 2. 4 
However, the Helmholtz model was found to encounter some principal errors. The 
weakness of the model is apparent in the way it predicts Cd to be constant while it is 
experimentally proven that Cd varies with potential and electrolyte concentration in 
real systems (Bard & Faulkner 1980). Variations in Cd with potential and electrolyte 
concentration suggest that either 𝜀 or d must depend on these variables. The Helmholtz 
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model also ignores interactions occurring further from the electrode than the first layer 
of adsorbed species. Hence a more sophisticated model was required. 
It was only the beginning of the following century that a double layer model was 
developed by Gouy (Gouy 1910), and Chapman (Chapman 1913) independently, in 
which electrolyte concentration and the applied potential were considered to both 
affect the value of the double layer capacity. At low concentrations of electrolyte there 
is a relatively low density of charge carriers. As a result, it might take a significant 
thickness of solution in order to compile the excess charge required to counterbalance 
the total excess charge density on the metal electrode side. Therefore, in this new 
model, the Helmholtz’s description was improved where the double layer would not 
be as compact but of a variable thickness, and the ions have freedom to move. This is 
described as the diffuse double layer. The highest concentration of excess charge 
would be closest to the electrode where at this distance electrostatic forces are most 
capable of conquering the thermal processes. Moving further away from the electrode 
the concentrations of charges would drop progressively as the electrostatic forces 
weaken. Hence, with such an approach Gouy and Chapman independently introduced 
the idea of the solution being subdivided into laminae, parallel to the electrode and 
with a thickness of dx (Bard & Faulkner 1980). 
 
 
Figure 2. 3 Evolution of the models for the double layer. (a) Initial model of 
Helmholtz (Helmholtz 1879), (b) Gouy-chapman model (Gouy 1910; Chapman 
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1913), (c) Stern model (Stern 1924), (d) BDM (Bockris, Devanathan, Muller) model  
(Bockris et al. 1963) 
 
All laminae are in thermal equilibrium with each other. Moving through various 
laminae, as the electrostatic potential (𝜙) varies, the energy level of ions of any species 
would vary accordingly. Therefore, the laminae can be considered as energy states 
with equivalent decadence and the number of concentrations of species in two laminae 
have a ratio that is determined by Boltzmann factor.  
The population in any other lamina can be evaluated by taking a reference lamina 
distant from the electrode, where each ion is at its bulk concentration 𝑛𝑖
0 (Bard & 
Faulkner 1980); 
      ni=ni
0exp ( 
−zi е ϕ 
kT
 )                            Equation 2. 5                   
where 𝜙 is measured with respect to the bulk solution, е represents the charge on the 
electron, k is the Boltzmann constant, T represents the absolute temperature, and 𝑧𝑖 is 
the number of units of electronic charge on ion i. 
Hence, in any lamina, the total charge per unit volume is given as; 
             ρ (x) = ∑ ni zi еi  = ∑  ni
0zi еi  exp ( 
−zi е ϕ 
kT
 )          Equation 2. 6 
From electrostatics it is a known fact that ρ (x) is related to the potential at distance x 
by the Poisson equation; 
   ρ (x) = - εε0
d2ϕ
dx2
                          Equation 2. 7 
On combining equations 2.6 and 2.7 we can describe the system with the Poisson-
Boltzmann equation (Bard & Faulkner 1980); 
 






 ∑  ni
0zi еi  exp ( 
−zi е ϕ 
kT
 )               Equation 2. 8    
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The equation is integrated and re-arranged recognizing that at distances far from the 
electrode surface, 𝜙 = 0 and (𝑑𝜙 𝑑𝑥⁄ )=0. For a symmetrical electrolyte the equation 
is specialised as;    
 
                     
dϕ
dx
 = ( 
8kTn0
εε0
 )1/2 sinh ( 
z е ϕ 
2kT
 )                   Equation 2. 9 
Where ni
0 is the number of concentration of each ion in the bulk and z is the magnitude 
of the charge on the ions. 
Moving further away from the surface, the potential is always observed to decay. For 
a highly charged electrode (having high electrostatic potential 𝜙) the drop is sharp as 
the diffuse layer is quite compact. As 𝜙 turns smaller, the decline becomes more 
gradual and takes an exponential form. Upon re-arranging the equation 2.9 in order to 
provide a general description for the potential profile in the diffuse layer identity, the 
spatial decay of potential can be characterised by к, characteristic thickness of the 
diffuse layer; 
         к = ( 
2n0z2e2
εε0kT
 )2                                              Equation 2. 10 
Where к has dimensions of distance. 
Finally, we can develop the differential capacitance as; 
 
              Cd =  
dσ M
dϕ0







)           Equation 2. 11 
 
With the Gouy-Chapman model, the actual capacitance is usually much lower than the 
predicted value. The partial success of Gouy-Chapman model suggests that there are 
still significant failures indicating major defects.  
Gouy-Chapman model predicted the ions as point charges that can approach the 
surface arbitrarily close. In conditions such as high polarisation, the distance 
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separating the metallic and solution-phase charge zones drop continuously towards 
zero. However, this is not the real case as ions come with finite size and it is not 
possible to approach the surface any closer than the ionic radius. Moreover, there is 
the requirement to account for a layer of solvent on the electrode surface. The 
restriction on the predicted capacitance is less apparent in the low electrolyte 
concentrations as the thickness of the diffuse layer is large compare to the thickness of 
inner Helmholtz plane (IHP) and outer Helmholtz planes (OHP) combined (Figure 
2.3). However, as the electrolyte becomes more concentrated, the charges become 
more tightly compressed against the boundary at OHP. This makes the whole system 
similar to Helmholtz model (Helmholtz 1879) and we expect the levelling of the 
differential capacitance. Hence, the plane at outer Helmholtz  (OHP) (is a crucial factor. 
Later, the new model suggested by Stern (Stern 1924) combined the two models of 
Helmholtz and the Gouy-Chapman by extending the considerations of these earlier 
models. The new model suggested that the double layer capacitance is made up of two 
components: The layer closest to the electrode surface that contains the solvents 
molecules and some other specifically adsorbed ions and molecules, is referred as the 
IHP. As we move further away from this region, solvated ions are present in the OHP. 
Beyond the inner Helmholtz plane, the ions approach to the surface due to electrostatic 
forces and are said to be non-specifically adsorbed. Hence, such solvated molecules 
stay distant to metal surface and form the outer Helmholtz plane. The molecules further 
away from the two regions of IHP and OHP that extends into bulk solution, lack the 
competency to compensate with the overall charges hence, forming the diffuse layer. 
Such situation is explained by Bockris, Devanathan and Muller model (Bockris et al. 
1963) where the layer near the interface is predominated by solvent molecules. 
According to the latest expression, the differential capacitance is re-defined as the 
inverse; 
 


















                   Equation 2. 12 
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Hence,  









                                     Equation 2. 13 
where 𝐶d, 𝐶H and 𝐶D respectively represent the capacitance of the electrochemical 
double layer, the capacitance of the compact layer (within the OHP) and the 
capacitance of the diffuse layer. The 𝐶d is dominated by the smaller of the two 
capacities 𝐶H and 𝐶D. The thickness of the CH is highly dependent on the ionic 
concentration and can reach up to 10 nm in diluted solutions (Oschatz et al. 2016).  
Debye length (λD) is the term used to define the distance covered from the OHP to the 
point where the ions are affected by the electrostatic effect of the electrode surface 
(diffuse layer), and the limit of detection of impedimetric and potentiometric 
biosensors are dependent on this crucial factor (Bard & Faulkner 2001). It is well 






                                Equation 2. 14 
 
NA is Avogadro’s number, q is the electron charge and I is the ionic strength. As the 
Equation 2.14 suggests, the Debye length is highly dependent on the ionic 
concentration of the solution and can reach up to 300 nm in diluted solutions 
(Hammond 2017).  It is a known fact that DNA/RNA molecules are negatively charged 
due to their phosphate groups in sugar backbone, and the length of each nucleotide is 
estimated as 0.34 nm (Piunno et al. 1999). For proteins, their charge is generally 
dependent on the pH conditions of the solution. The isoelectric point of a protein is 
defined as the pH at which the net charge of the protein is zero. In order to overcome 
the limiting factor of Debye length on the sensitivity of the sensor, researchers 
established alternatives to overcome such screening effect. The use of polymer chains 
(like PEG) on the electrode surface was introduced to provide detection of 
biomolecules in electrolyte solutions with higher ionic strength, that increases the 
effective screening length (Gao et al. 2015). A couple of other studies introduced new 
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strategies in order to work under high ionic strength electrolyte solutions  (Jang et al. 
2015; Jolly 2016)  
 
2. 3 Electrochemical detection techniques  
Depending on the mode of measurement that is performed, electrochemical sensors 
are classified into groups (Thévenot et al. 2001; Grieshaber et al. 2008) :  
amperometric, potentiometric, conductometric, impedimetric, ion charge or field 
effect. This section will be presenting part of these types with particular focus given 
on the techniques reported in the experimental study of this thesis. 
 
2.3. 1 Amperometry 
Amperometric measurements are carried out by recording the current that results from 
the oxidation and reduction reactions of electroactive species when a fixed potential is 
applied at the working electrode with respect to the reference electrode (Grieshaber et 
al. 2008). Faradaic currents can be either directly generated by the redox activity of 
the analyte at the electrode interface or of the interaction of an electroactive mediator 
with the biomolecule of interest (Luppa et al. 2001). The second approach is most 
commonly preferred and amperometry is considered as one of the most sensitive 
techniques in electrochemistry where the resulting current is directly correlated to the 
bulk concentration of electroactive species in analyte solution (Thévenot et al. 2001).  
The method of amperometry is classified depending on the nature of the potential 
applied for the electrochemical measurements: the technique is referred as 
amperometry only if a constant potential is applied between reference and working 
electrode, whereas it is referred as voltammetry if controlled alterations on potential 
are made with specific waveshapes and amplitudes. As a result, different types of 
voltammetry can be applied by using broad applied voltage profiles but voltammetry 
is still considered as an amperometric method as the working principle for both is the 
same (Bard & Faulkner 1980; Andrade et al. 2011); 
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In a typical assay based on voltammetry, the current is monitored upon applying an 
appropriate potential wave and the resulting currents are generated by three different 
contributions:  
 
1. Capacitive currents (Ic, Non-Faradic currents), 
2. Faradaic currents (If), 
3. Adsorption effects (Ia). 
 
Ic and adsorption effects perform the background current which do not offer any 
analytical information in response to an electrochemical reaction. On the other hand, 
the quantification of the processes of interest by analytical species inside the 
electrochemical setup is provided by If. The accumulation of charges at the interfacial 
region generate the capacitive currents (Ic) at the electrochemical double layer. The 
capacitive currents are sensitive to the potential alterations applied at the electrode 
surface:           
      Ic=𝐶𝑑
𝑑𝑉
𝑑𝑡
                                                                  Equation 2. 15 
where 𝐶𝑑 is the capacitance of the electrochemical double layer and V is the applied 
potential at the electrode surface. Therefore, the faster the potential change then the 
higher the capacitive current will be. In order to minimise the capacitive current, it is 
always suggested to have reasonable low scan rates as Ic increases linearly with the 
scan rate. 
On the other hand, the Faradaic current (If) is the major component that constitutes to 
the quantitative analysis of test molecules and its signal strength and rate is known to 
be influenced by a few factors:  
 
1. concentration of the electroactive species (If is linearly proportional to     
    concentration 
2. mass transfer (diffusion rate ) of the oxidised electroactive active species in  
    the solution towards the electrode 
3. charge transfer taking plane on the electrode surface after electroactive  
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    species approach the electrode 
 
The kinetic rate of the reaction is proportional to the current measured. Depending on 
the nature of the analyte analytical conditions, the current is controlled by the slowest 
case between mass and the electron transfer. For instance, the current flow is limited 
by the mass transfer, if the mass transfer of the electroactive species from the bulk is 
slower than the electron transfer (Bard & Faulkner 1980). 
The currents due to adsorption effects, on the other hand, depend on the speed at which 
the potential steps are applied and defined by the following formula; 





                                       Equation 2. 16 
Where г𝑎 refers to the amount of species adsorbed per unit area on the electrode 
surface. The adsorption peak presence and its shape provides information about the 
contamination and quality of the electrode under investigation. 
 
2.3. 2 Cyclic voltammetry (CV) 
Cyclic voltammetry is most commonly preferred as a characterisation technique for 
the kinetics of a reaction and the measurements are current signals that are based on 
the electrochemical activities of the species inside the analyte. Cyclic voltammetry is 
a well-established and commonly used technique for initial electrochemical studies of 
new systems and has proven to be quite useful for gathering information about 
complicated electrode reactions. The measurements are carried out by applying a 
varying electrode potential at the working electrode that is swept back and forward 
linearly with time vs. the reference electrode. The resulting flowing current is 
monitored with time. The voltage is measured between the reference and working 
electrode whereas the current is monitored between the working and counter electrode. 
When a specific potential window is imposed on the molecules that are present inside 
the solution this can cause them to oxidise (lose electrons) or reduce (to gain electrons). 
Such molecules are referred as redox probes and a CV scan will show its respective 
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peaks. As illustrated in Figure 2.4 (a), the voltage is swept between two values at a 
fixed rate. The scan is reversed when the voltage reaches V2 and the voltage is swept 
back to V1. The duration of the scan must allow sufficient time for a meaningful 
chemical reaction to take place hence, the scan rate, (V2 - V1) / (T2-T1) is a critical 




Figure 2. 4 Example cyclic voltammetry waveform (a) Cyclic voltammogram of a 




𝑎) are the potential and current at 
cathodic and anodic peaks, respectively. Fe (CN)6 
3-/4- is adopted as an example for 
typical reduction and oxidation reactions of a redox molecule at cathodic and anodic 
peaks. The diagrams are re-created from (Andrade et al. 2011). 
 
The resulting measurements are in turn plotted as current vs. voltage graph that is 
referred as voltammogram. For instance, in Figure 2.4 (b) when the voltage applied at 
the working electrode (WE) increases and reaches a value close to the reduction 
potential of the redox molecule, WE loses an electron which becomes associated with 
the redox molecule and the molecule in turn becomes reduced. Therefore, the transfer 
of electron from the electrode surface to the solution results in the appearance of a 
reduction peak in the voltammogram. As the voltage is reversed in order to complete 
the scan toward V1, potential approaches the oxidation potential of the redox molecule. 
This process will result in current of opposite polarity as compared to forward scan 
and the second peak provides information about the reversibility of a reaction at the 
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given scan rate. The anodic and cathodic currents measured by the system corresponds 
to the sum of two components (Bard & Faulkner 1980; Andrade et al. 2011) :  
1. A capacitive component, also referred as non-Faradaic process that 
results from re-distribution of charged and polar species at the surface 
of the electrode. 
2. A component that results from transfer of electrons between the 
electrode and the redox species free in solution or immobilised at the 
electrode surface. This is also refereed as Faradaic process.  
 
The Faradaic component of current is influenced by the diffusion rate of the 
electroactive species towards the electrode surface. For a redox species (R) with a 
redox potential of E0, the Faradaic current is expressed as followed; 
 
If = nFAD0                                                                              Equation 2. 17 
Where A is the electroactive area of the electrode (cm2), n is the number of electrons 
involved in the redox transfer event (usually 1), F is the Faraday’s constant (C mol−1), 
D is the diffusion coefficient of the species reduced and oxidised (cm2/s). 
For a fully reversible system, the anodic and cathodic peak current is described by 
Randles-Sevčik law (Bard & Faulkner 1980): 
                                  ip = 0.4436𝐴𝑛3/2 (
𝐹3𝐷ʋ
𝑅𝑇
)1/2c                               Equation 2. 18 
Where ʋ is the scan rate (V/s), c is the bulk concentration of the redox species 
(mol/cm3), T is the temperature (K) and R is gas constant (J K−1 mol−1). 
The formula is equally valid for reduction and oxidation peaks and performs linear 
proportionality to the concentration of the electroactive species and the square root of 
the scan rate, ʋ. The plot of ip vs. ʋ
 1/2 is an important diagnostic tool and if the curve 
is linear it is reasonably safe to conclude that the electrode reaction is controlled by 
diffusion.  
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2.3. 3 Differential pulse voltammetry (DPV) 
Differential Pulse Voltammetry was developed with the aim of reducing the non-
Faradaic (capacitive) currents in order to achieve better sensitivity (Bard & Faulkner 
1980). The potential waveform of Differential Pulse Voltammetry is composed of 
small pulses (with constant amplitude) that are superimposed upon a staircase wave 
form. The current is then evaluated by taking the difference between the currents right 
before and at the end of the pulse. Hence, DPV is more immune to background 
currents. This is because the non-Faradaic (capacitive) currents drop exponentially 
with time where the Faradaic current decays with t -1/2 that results in a more sensitive 
system. A typical voltammogram displays the differential currents versus the applied 
potential and the concentration of the analyte in solution is directly proportional to the 




Figure 2. 5 Potential waveform for Differential Pulse Voltammetry. The potential 
waveform is composed of small pulses (of constant amplitude) that are superimposed 
upon a staircase wave form. The diagram is re-created from (Basi Electrochemistry 
2020). 
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2.3. 4 Square wave voltammetry (SWV) 
In a historical context, the square wave voltammetry originates from the Kalousek 
commutator (Ramaley & Krause 1969) and Barker’s square-wave polarography 
(Barker & Jenkins 1952; Barker & Gardner 1992). The modern version of SWV that 
is adapted into today’s digital electrochemical instruments, adopts a staircase potential 
ramp modified with square-shape potential pulses (Figure 2.6) (Mirceski et al. 2013). 
Such a methodology was developed in order to eliminate the problem of background 
signals due to non-faradaic (background) currents in methods such as cyclic 
voltammetry. Each step of the staircase ramps in square wave voltammetry (Figure 
2.6) imposes two equal potential pulses that are opposite in direction but equal in 
height. Single potential cycle in SW consist of two of such potential pulses. For the 
case of a square wave voltammetry experiment, the potential cycle is applied for each 
step of the staircase ramp. The method provides an insight into the electrode 
mechanism as the electrode reaction is driven in both anodic and cathodic directions 
during single potential cycle. The duration of a single pulse, tp=t/2, represent the 
critical time of the voltammetric experiment and the interpretation of the data can be 
carried out by also using the frequency of the potential modulation as: f=1/t (Mirceski 
et al. 2013). The net current, inet, is evaluated by taking the difference between the 
forward current and reverse current (ifor-irev) that is calculated at the end of each half 
cycle respectively. Such a subtraction further suppresses the non-Faradaic 
(background) current. The net current is centred on the redox potential and the peak 
height of net current has a linear relationship with the concentration of the electroactive 
species. The method offers direct detection limits as low as 10-8 M (Kounaves 1997). 
The method has couple advantages compare to others. One of them is its rejection to 
background currents, which becomes a problem in the case of cyclic voltammetry. In 
CV, both Faradaic and non-Faradaic currents are produced, and this leads to the 
difficulty of differentiating analytical peaks from background signal (Bard and 
Faulkner 1980).  Square wave voltammetry was developed in order to overcome such 
difficulties and the voltage pulse technique results in an increase in the ratio of 
Faradaic current and non-Faradaic current, hence the sensitivity of measurement. 
Another advantage is the speed (Samuel et. al). Square wave voltammetry can be 
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adopted to perform an experiment much faster, at scan rates up to 1 V/sec or faster, 
compare to differential pulse techniques with typical scan rates of 1 to 10 mV/sec  
(Osteryoung & Osteryoung 1985).  The areas that commonly adopt square wave 
voltammetry include: the study of electrode kinetics with regard to preceding, 
following or catalytic homogenous chemical reactions, decision of some species at 
trace levels and its adoption in HPLC with electrochemical detection (Kounaves 1997). 
              
Figure 2. 6 Potential wave form for square wave voltammetry. The diagram is re-
created  from (Basi Electrochemistry 2020). 
 
2.3. 5 Electrochemical impedance spectroscopy (EIS) 
In Electrochemical Impedance Spectroscopy, a.c. potential (typically 5-10 mV) is 
adopted rather than dc signal, for stimulating the system. This is due to the richer 
information provided by ac signal which offers better characterisation of the system. 
The information is used to quantitatively identify the electrochemical reactions taking 
place at the sensor interface (Janata 2002; Lasia 2002; Barsoukov & Macdonald 2005; 
Orazem et al. 2006). 
It is crucial to distinguish between two different types of EIS measurements: Faradaic 
(using redox markers) and non-Faradaic. Faradaic measurements employ equal 
concentration of a redox couple of reduced and oxidised forms inside measurement 
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solution. These redox markers result in Faradaic processes that leads to Faradaic 
currents in the system. The method monitors these currents hence evaluates the charge 
transfer resistance that is the electrostatic repulsion between the working electrode 
surface and the redox couple within the electrolyte solution. Such that the resistance 
of the system is a measure of how easily the redox markers can approach the electrode 
surface. On the other hand, for non-Faradaic measurements, the redox markers are 
eliminated. For such systems, the impedance of the system is dependent on the solution 
resistance and the charge distribution of ions in solution. The non-faradaic response is 
dominated mainly by the changes in double layer capacitance. In EIS, a small a.c. 
potential is applied to the system; 
                     V(𝑡) = 𝑉osin(𝜔𝑡)                                    Equation 2. 19 
Where 𝑉o is amplitude of voltage signal and 𝜔 is the angular frequency (2𝜋𝑓). 𝑓 is 
measured in Hertz. The resulting a.c. current response as a function of time is as 
followed; 
                    I(𝑡) = 𝐼osin(𝜔𝑡 − 𝜃)                                Equation 2. 20 
Where 𝐼o is the amplitude of current signal and 𝜃 is the system response phase shift. 
By adopting ohms law, the complex notation can be transferred into impedance form; 
 






 = 𝑍o 
sin (ωt)
sin (ωt+θ)
                    Equation 2. 21 
Hence, by using the following Euler’s equation;  
                                    exp(jθ)= cosθ + jsinθ                          Equation 2. 22                                                           
Where j is the imaginary number. Equations 2.19 and 2.20 can be further expressed as 
a function of time as followed; 
                                   V(𝑡) = 𝑉o exp(j𝜔𝑡)                                 Equation 2. 23                                                          
                                   I(𝑡) = Io exp(j𝜔𝑡 − j𝜃)                                Equation 2. 24                                                       
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Hence, the impedance can be expressed as a complex number by using Equations 2.22, 
2.23 and 2.24 in Equation 2.25 







                  = 𝑍o exp (jθ) = 𝑍o (cosθ+jsinθ) = 𝑍'+ j𝑍”                   Equation 2. 25     
Where Z0 is the amplitude of the impedance signal, Z' and  Z” are the real and 
imaginary parts of the impedance, respectively. In further explanation, the real part 
(Z') is the resistance of the circuit to the flow of current and Z” is the ability of the 
circuit to store electrical energy. Such that these components of impedance reflect the 
resistive and capacitive components of the fabricated biosensor. The most common 
circuit that is adopted to best fit the description is Randles equivalent circuit which is 
composed of solution resistance Rs, the resistance to charge transfer Rct, the double 
layer capacitance Cdl, and a Warburg impedance element W (Lisdat & Schäfer 2008). 
 
                 
 
Figure 2. 7 The Randles’ equivalent circuit representation for an electrode in contact 
with an electrolyte. The double-layer capacitance Cdl refers to the amount of charge 
stored in the double layer at the interface of electrode surface and the electrolyte. Rct 
is the charge transfer resistance, Rs is the solution resistance and ZW is the Warburg 
element (Lisdat & Schäfer 2008). 
 
However, a slight modification was introduced on Randles equivalent circuit after 
several studies (Brug et al. 1984) (Hirschorn et al. 2010) have shown that replacing Cdl 
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with constant phase element (CPE), is a better representation of the distributed nature 
of the electrochemical double layer. The impedance of constant phase element (CPE) 
is now given by; 
                                            ZCPE = Yo(jω)–𝛼                                        Equation 2. 26  
Where 𝜔 is the frequency and Yo is the magnitude of admittance where 𝛼≤1.  
         
 
Figure 2. 8 Modified version of Randles equivalent circuit. CPE is the constant phase 
element, Rs is the solution resistance, Rct is the charge transfer resistance and Zw is the 
Warburg element. 
 
Hence, and estimation for the replaced capacitor double layer can be done as followed; 
 




                                                          Equation 2. 27 
In real EIS measurements, the Faradaic currents are affected by the diffusion 
processes. This factor is taken into account by the Warburg impedance, W, which is 
the impedance element due to diffusion of ions from bulk solution to electrode 
surface. This frequency dependent element only becomes predominant at lower 
frequencies with a phase angle of 45º in a diffusion controlled Faradaic process. 
Typical result from an electrochemical impedance spectroscopy is shown in Figure 
2.9. The Nyquist plot given in the figure provides a way of comparing Rct values, given 
by the diameter of the semicircle Z, calculated from each assay. 
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Figure 2. 9 Example Nyquist Plot of an EIS measurement (Lisdat & Schäfer 2008). 
 
2.3.5. 1 Non-Faradaic EIS measurements 
The main distinguishing factor of Faradaic and non-Faradaic impedance approaches 
is the absence of redox molecules. In such an approach the transduction occurs 
through variations in double layer capacitance (Cdl) rather than resistance of the 
system to charge flow (Rct) (Daniels & Pourmand 2007; Tsouti et al. 2011). The 
capacitance arises as a result of immersing the electrode inside a solution and 
applying a certain potential. This will lead to the orientation of charged species and 
dipoles on the electrode interface which generate the double layer capacitance, a 
quantity that is physically measurable and quite sensitive to variations on the 
interface (Santos et al. 2014). According to literature, the common approach to 
evaluate capacitance is ignoring the contributions by Rct and W and replacing an 
equivalent circuit that consists of a single resistor in series with a capacitor (Couniot 
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Figure 2. 10 Representative circuit for a non-faradaic measurement 
 
 
As a result, the Equation 2.25 for the evaluation of impedance that was expressed 
earlier takes a new form; 
                              Z =Z'+ j Z” ≈ Rs
* -   j
1
ωCDL
∗                                Equation 2. 28 
 
In Equation 2.28, the real part of the capacitance can be expressed as followed; 
                                                     CDL
∗ = - 
1
ωZ"
                                    Equation 2. 29 
 
Second approach that is reported in literature is the evaluation of a complex 
capacitance (C*) on using the impedance data (Jolly, Formisano, et al. 2015) (Jolly, 
Tamboli, et al. 2016); 






  = C’ +jC”               Equation 2. 30 
 
Hence, in such an approach the real (C’) and imaginary (C”) components of 
capacitance are evaluated on using impedance values of Z’ and Z”. This is better 
represented by a Cole-Cole plot that is given in Figure 2.11 where the Nyquist plot for 
an electroactive peptide-SAM that is immobilised on gold electrode at its half-wave 
potential is used to evaluate the capacitive response of the system. The diameter of the 
semicircle in capacitance graph gives an estimate for the capacitance of the system.  
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Figure 2. 11 Nyquist impedimetric plot (left) of Z” versus Z’ for electroactive peptide-
SAM immobilised on gold electrode surface at electrode potential corresponding to 
half-wave potential. The analogous capacitive response of Z” versus Z’ (right). 
 
 
2. 4 Other techniques 
Apart from all the electrochemical techniques that were explained earlier, surface 
plasmon resonance and UV-spectrophotometry were adopted during the development 
of specific biosensor methodologies in this thesis. 
 
2.4. 1 Surface plasmon resonance (SPR) 
Since the development of the first surface plasmon based biosensor in 1983 (Prabowo 
et al. 2018),  the use of the technique increased rapidly. There is an underlying physical 
explanation for the functioning of SPR (Merwe 2002; Formisano 2016). When a beam 
of light passes from a medium/material with a higher refractive index (e.g. glass prism) 
into a medium/material with lower refractive index (e.g. water) some light is reflected 
from the interface. The light is completely reflected only when the angle of strike of 
the light onto interface (angle of incidence, ϴ) is bigger than the critical angle (ϴc).  
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Figure 2. 12 Schematics for Surface Plasmon Resonance (SPR). A dark line in the 
reflected beam (on detector) results from the excitation of the surface plasmons at 
certain angle of light. Upon molecular binding events (DNA/miRNA binding) there is 
a shift of the angular positioning of this dark line and the dark line can be monitored 
as a dip in the SPR reflection intensity. The shift on the position of the dip represents 
the molecular binding event or a conformational change in the molecules near surface. 
The diagram is re-created  from (Jolly 2016). 
 
 
However, when the glass surface is covered with a thin film of a noble metal such as 
gold, some of the light is lost into metal and the reflection is not observed to be total. 
This lost is observed to be greatest at a second angle that is greater than critical angle 
and at which the reflected angle intensity reaches to minimum. Now this angle is 
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referred as the surface plasmon resonance angle ϴspr that results from the oscillation 
of mobile electrons at the surface of the metal film (e.g. gold). When wave vector of 
the incident wave matches the metal plasmons (mobile electrons), it results in the 
resonance of the plasmons. In such a condition, the energy of the photons is transferred 
to plasmons. This resonance is also referred as surface plasmon resonance. As a result, 
the coupling of the incident wave to the oscillating electron (plasma) on the surface 
leads to energy loss and a drop on the intensity of reflected light. The wave that 
penetrates into metal (evanescent wave) decays exponentially in the perpendicular to 
the metal surface into the medium. The depth of the evanescent wave from the sensor 
surface is within 300 nm depending on the thickness of the gold film and the refractive 
index of the medium above the metal surface (Merwe 2002). The method of SPR 
excites and detects collective oscillations of surface plasmons (free electrons) via 
Kretschemann configuration (Figure 2.12), where light is focused onto a metal film 
through a glass prism and the resulting reflection is detected. The dark band line in the 
reflected beam (Figure 2.12, Detector) is created by the absorption of light at the 
certain incident angle where plasmons are set to resonate with light. The dark band 
line is observed as a dip in the SPR reflection intensity and a shift in the reflection of 
the dark band line corresponds to a molecular binding to the gold film. The molecular 
binding events are studied commonly by monitoring this shift versus time graphs 
(Szabo et al. 1995; Mcdonnell 2001; Karlsson 2004). 
 
2.4. 2 Ultra violet (UV) spectrophotometry 
Ultraviolet-visible spectroscopy is an important tool for the qualitative analysis and 
identification of chemicals in analytical chemistry. Its main use is considered as 
quantitative determination of different organic and inorganic compounds in solution 
(Ferree et al. 2001; Albalasmeh et al. 2013). Similar to SPR, spectroscopy is related to 
the interaction of light with matter. Upon absorption of light by matter, the energy 
content of atoms/molecules increases and UV absorption by a chemical compound will 
display a distinct spectrum.   
UV spectrophotometer principle follows the Beer-Lambert Law that states that when 
a beam of monochromic light is passed through a solution with absorbing species, the 
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reducing rate of radiation intensity along with the thickness of the absorbing solution 
is proportional to the concentration of the solution and the incident rate (Swineharf 
1962): 
                                               A= log10
𝑃0
𝑃
 = abc                          Equation 2. 31 
 
Where A is the absorbance, Po refers to the intensity of light upon a sample cell, P 
refers to the intensity of light upon leaving the sample cell, a refers to the molar 
absorptivity, b refers to the length of the sample cell, c refers to the concentration of 
the solute. 
 
              
 
Figure 2. 13 Beer-Lambert Law. Principle of Beer-Lambert Law that relates the 
concentration of the sample to the passed light path length (Swineharf 1962). 
 
The concept and principle of UV spectrophotometer has many applications and one 
that is most common is the identification of unknown compounds. This is normally 
carried out by comparing the resulting spectrum with a reference compound for 
observing if the spectrums coincide hence the compound is successfully identified. UV 
spectrophotometry in this thesis has been employed for the identification of nucleic 
acids and proteins inside a solution. It was used as a validation technique to confirm 
the existence of the nucleic acids inside the solution by comparing the wavelengths for 
the absorbance peaks to ones reported in literature (Tinoco et al. 1980; Aitken & 
Learmonth 2009). 
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Chapter 3 Direct and sensitive 
electrochemical detection of miR-
21-5p as circulating biomarker 
for pancreatic cancer  
 
 
In this chapter, the development of a highly sensitive electrochemical detection 
platform for miRNA sensing is presented. If a certain miRNA is detected in blood, it 
can act as a fingerprint for cancer or many other diseases. The platform was developed 
by the adoption of Peptide Nucleic Acids (PNA) as the capture probe on a gold 
electrode surface. The main focus was to inspect the role of total probe to thiol ratio 
on a gold electrode surface for advancing the existing limit of detection, with no 
additional labelling steps. Initially, a controlled fabrication strategy was adopted for 
the detection of target DNA which is less vulnerable to RNAse degradation compared 
to miRNA. Hence, after optimisation of the probe for DNA detection, the strategy can 
be easily adapted for miRNA detection. Electrochemical impedance spectroscopy was 
used to monitor the changes in charge transfer resistance on the electrode surface due 
to binding activities of target miRNAs. The optimisation studies presented in this 
chapter include: electrochemical impedance spectroscopy measurements upon 
designing a DNA-equivalent of the PNA-probe for the approval of the better 
performance of PNA-probes, detection of long target DNA, specific to the human 
pathogen C.difficile, by using PNA-probes, re-adjusting the design of PNA-probes for 
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3. 1 Background 
Early detection is a core module for the control of the spread of cancer and improves 
the chances of survival. Being discovered in C. Elegans in 1993 and soon after in all 
living organisms (Ferracin et al. 2011), microRNAs (miRNAs) are a class of 19-24 
nucleotide-long non-coding RNAs (Ambros 2004; Bartel 2004; Iorio & Croce 2011) 
which regulate the expression of nearly one third of all human genes. It was only in 
the last decade that significant evidence emerged showing that miRNAs are involved 
in the pathogenesis of cancer (Ramaswamy et al. 2001; He et al. 2005; Lu et al. 2005) 
and became an area of interest for oncology research. A few examples include the up-
regulation of miR-155 and miR-21, and down-regulation of miR-91 in breast cancer, 
the up-regulation of miR-17-3p and miR-92 in patients with colorectal cancer (CRC) 
(Ng et al. 2009), or the down-regulation of miR-145 in several cancer types (blood 
cancer, colon cancer, breast and ovarian cancer, prostate cancer) (Esquela-kerscher & 
Slack 2006; Akao et al. 2007; Ichimi et al. 2009; Spizzo et al. 2013; Dahiya & Morin 
2010). 
This study will be addressing the detection of circulating miR-21-5p, a pancreatic 
cancer biomarker (Wang et al. 2013; Matsuzaki & Ochiya 2017; Qu et al. 2017), as a 
non-invasive biomarker for the early detection of the disease. The early diagnosis of 
pancreatic cancer is difficult and currently no protein biomarkers in blood can be used 
to identify the disease in its early stages. The disease usually becomes fatal within 
months of diagnosis. Hence, the exploration of detection techniques for early diagnosis 
of the disease will greatly benefit patients with pancreatic cancer. 
Most techniques are restricted to central laboratories, some of these being powerful 
but complex. There is still the need for portable, simple and sensitive techniques to 
quantify levels of miRNAs inexpensively. Therefore, this study adopts 
electrochemical approaches for the development of a point-of-care detection. 
Electrochemical biosensors come with various advantages, such as specificity, 
portability, and low cost (Wang 2006). Previous studies have shown that miRNA 
detection down to femtomolar (fM, 10-5 M) levels could be achieved by adopting 
amplification steps such as use of nanoparticles (Jolly et al. 2016; Peng & Gao 2011) 
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and enzymes (Ren et al. 2013). However, such steps lack simplicity and this work 
focuses on eliminating any additional steps, and achieving low limits of detection by 
direct measurements. 
It is reported in the literature that the accurate control of PNA (or DNA) probe density 
on gold electrodes could be achieved by the immobilisation of thiol-modified PNA (or 
DNA) with a thiol spacer (Keighley et al. 2008). Using this approach, a 385-fold 
change in Rct was achieved upon hybridisation using electrochemical impedance 
spectroscopy (EIS). Hence this technique can be adopted in order to optimise the 
sensitivity of the assay. In this chapter we will be carrying out a detailed EIS-based 
study of various ratios of thiol-modified PNA to mercaptohexanol (MCH) on gold 
electrodes in order to identify the optimised ratio for the best hybridisation efficiency. 
Optimisation of the probe density is a crucial step prior to taking any further steps 
towards fabrication. 
 
3. 2 Materials and methods 
3.2. 1 Apparatus 
The EIS experiments were carried out with PalmSense4 compact potentiostats 
(PalmSense, Netherlands) and a three-electrode cell system: an Ag/AgCl (KCl) 
reference electrode (BASi, USA) connected via a salt bridge filled with 10 mM of 
phosphate buffer (pH 7.3), a Pt counter electrode (ALS, Japan), and a gold working 
electrode (2.0 mm diameter from CH Instruments, USA). 
The Faradaic EIS with PNA probe was conducted in 10 mM PB (pH 7.3) measurement 
buffer containing 10 mM of the ferro/ferrocyanide ([Fe(CN)6])
3-/4-  redox couple over 
a frequency range from 100 kHz to 100 mHz, with a 10 mV ac.voltage superimposed 
on a dc bias voltage of 0.2 V (formal potential of the redox couple) vs. Ag/AgCl. The 
Faradaic EIS with DNA probe was conducted in a buffer with a higher ionic strength, 
which is necessary for the screening of the negative charges of DNA (Keighley et al. 
2008). As a result, the 10 mM PB buffer that was used for the EIS measurements with 
the PNA-probe was replaced with 50 mM PB containing 100 mM K2SO4 (pH 7.0) for 
the case of DNA-probe. 
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3.2. 2 Oligonucleotides 
High performance liquid chromatography (HPLC) purified PNA probe sequences 
were purchased from Cambridge Research Biochemicals, UK, in lyophilised form, 
while synthetic oligonucleotide sequences were purchased from Sigma Aldrich, UK. 
The PNA and DNA probe sequences, listed in the first two rows in Table 3.1, were 
used for the probe optimisation studies presented in section 3.3.1 for the detection of 
long pathogenic DNA specific to the C.difficile bacteria (Joshi et al. 2014). The PNA 
probe sequence in the fourth row is complementary to the miRNA-21-5p sequence 
given in the fifth row. MiRNA-21-5p is specific to pancreatic cancer (Qu et al. 2017). 
The non-specific miRNA sequence in the final row of Table 3.1 was adopted for the 
control studies. 
 
Table 3. 1 List of PNA probes, target DNA and miRNA sequences used in this work. 
AEEA is a glycol linker of nine atoms (8-amino-3, 6-dioxaoctanoic acid). 
 
PNA probe 1 
(fully complementary to DNA target 1) 
SH-C6-AEEA TTT TTT TTA ATA 
CTA ACA CTG C 
DNA probe 1 
(fully complementary to DNA target 1) 
5’-SH-C6-TTT TTT TTA ATA CTA 
ACA CTG C-3’ 
DNA target 1 
(complementary to PNA probe 1 & DNA 
probe 1) 
3’-AAA TTA TGA TTG TGA CGT 
AAT CCC AAT ACA ACG TCA ATG 
ACC TAC CGT T -5’ 
PNA probe 2 (fully complementary to 
miR-21-5p) 
SH-C6-AEEA TTT TCA ACA TCA 
GTC TGA TAA GCT A 
miR-21-5p sequence (fully 
complementary to PNA probe 2) 
3’-AGU UGU AGU CAG ACU AUU 
CGA U-5’ 
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As compared to the C6 linker, when a C6-AEEA linker is adopted in PNA probes a 
significant reduction in the non-specific interactions is observed (Jolly et al. 2016). 
Such a property of the PEG-like linker (C6-AEEA) is due to the creation of a hydration 
layer because of the presence of the AEEA. Each PEG ether group is capable of H-
binding to two water molecules creating a strong hydration shell (Wang & Kreuzer 
1997). Hence, proteins and other charged molecules are prevented from penetrating 
the hydration layer and being adsorbed onto the surface (Jolly et al. 2016). 
 
3.2. 3 Biosensor fabrication 
The gold working electrodes were first mechanically polished for 2 minutes with 1 µM 
diamond solution (Buehler, USA) on a polishing pad (BASi, USA). This was followed 
by mechanical polishing using alumina slurry with decreasing particle sizes (starting 
with 1 µm, then 0.3 µm and finishing with 0.05 µm). Polishing was carried out for at 
least 2 minutes with each particle size. In between each polishing step, 5 minutes 
sonication in ethanol and rinsing in Milli-Q water were performed to remove any 
residues. After the final polishing, 10 minutes of sonication in ethanol followed by 10 
minutes in Milli-Q water was carried out. Electrodes were then rinsed with Milli-Q 
water and electrochemically cleaned in 0.5 M H2SO4 (Sigma, Aldrich) by scanning the 
potential between the oxidation and reduction of gold, 0 V and +1.5 V vs. an Ag/AgCl 
reference electrode, for 50 cycles until the voltammogram graphs showed no further 
changes. Finally, the electrodes were rinsed with Milli-Q water and dry cleaned with 
a nitrogen gun. 
The PNA probe fabrication was carried out by co-immobilisation of clean electrodes 
with the thiolated ssPNA probe sequence and 6-mercapto-1-hexanol (MCH, Sigma-
Aldrich, UK) in 50% dimethyl sulfoxide (DMSO, Sigma-Aldrich, UK), 50% ultra-
pure water (v/v) immobilisation solution for 16 h in a humidity chamber. The initial 
concentration of MCH (10 mM) was prepared in Ethanol (BioUltra for molecular 
biology, ≥99.8%, Sigma-Aldrich, UK) and diluted to the required concentration in the 
immobilisation buffer for the preparation of a range of molar ratios of ssPNA and 
MCH. All electrodes were prepared with 1 µM thiol modified PNA and with varying 
molar ratios of MCH (e.g. 1:4 molar ratio of PNA:MCH refers to 1 µM thiol modified 
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PNA + 4 µM MCH prepared in the same immobilisation solution). Each electrode was 
incubated in 100 µL of the immobilisation solution for 16 h at 4° C. A minimum of 
three electrode samples were prepared at each PNA:MCH mole fraction. After 
immobilisation, the electrodes were rinsed with excess Milli-Q water to remove any 
unattached thiols and were backfilled with 1 mM MCH at room temperature for one 
hour, in order to ensure complete thiol coverage. The electrodes were then rinsed with 
excess Milli-Q water and placed in the measurement buffer for 2 hours to stabilise the 
SAM. 
The DNA probe fabrication was carried out by following the optimised protocol in 
literature (Keighley et al. 2008) which requires the co-immobilisation of clean 
electrodes with the thiolated ssDNA probe sequence and 6-mercapto-1-hexanol 
(MCH, Sigma-Aldrich, UK) in 0.8 M phosphate buffer (PB) + 1.0 M NaCl + 5 mM 
MgCl2+ 1 mM ethylene diamine tetraacetic acid (EDTA), pH 7.0. The DNA charge is 
screened by the high ionic strength and Mg+2 ions which also allows high probe 
densities. All electrodes were prepared with 1 µM thiol modified DNA with varying 
molar ratios of MCH. A minimum of three electrode samples were prepared at each 
DNA:MCH mole fraction. Following the immobilisation, electrodes were sequentially 
rinsed with: immobilisation buffer, 200 mM PB, 10 mM PB and finally 10 mM PB + 
10 mM EDTA to remove any remaining Mg2+. The electrodes were then backfilled 
with 1 mM MCH for one hour in order to ensure complete thiol coverage. The 
electrodes were then rinsed with excess Milli-Q water and placed in the measurement 
buffer for 2 hours to stabilise the SAM. 
 
3. 3 Results and discussion 
3.3. 1 PNA-probe vs. DNA-probe studies using EIS technique 
Initially, the better performance of the PNA-probes compared to DNA-probes was 
investigated for the detection of the target DNA. This is mainly because of the crucial 
need to develop an initial controlled fabrication strategy for the detection probe. As 
DNA is more stable compared to target miRNA, which has a higher vulnerability to 
RNase degradation (Qian et al. 2017), target DNA was adopted for the optimisation 
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studies. The DNA sequence that is specific to the human pathogen C.difficile that 
causes antibiotic associated diarrhoea in humans was selected (Joshi et al. 2014) for 
its potential application for clinical diagnosis. Electrochemical impedance 
spectroscopy measurements were carried out for the detection of the DNA sequence. 
The strategy was in turn adapted for the detection of the miRNA target in upcoming 
sections.  
 
      (a) 
     (b)     
                
 
Figure 3. 1. Percentage variations of Rct upon hybridisation with target DNA that is 
specific to the human pathogen C.difficile. Measurements were carried out with 
various ratios of (a) probe PNA to MCH and (b) probe DNA to MCH on the electrode 
surface, after incubation with 2 nM and 20 nM concentrations of complementary target 
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DNA. All EIS measurements with PNA-probes were carried out in 10 mM PB (pH 
7.3) containing 10 mM of the ferro/ferrocyanide ([Fe(CN)6])
3-/4-. 10 mM PB buffer 
was replaced with 50 mM PB containing 100 mM K2SO4 (pH 7.0) for all DNA-probe 





The % variation of Rct shown in Figure 3.1 (a) increases significantly upon 
hybridisation as the ratio of PNA to MCH functionalised on the surface is reduced 
gradually from 1:4 to 1:29. However, further decreases in the PNA density at the 
surface results in a decreasing %Rct upon hybridisation. The highest value of %∆Rct, 
hence the best hybridisation, was observed when a fraction of 0.03 (1:29 ratio) PNA 
to spacer molecule MCH was adopted on the surface. The further reduction of this 
ratio results in reduced hybridisation, this is due to the reduced amount of probe 
(ssPNA) on the surface, resulting in insufficient capture of the target. On the other 
hand, at ratios higher than 1:29 (e.g. 1:4), steric hindrance reduces the hybridisation 
efficiency with the target (Keighley et al. 2008). Another limiting factor at higher 
ratios could be the large initial Rct that is significantly high compared to the 
overall %Rct variation upon hybridisation. 
The % variation of Rct for the DNA-probe in Figure 3.1 (b), on the other hand, 
remained significantly lower upon incubation with the target DNA, and the results did 
not display consistency. The most consistent stabilisation and increase of surface 
charge transfer resistance after hybridisation was observed with electrodes 
immobilised with a DNA:MCH ratio of 1:5. Even then the %Rct variation upon 
incubation with 20 nM DNA, remained significantly low (6.4% ± 0.28). Hence our 
results suggested a better performance of the PNA probes for detection of DNA, with 
7-times the hybridisation efficiency when compared to DNA probes. The strategy of 
using PNA-probes for DNA detection was re-investigated by using quartz crystal 
microbalance with dissipation (QCM-D) and field-effect transistor-based biosensor 
(Bio-FET) for proof of detection on different platforms (Appendix II & III). 
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3.3. 2 Investigation of miRNA detection using EIS technique 
Following the justification of the success of PNA probes for DNA detection, the same 
strategy was adopted for the fabrication of the PNA-probe for the recognition of miR-
21-5p. Faradaic mode EIS was adopted for the evaluation of the stability of the 
fabricated probe, its specificity, and target binding steps. The measurements were 
performed in 10 mM of [Fe(CN)6]
-3/4- the redox couple, to monitor the resistance to 
charge transfer upon target binding events. Initially the PNA biosensor was measured 
for its stability in a 10 mM PB (pH 7.3) buffer containing 10 mM of the 
ferro/ferrocyanide ([Fe(CN)6])
3-/4-  redox couple (Figure 3.2 a, red curve). Three rounds 
of incubations, each for 30 minutes, were carried out. An %Rct variation that was less 
than 5% confirmed the stability of the PNA-probe. Finally, the PNA-probe was tested 
for its non-specific binding upon incubation in 10 mM PB (pH 7.3) which contained 
non-specific miRNA (Figure 3.2 a, blue curve). The results given in Figure 3.2 (a) 
indicate a negligible change in the Rct of the platform upon incubation in blank buffer, 
as well as when the probe was exposed to 1 nM of non-specific miRNA sequences, 
which resulted in a 0.71% variation in Rct  (535.6 Ω → 539.2 Ω). After the successful 
evaluation of the system with non-specific interactions, the developed platform was 
tested for its binding efficiency to target miRNA (Figure 3.2 (b)). The probe surface 
was initially incubated with 10 nM of fully-complementary miRNA sequences. This 
has resulted in a change of Rct from 566.5 Ω to 658.3 Ω, an increase of 16.2%, which 
was then doubled to 30.6% after incubation with a higher target concentration of 100 
nM. Hence, this variation can be related to the PNA/miRNA duplex that forms as a 
result of hybridisation. The uncharged PNA platform alters to a negatively charged 
platform due to the presence of miRNA. The negatively charged miRNA on the 
electrode surface then in turn increases resistance (Rct) to the redox ions inside the 
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 PNA + complementary miRNA (10 nM)
 PNA + complementary miRNA (100 nM)













Figure 3.2  EIS characterisation of the PNA-probe. The Nyquist plot in (a) 
corresponds to the electrode surface stabilised with PNA probe followed by non-
specific binding of 1 nM miRNA. The Nyquist plot in (b) corresponds to the electrode 
surface stabilised with PNA probe (black), followed by initial hybridisation with 10 
nM complementary miRNA target (red) and second incubation of 100 nM 
complementary miRNA (blue). The plots in (a) and (b) correspond to two different 
electrodes, the reproducibility of the results are presented in the upcoming sections. 
 
 
3.3. 3 Probe optimisation for the enhancement of PNA-miRNA 
hybridisation signals 
EIS in Faradaic mode was adopted to investigate the result of various mole fractions 
of PNA to thiol (PNA to MCH) in the immobilisation solution for the enhancement of 
the hybridisation signal. Thiol-modified PNA probes and mercaptohexanol were co-
immobilised onto gold electrodes and the charge transfer resistance for the electrode 
surface was determined by electrochemical impedance spectroscopy. Typical Nyquist 
plots for the PNA/MCH functionalised electrode surface before and after 
complementary miRNA incubation are shown in Figure 3.3.(a) & (b). 
According to the results, a 1:5 ratio of PNA:MCH for the self-assembled layer 
performed an Rct variation of 15.99% with a standard deviation of ±2.53% upon 
incubation with 10 nM of complementary miRNA. Such a result corresponds to a 7-
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fold increase in the initial %∆Rct measured upon stabilisation of the probe (%∆Rct upon 
stabilisation = 2.33% ±2.37%). 
Although the %∆Rct for the 1:2 ratio of PNA:MCH self-assembled layer performed a 
negligible variation upon stabilisation (∆Rct = 2.4% ±2.68%), this almost remained the 
same after incubation with 10 nM of complementary miRNA (∆Rct = 1.03%  ±0.05%) 
which reflects a very poor hybridisation efficiency. The complete analysis of various 
PNA:MCH mole fractions and %∆Rct upon miRNA hybridisation is shown in Figure 
3.3.c. 
 
The %∆Rct increases significantly upon hybridisation as the ratio of PNA to MCH 
functionalised on the surface is reduced gradually from 1:2 to 1:15. A sharp drop is 
observed upon reducing the ratio further to 1:20. Although a high density of PNA, 
such as in the 1:5 ratio, is expected to result in a high density of hybridised DNA on 
the surface, further increases of the PNA fraction (ratio 1:2) results in a decrease of the 
fractional change in Rct upon hybridisation. This is due to the combination of two 
effects (Keighley et al. 2008); first is the steric hindrance that reduces the hybridisation 
efficiency with the target, and the second is the larger initial Rct. 
The best hybridisation efficiencies were performed upon adopting 1:10 and 1:15 ratios 
of PNA to MCH on the surface. When the probe density was reduced further to a 1:20 
ratio, the hybridisation efficiency drops due to an insufficient amount of probe on the 
electrode surface (Keighley et al. 2008). Although the 1:15 ratio displayed the highest 
hybridisation efficiency, it performed to be a less stable probe upon incubation with 
blank, compare to 1:10 ratio. Hence, we have decided to adopt a 1:10 ratio for further 
assays of miR-21-5-p detection. Although the literature reports a ratio of 1:4 
(PNA:MCH) for the label-free detection of DNA/miRNA  (Jolly et al. 2016) (Jolly et 
al. 2015) (Keighley et al. 2008) with EIS, our studies have shown that it is crucial to 
carry out a personalised optimisation study for any target sequence and adopt the most 
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Figure 3. 3 (a) Nyquist response when 1:2 PNA to MCH ratio is adopted for detection. 
(b) Nyquist response when 1:15 PNA to MCH ratio is adopted for detection. (c) 
Percentage variations of Rct upon hybridisation by adopting various ratios of PNA to 
MCH on electrode surface. All EIS measurements were carried out in 10 mM PB (pH 
7.3) containing 10 mM of the ferro/ferrocyanide ([Fe(CN)6])
3-/4-. The error bars 




The results in Figure 3.3 once again confirm that it is crucial to carry out the 
optimisation study for any sequence, and the results will vary depending on the 


















 10 nM miRNA
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sequence that is worked with. There is a possible explanation for this result. Such an 
observation for the case of a long DNA sequence (Figure 3.1 a) could be attributed to 
the fact that when dealing with longer target sequences, there is the need for better 
spacing of the probe-PNA. This is due to the fact that long sequences of DNA are even 
more negatively charged and when captured on the surface will perform an 
electrostatic repulsion force with the adjacent captured sequence, and this can result in 
poor binding if there isn’t sufficient spacing of the probe. On the other hand, if the 
probes are spaced too loosely then they won’t be sufficient to capture the target. Hence, 
it is crucial to perform the optimisation study to find the perfect trade-off between 
these factors. 
 
3.3. 4 Detection limit of the optimised miRNA sensor 
Limit of Blank (LOB), Limit of Detection (LOD) and Limit of Quantitation (LOQ) are 
terms used to describe the smallest concentration of the analyte that can be reliably 
measured by an analytical procedure (Armbruster & Pry 2008) and all of these 
parameters have distinct definitions that should not be confused. LOB and LOD are 
crucial terms in assays for the discrimination between the presence and absence of an 
analyte, whereas LOQ is used in clinical diagnosis for measuring reliable levels of 
analytes (Armbruster & Pry 2008). 
LOB can be defined as the highest apparent analyte concentration expected to be found 
when replicates of a blank (containing no analyte) sample are tested, and the term is 
defined with the following formula (Armbruster & Pry 2008):  
                      
                                     LOB = meanblank + 1.645(SDblank)                        Equation 3. 1 
 
Where meanblank refers to the mean result of replicated measurements for blank and  
SDblank refers to the standard deviation for blank. 
On the other hand, LOD is defined as the lowest concentration of analyte that can be 
reliably distinguished from LOB at which the detection is feasible. LOD is evaluated 
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by using both the calculated LOB and the results from testing repetitions of samples 
known to contain a low concentration of the analyte. The LOD then becomes 
(Armbruster & Pry 2008); 
 
               LOD = LOB + 1.645(SD low concentration sample)        Equation 3. 2 
 
The optimised sensor with a 1:10 ratio of PNA to MCH on the gold electrode surface 
was initially challenged with a high concentration of non-specific miRNA (1 nM) for 
its selectivity, then with various concentrations of complementary miRNA for its 
sensitivity and evaluation of LOD. 
     

















Figure 3. 4 Limit of detection study. The bars represent average percentage changes 
in Rct upon incubation with non-specific solution followed by various concentrations 
of full-complementary target miRNA. The error bars represent the standard deviation 
between three separate electrodes. 
 
The results in Figure 3.4, reveal a detection limit which is brought down to fM levels 
with no additional amplification steps, but only with the probe optimisation study. The 
variation of Rct was observed to be at the negligible level of 0.78% ±0.07% upon non-
specific interactions; and was observed to be gradually increased by increasing the 
concentration of complementary miRNA. By adopting Equation 3.2, the detection 
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limit for miR-21-5p was calculated to be 0.77 fM. LOQ on the other hand is the lowest 
concentration at which a reliable detection is possible, provided the predefined goals 
for bias and imprecision are met. LOQ could be the equivalent to LOD or higher. It 
cannot be lower than LOD as we expect that the LOD of a system lies somewhere 
below the experiment’s functional sensitivity. Being initially introduced by a study for 
developing the clinical diagnosis tool to characterise thyroid stimulating hormone 
(TSH) assay efficiency for distinguishing euthyroid from hyperthyroid patients at low 
TSH concentrations, the functional sensitivity of the system is defined at a 
concentration that leads to a Coefficient Vector (CV) = 20% (Armbruster & Pry 2008).  
The coefficient vector is defined as the ratio of standard deviation to the mean. This is 
applicable to the clinical diagnosis and management where LOQ is adopted to measure 
low levels of hormones (e.g. TSH). In the case of our studies, we assumed a predefined 
limit of 15% for the standard deviation against corresponding analyte concentrations, 
that is a feasible assumption for analytical methods (Shrivastava & Gupta 2011). Upon 
evaluating the coefficient vector for each of our measured analyte concentrations, 100 
fM revealed a CV of 15.8%.  The value exceeds the pre-defined value of 15%, hence, 
100 fM was decided as the LOQ (Shrivastava & Gupta 2011). For the analyte 
concentrations higher than 100 fM, the coefficient vector was evaluated to be much 
lower than the pre-defined value which corresponds to a good functional sensitivity. 
 
3.3. 5 Detection in serum 
After successful evaluation of the system with the target miRNA prepared in 10mM 
PB buffer, we proceeded to test the sensor for its efficiency with the target miRNA 
spike-in serum. Hence, an initial assay was carried out where the target miRNA 
concentrations were prepared in 10% serum for the incubations. Interestingly, the 
results show an improved variation on Rct values when the miRNA samples were 
prepared in the 10% serum. 
C h a p t e r  3                                            P a g e  | 95 
 
   


















 Complementary miRNA in 10% serum
 10% serum only
 
Figure 3. 5 Red bars represent the average Rct variations upon incubations with 10% 
serum only. Black bars represent the incubations that initially started with 1 nM of 
non-specific miRNA spike-in 10% serum, followed by various concentrations of target 
miRNA prepared in 10% serum. The error bars represent three separate electrodes. 
 
The results presented in Figure 3.5 indicate a significant increase (~4-fold) on Rct 
values compared to the case of detection in 10 mM PB buffer (Figure 3.4). However, 
the background measurements with serum also had a high variation of Rct at the same 
time which drops our LOQ in serum. For better investigation, both results of Rct 
variations in Figures 3.4 & 3.5 were combined in a graph shown in Figure 3.6. 
The %Rct variation due to non-specific interactions in both cases were eliminated from 
the results by adopting a normalisation line (dashed line) in Figure 3.6. Hence, it is 
confirmed that the 1.21% ±0.21% variation of Rct upon 1 fM   miRNA incubation was 
raised more than 4-fold to be 5.15% ±3.48% when incubation was carried out in 10% 
serum. LOQ in 10% serum was evaluated as 10 pM. Although the LOD is lower, the 
functional sensitivity of the system with serum samples is best represented by LOQ, 
as it reflects reliable measurements for clinical diagnosis (Armbruster & Pry 2008). 
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 hybridization in 10% serum









Figure 3. 6 Variation of Rct in buffer and 10% serum. The error bars represent three 
separate electrodes. 
 
There could be an explanation for such a result. It is a known fact that miRNA suffers 
from RNAse degradation when not shielded from a nuclease rich environment. 
Although the behaviour of miRNA, in circulating blood, remained enigmatic for a long 
period of time, recent evidence suggests that they are protected by encapsulation in 
microvesicles or proteins of the Argonaute (AGO) family in blood plasma/serum. Such 
encapsulation shields the extracellular miRNA from RNAse degradation (Taylor et al. 
2013) (Etheridge et al. 2013) (Turchinovich et al. 2013) (Kinet et al. 2013). 
Hence, the results shown in Figure 3.6, could be attributed to the fact that when 
miRNA is prepared in a buffer it is still exposed to environmental nucleases causing a 
drop in the actual yield, leading to less hybridisation. However, in a 10% serum, there 
are sufficient amount of proteins that attach to the major binding sites of miRNA 
(Malonga et al. 2006) and protect them from degradation. This could be the possible 
reason as to why the best yield of miRNA and hybridisation with the detection probe 
was obtained in a 10% serum. EIS measurements were repeated with a miRNA spiked 
in 100% serum (Appendix I). Although the variations of Rct were higher compared to 
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control measurements there is still a need for improving the LOD of the platform in a 
100% serum environment (Appendix I). 
 
3. 4 Conclusions 
The results presented in this chapter correspond to the experimental manifestation of 
high sensitivity in electrochemical detection platforms without the need for target 
labelling. With the aim of improving the miRNA sensing, the work in this chapter 
presents a simple and sensitive electrochemical PNA-based biosensor that functions 
with no additional amplification steps. By combining the electrochemical detection 
techniques found in the literature together with our approach of probe optimisation, 
we have achieved significant improvements in Rct variations of the system upon target 
detection. With the current platform, a LOD of 0.77 fM of miR-21-5p was achieved in 
buffer that is almost as good as the previous results reported in literature by use of 
additional amplification steps (LOD of 0.38 fM) (Jolly et al. 2016). Despite the issues 
of non-specific binding in serum, we have achieved a LOQ of 10 pM in a serum 
environment which is a big step towards real case applications. The presented 
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Chapter 4 Simple fishing and pre-
concentration of microRNA with 





Electrochemical detection seems promising for future miniaturised point-of-care 
applications (Silva et al. 2017) and studies so far revealed promising results for the 
electrochemical detection of circulating miRNAs, which are ideal candidates to serve 
as cancer biomarkers (Jolly et al. 2016). The levels of circulating miRNAs provide 
valuable information about cancer in its early stages, before the symptoms arise 
(Lawrie et al. 2008; Chen et al. 2008; Mitchell et al. 2008). Herein, we present the 
development of a new methodology for the simple fishing of target miRNAs from 
solution via magnetic beads which results in the separation and pre-concentration of 
the target prior to analysis, that is crucial for signal amplification for detection. The 
methodology is developed in order to offer detection in complex solutions (e.g. blood) 
which is a major complication for current platforms. Magnetic beads are known to be 
robust and versatile tools for the separation of nucleic acids and are a well known solid 
support for electrochemical detection (Palecek & Fojta 2007). Our methodology 
utilises magnetic beads for capture of the target miRNAs from solution and brings the 
concentrated target to the sensor surface. Herein, we modify the magnetic beads with 
locked nucleic acids (LNA), which have a high affinity for their complementary 
RNA/miRNA sequence, therefore they further encourage the capture of the target 
(Natsume et al. 2007). The separated, hence concentrated miRNAs, are in turn brought 
to a sensor surface that is immobilised with peptide nucleic acids (PNA). 
Electrochemical Impedance Spectroscopy (EIS) is one of the electrochemical 
measuring techniques that tracks the variation of charge transfer resistance (Rct) upon 
hybridisation. The studies of EIS so far on adopting PNA probes has reported the 
detection of 100 times larger Rct values compared to previous DNA probe studies 
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(Keighley et al. 2008b). As a result, PNA probes are incredibly promising tools for 
impedance sensing. Upon adopting the methodology, we have achieved an average Rct 
variation of 32.4% ± 5.4% upon hybridisation of the PNA-probe with its target miRNA 
using LNA-modified magnetic beads. This is significantly higher than the 0.71% 
variation of Rct that was observed for hybridisation with non-specific miRNA. Hence, 
the EIS results confirm the success of our methodology for the fishing of miRNA from 
solution and its direct electrochemical detection on PNA-immobilised gold electrode 
surfaces. To the best of our knowledge, our study is the first experimental work for the 
magnetic beads-based capture of miRNA from solution using high affinity LNA-
probes, that doesn’t require prior sample preparation for target labelling or the 
adoption of enzymatic labelling on the probe surface for detection. 
 
4. 1 Background  
Magnetic beads hold many applications and are a well-known solid support for 
electrochemical detection (Wang et al. 2002; Katz et al. 2004; Palecek & Fojta 2007). 
Recently there has been an interest in the design of new electrochemical biosensors for 
nucleic acid detection using magnetic beads that offer efficient magnetic separation 
(Gogotsi & Uvarova 2003). The adoption of the beads for the electrochemical 
detection of miRNA was initially suggested by Bettazzi et al. (Bettazzi et al. 2013) and 
the study revealed a detection limit of 7 pM for miR-222, where the sequence was 
chosen as a model due to its involvement in brain, lung and liver cancers. The 
methodology required the functionalisation of the streptavidin coated magnetic beads 
with a biotinylated DNA probe that was specific to the target miRNA. This was 
followed by the extraction of the target miRNAs from the cell samples and their 
labelling with biotin. The biotinylated target was then hybridised with the DNA 
capture probe on the magnetic bead. The resulting biotinylated hybrid was labelled 
with a streptavidin-alkaline phosphatase conjugate. The magnetic beads that hold the 
biotinylated DNA-miRNA hybrid with streptavidin-alkaline phosphatase conjugate 
were then magnetically entrapped on to a screen-printed electrode. The substrate was 
added for measuring the enzymatic product, and the measurements were carried out 
using differential pulse voltammetry. The assay was integrated into a microfluidic 
device that facilitated multiplexed analysis. 
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The following year, in 2013, a similar study reported detection limits as low as 
femtomolar (fM, 10−15) levels for voltammetric detection of miRNA by designing a 
magnetic beads based assay on a multi-channel screen-printed array of electrodes 
(Erdem et al. 2013). In the same year, another study achieved the creation of a highly 
sensitive platform that revealed attomolar (aM, 10-18) level detection of oral-cancer 
related miRNAs (Wang et al. 2013). Similar to previous studies streptavidin coated 
magnetic beads were initially modified with a biotinylated capture probe (Pc). The 
methodology showed a slight variation from previous methods, as a second probe was 
adopted as signal probe (Ps) that was modified with a biotin tag at two ends. In the 
absence of target microRNA, the Pc and Ps would not hybridise due to low melting 
points. Whereas when incubated with target miRNA (T), the capture probe (Pc) would 
be able to hybridise with T (target miRNA) and Ps (signal probe) forming “Y” junction 
structures on the magnetic beads. This step was followed by the capture of horseradish 
peroxidase (HRP) conjugated streptavidin by the biotinylated signal probes and the 
resulting HRP-tagged surface of magnetic beads were adsorbed onto the working 
electrode surface that was electrically magnetic-controllable, enabled by a voltage on 
the electric coil. The resulting HRP-tagged magnetic beads catalyse the H2O2-
mediated oxidation of TMB (3,3’,5,5’-tetramethylbenzidine sulfate). The electrically 
magnetic-controllable electrochemical biosensor allowed the detection of miRNA 
concentrations at attomolar levels, with a linear range of 1 aM~10 fM. (Wang et al. 
2013). 
In 2013, Bartosik et al (Bartosik et al. 2013) reported another study for the detection 
of miRNA using magnetic beads. This work utilised target miRNA pre-labelled with 
the electroactive Os(VI)bipy (six-valent osmium and 2,2′-bipyridine) complex on the 
ribose sugar molecule at the 3′-end of miRNA. The magnetic beads that were 
immobilised on the complementary probe were then used to capture Os(VI)bipy-
labelled miRNAs followed by the thermal release of the target and electrochemical 
detection at a hanging mercury drop electrode at femtomole levels (Bartosik et al. 
2014). It was not long after in 2014 that an electrochemical magnetosensor platform 
for the direct detection of miRNAs in raw RNA samples on commercial screen-printed 
electrodes was suggested (Campuzano et al. 2014). The method eliminated the pre-
labelling of the target as suggested by previous studies. Carnarian Italian ringsport 
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virus (CIRV) p19 protein was immobilised through its terminal chitin-binding domain 
(CBD) to chitin-functionalised magnetic beads and utilised to capture previously 
hybridised duplexes of miRNA/anti-miRNA. The captured hybrid was labelled with 
Strep-HRP polymer and the resulting magnetic beads were then magnetically anchored 
onto screen-printed carbon electrodes. The method performed a detection limit of 0.04 
nM by measuring the catalytic amperometric current upon the addition of H2O2 and 
hydroquinone. 
An even lower detection limit of 10 aM was achieved in 2017 (Vargas et al. 2017) by 
adopting a similar methodology to Campuzano et al, which eliminates the pre-labelling 
of target miRNAs. The methodology utilised the direct hybridisation of the target 
miRNA (miRNA-21) with a biotinylated DNA capture probe that was previously 
immobilised on streptavidin-modified magnetic beads. The resulting helix was 
initially labelled with a specific DNA–RNA antibody and the bacterial protein A 
(ProtA) conjugated with horseradish peroxidase (HRP) homopolymer (Poly-HRP40) 
as an enzymatic label for signal amplification. Then the modified magnetic beads were 
anchored onto a working electrode surface of commercial screen-printed electrodes 
utilising the H2O2/hydroquinone (HQ) system. Finally, amperometric detection was 
performed. 
With the aim of advancing the current technologies of magnetic bead-based 
electrochemical detection, the first and most crucial step forward is the analysis of how 
well the current methodologies satisfy the requirements of a final product that is 
commercially viable. Through a gap analysis, one can identify the space between 
where the current technology is and where it has to be in order to desing a demanded 
sensor. This analysis is extremely beneficial in order to develop a new methodology 
that fulfils the weaknesses of current models. Hence, Table 4.1 provides an insight into 
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Table 4. 1 List of current magnetic beads-based electrochemical detection 
methodologies for miRNA detection 
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4.1. 1 New Assay Design 
In order to improve the current methodologies in literature, we designed a new assay 
that combines the high affinity and separation properties of LNA modified magnetic 
beads with the high stability of PNA probes on gold electrode surfaces in order to 
develop a magnetic-beads based direct electrochemical detection of miRNAs from 
solution. Our methodology initially replaces the DNA/RNA capture probe that is 
adopted in the literature with a probe that has a higher affinity to miRNAs. One nucleic 
acid that is known for displaying extraordinary hybridisation affinity towards RNA is 
Locked Nucleic Acid (LNA). The enhanced affinity is a result of the modified 
chemical structure of LNA (Laschi et al. 2009) that leads to the high melting points of 
LNA-RNA (Natsume et al. 2007) and makes LNA well suited for miRNA detection 
and analysis for cancer diagnosis. Hence, a biotinylated LNA probe was adopted and 
LNA-modified streptavidin coated magnetic beads were utilised for capturing miRNA 
from solution. After separation of the target miRNA from solution, a number of 
thermal and chemical denaturation methods were investigated for the most efficient 
release of the captured miRNA target from magnetic beads. A PNA-immobilised gold 
electrode was adopted for the identification of the miRNA that was captured by 
magnetic beads. PNA oligonucleotides when immobilised on gold electrode surfaces 
provide exceptional stability and great detection limits for the identification of low 
concentrations of miRNA in a solution (Jolly et al. 2015; Jolly et al. 2016). Hence, 
such a methodology does not only eliminate the pre-labelling step of target but also 
benefits from the high affinity properties of LNA-probes for capturing low 
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Figure 4. 1 Schematic diagram of the assay. (1) Streptavidin coated magnetic beads 
ready for probe modification. (2) Biotinylated LNA capture probes are immobilised 
on magnetic beads via streptavidin-biotin bonding. (3) Surface blocking carried out 
with biotin in order to prevent non-specific binding. (4) Probe-modified and biotin 
blocked beads incubated with miRNA target (diluted for desired concentration in 10 
mM PB) (5) chemical or thermal release of the miRNA from magnetic beads surface. 
(6) Re-hybridisation of captured miRNA with PNA-probe for electrochemical 
detection. 
 
4. 2 Materials and Methods 
4.2 1 Preparation of magnetic beads 
Prior to any assay, the PierceTM Streptavidin Magnetic Beads (Thermo Scientific) were 
washed with 25 mM Tris-buffered saline containing 0.1% TweenTM-20 Detergent 
(Thermo Scientific). This was carried out by adding 30µL (0.3 mg) of magnetic beads 
into 1.5mL micro centrifuge tube that was placed on a magnetic stand to collect the 
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beads to the side of the tube. The supernatant was removed with the help of pipette 
and discarded. Then 1 mL of wash buffer (Tris-buffered saline) was added to the tube. 
The tube was inverted several times and gentle vortex was applied for an even mix. 
The beads were then collected with magnetic stand to the side of the tube and the 
supernatant was removed. It is crucial not to allow beads to dry and if necessary, the 
beads were stored in wash buffer until the incubation with the LNA probe was carried 
out. 
 
4.2 2 Oligonucleotides 
The synthetic biotinylated LNA capture probe was purchased from Eurogentec, UK, 
in lyophilised form while the HPLC purified synthetic miRNA sequences were 
purchased from Sigma-Aldrich, UK, in lyophilised from. The PNA probe was 
purchased from Cambridge Research Biochemical, UK. The sequences are shown in 
Table 4.2. 
 
Table 4. 2 LNA, PNA and miRNA sequences used by this study. The full 
complementary sequence on the first row corresponds to the miR-21-5p sequence 
specific to pancreatic cancer. TEG stands for tetra-ethyleneglyco linker (15 atoms) 
which is used to add Biotin to an oligonucleotide. AEEA is a glycol linker of nine 
atoms (8-amino-3,6-dioxaoctanoic acid). LNA modification sites in each sequence are 
represented by (ln). 
 
miR-21-5p sequence (full 
complementary) 
3’-AGU UGU AGU CAG ACU AUU CGA 
U-5’ 
LNA Probe: 5’-Biotin-TEG T(lnC)A-A(lnC)A-TCA-G(lnT)C-TGA-
T(lnA)A-G(lnC)T-(lnA)-‘3 
PNA probe: SH-C6-AEEA-TTT TCA ACA TCA GTC TGA TAA GCT A 
Non-specific miRNA sequence 3’-AGU UGU ACC AGA UAU CCG UAA 
A-5’ 
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4.2 3 Bio-functionalisation of magnetic beads 
Prior to bio-functionalisation, the PierceTM Streptavidin Magnetic Beads (Thermo 
Scientific) were washed by following the procedure given in section 4.2 1. This was 
then followed by washing the beads within the immobilisation buffer (10 mM PB 
buffer, pH 7.3) that was carried out by adding 1 mL of 10 mM PB buffer (pH 7.3) to 
the tube that contained the pre-washed dry beads. The tube was inverted several times, 
and a gentle vortex was applied for an even mix and the beads were collected with the 
magnetic stand. The supernatant was removed, and the dry beads were incubated with 
300 µL of 1 µM biotinylated LNA-probe solution immediately. 1 µM of biotinylated 
LNA-probe solution was prepared in 10 mM PB buffer (pH 7.3) prior to 
immobilisation with magnetic beads. The incubation with LNA-probe solution was 
carried out at room temperature for 1 hour with continuous mixing. In the end, 
modified beads were collected by placing the tube on the magnetic stand again and 
removing the supernatant for further analysis. Then the modified beads were washed 
with 10 mM PB buffer twice and were incubated with 100 µM biotin (prepared in 10 
mM PB buffer, pH 7.3) in order to block the remaining streptavidin active sites on the 
probe-functionalised surface, hence eliminating the undesired binding of other 
biotinylated oligonucleotides. After biotin blocking, the beads were collected with the 
magnetic stand, and supernatant was removed for further analysis. This was followed 
by a final wash of the beads in 10 mM PB buffer. 
 
4.2 4 Hybridisation of LNA-functionalised magnetic beads with target 
miRNA 
1 µM of 300 µL target miRNA was prepared in 10 mM PB (pH 7.3) and heated at 
95˚C in a water bath for 5 minutes prior to incubation. The heating was carried out in 
order to prevent the formation of hairpins or secondary structures, as the evidence 
suggests that miRNAs have a tendency to form both hairpin and homoduplex 
structures in solution (Belter et al. 2014). This was followed by incubating the dry 
LNA-functionalised (bio-functionalised) magnetic beads with 300 µL of the target 
miRNA solution for 30 minutes at room temperature, with continuous mixing for the 
hybridisation to take place. In the end, the beads were collected with the magnetic 
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stand, and the remaining solution was removed for further analysis. The beads that 
contained the LNA-miRNA hybrids were washed twice in 10 mM PB buffer and then 
a number of thermal/chemical denaturation methods were studied for the most efficient 
release of the target miRNA from the magnetic beads surface. These methods are 
explained further in Section 4.2 5. Following the denaturation step, the beads were 
separated from the solution by use of the magnetic stand and the solution that contained 
the captured miRNA target was removed for electrochemical detection on PNA-
probes. 
 
4.2 5 Physical and Chemical Methods for LNA-miRNA Denaturation 
A variety of physical and chemical denaturation methods were investigated for the 
optimum release of miRNA target from the surface of magnetic beads after being 
captured by the LNA-probe. This study is crucial for the optimum yield of the target 
sequence for the detection studies. 
 
4.2.5. 1 Heating 
The final solution of LNA-modified magnetic beads (300 µL) that were previously 
hybridised with target miRNA, was heated in a water bath at 95˚C for 10 minutes. 
4.2.5. 2 Removal of Salts 
A low salt concentration can lead to the denaturing of DNA double-strands due to the 
removal of ions that stabilise the negative charges on each of the two single strands. 
Electrochemical detection studies have shown that successful hybridisation of DNA-
DNA (Keighley et al. 2008a), DNA-RNA (Wang et al. 2001) or LNA-RNA (Laschi et 
al. 2009) requires the presence of ions that will provide the screening for the negative 
backbone phosphate groups that are present both in DNA and RNA single strands. 
Hence, for the denaturation experiments 300 µL of Milli-Q water that was free from 
salts was added to the tube containing LNA-functionalised magnetic beads previously 
hybridised with target miRNA. The mixture was incubated at ambient temperature for 
10 minutes prior to measurements with UV spectrophotometry. 
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4.2.5. 3 Alkaline solution  
In previous studies, various concentrations of NaOH (0.01, 0.1 and 1 M) were 
investigated for their efficiency for the denaturation studies of DNA duplexes. 
Amongst the three concentrations, 1 M NaOH achieved 90% denaturation of DNA 
fragments in one minute followed by complete denaturation in 10 minutes (Wang et 
al. 2014). Hence, we adopted the same concentration for the chemical denaturation 
studies of the LNA-miRNA duplex. The stock solution of NaOH (10 M) was prepared 
upon dissolving 4 g of NaOH (Sigma-Aldrich) in 10 mL of Milli-Q water. The NaOH 
was diluted from 10 to 1 M in Milli-Q for the assays. 300 µL of 1 M NaOH were added 
to the tube containing LNA-functionalised magnetic beads previously hybridised with 
target miRNA. The mixture was incubated at ambient temperature for 10 minutes prior 
to measurements with UV spectrophotometry. 
4.2.5. 4 Dimethyl Sulfoxide (DMSO) 
DMSO is another agent that has proven to provide efficient denaturation by lowering 
the melting temperature of the DNA. Upon trying various concentrations of DMSO 
(25%, 50% and 60%), Wang & Son et al. achieved complete denaturation of DNA in 
60% DMSO in one minute followed by further denaturing to 90% over time (Wang & 
Son 2013). On the other hand, another study (Wang et al. 2014) revealed the 
denaturation capability of DMSO with higher concentrations and proved that 60% 
DMSO is sufficient for the complete denaturation of DNA in contrast to low 
concentrations. Hence, DMSO was purchased from Sigma-Aldrich at a grade for 
molecular biology use (99.9%). 300 µL of 60% DMSO was prepared in Milli-Q water. 
The solution was added to the tube containing LNA-functionalised magnetic beads 
that were previously hybridised with target miRNA. The mixture was incubated at 
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4.2.5. 5 Urea 
The denaturation ability of urea has been widely attributed to its capability to disturb 
interpeptide and interchain hydrogen bonds (Herskovits 1963). Several early studies 
looking into the effects of urea on suitable model compounds (Levy & Magoulas 1961) 
and detergent micelles (Bruning & Holtzer 1961) have suggested this property of urea 
is grossly oversimplified and at least partly attributed to the destabilisation of 
hydrophobic interactions. Hence, the urea was considered capable of destroying not 
only hydrogen bonds but also other sources of stabilisations, like hydrophobic 
interactions. Shen et al. adopted a 50% (w/w) urea solution for target DNA 
dehybridisation on the surface of magnet submicrobeads following their capture with 
DNA-probes (Shen et al. 2012). The technique achieved a limit of detection of 8.5 fM. 
In addition, Zhang et al also used a 50% (w/w) urea solution to release target DNA 
from the surface of magnetic nanobeads immobilised with probe DNA (Zhang et al. 
2009). Hence, we employed the same methodology and 300 µL of 50% (w/w) urea 
were prepared for incubation in a tube containing LNA-functionalised magnetic beads 
previously hybridised with target miRNA. The mixture was incubated at ambient 
temperature for 10 minutes prior to measurements with UV spectrophotometry. 
 
4.2 6 UV-Spectrophotometer measurements for validation of design 
steps 
A Shimadzu UV-1800 with Thermal Melt Analysis System was adopted in order to 
validate the assay steps. The solutions of LNA-probe and target miRNA prior to their 
bio-functionalisation and hybridisation on magnetic beads surface were analysed by 
UV-spectrophotometry. This was followed by the analysis of the final solution of 
target miRNA after its capture on the magnetic beads surface and release. 8-series 
micro cells with silicone plugs that fit inside the spectrophotometer were adopted in 
order to measure the samples; this has the benefit of allowing the user to analyse 8 
different samples during one measurement. The amount of light that is absorbed by 
the solution is dependent on the concentration, the path length of the light through the 
cuvette and how well the analyte absorbs the light at a certain wavelength. It is a known 
fact that single or double stranded DNA, RNA or LNA oligonucleotides, absorb 
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ultraviolet (UV) light due to the existence of heterocyclic rings of the nucleotides. The 
absorbance levels are usually observed to be around 260 nm (Tinoco et al. 1980; 
Okonogi et al. 2002) and these absorbance properties can be adopted for their 
quantification (Engman et al. 2004). Hence, UV spectrophotometry was run within the 
region of 190 nm-800 nm, which allows enough room to identify the LNA-probe, 
initial target miRNA, and the captured target miRNA. Initially, a baseline 
measurement was carried out by adding 80 µL of buffer solution (10 mM PB) to each 
of the micro-cells which sets a reference baseline prior to the actual measurements of 
nucleic acids within the same buffer. Following the baseline measurement, each micro-
cell was emptied and re-filled with 80 µL of solutions which contained the nucleic 
acids prepared in the same buffer (10 mM PB) for the analysis. 
 
 
                      
 
Figure 4. 2 Shimadzu UV-1800 spectrophotometer with Thermal Melt Analysis 
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4.2 7 Electrochemical detection of captured miRNA  
Gold working electrodes were mechanically polished for 2 minutes with 1 µM 
diamond solution (Buehler, USA) on a polishing pad (BASi, USA). This was followed 
by mechanical polishing using alumina slurry with decreasing particle sizes (starting 
with 1 µm, then 0.3 µm, and finishing with 0.05 µm). Polishing was carried out for at 
least 2 minutes in each particle size. In between each polishing step, 5 minutes of 
sonication in ethanol and rinsing in Milli-Q water were performed to remove the 
residues. After the final polishing, 10 minutes of sonication in ethanol followed by 10 
minutes in Milli-Q water was carried out. Electrodes were then rinsed with Milli-Q 
water and electrochemically cleaned in 0.5 M H2SO4 (Thermo Fisher Scientific, UK) 
by scanning the potential between the oxidation and reduction of gold, 0 V and +1.5 
V vs. an Ag/AgCl reference electrode, for 50 cycles until the voltammogram graphs 
suggest no further changes. Finally, the electrodes were rinsed with Milli-Q water and 
dry cleaned under a nitrogen gun. 
Clean electrodes were then co-immobilised with the thiolated ssPNA probe sequence 
and 6-mercapto-1-hexanol (MCH, Sigma-Aldrich, UK) in 50% dimethyl sulfoxide 
(DMSO, Sigma-Aldrich, UK) 50% ultra-pure water (v/v) immobilisation solution for 
16 h in a humidity chamber. After immobilisation, electrodes were rinsed with excess 
Milli-Q water to remove any unattached thiols and were backfilled with 1 mM MCH 
for one hour in order to ensure complete thiol coverage. Electrodes were then rinsed 
with excess Milli-Q water and placed in the measurement buffer for 2 hours to stabilise 
the SAM. 
The experiments were carried out with a PalmSense4 compact potentiostat 
(PalmSense, Netherlands) and a three-electrode cell system: An Ag/AgCl (KCl) 
reference electrode (BASi, USA) connected via a salt bridge filled with 10 mM 
phosphate buffer (pH 7.3), to a Pt counter electrode (ALS, Japan), and gold working 
electrode (2.0 mm diameter from CH instruments, USA). The Faradaic EIS was 
conducted in 10 mM PB (pH 7.3) measurement buffer containing 10 mM of the 
ferro/ferrocyanide ([Fe(CN)6])
3-/4-  redox couple over a frequency range from 100 kHz 
to 100 mHz, with a 10 mV ac voltage superimposed on a dc bias voltage of 0.2 V vs. 
Ag/AgCl (corresponding to the formal potential of the redox couple). 
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4. 3 Results and discussion  
4.3. 1 The use of UV-Spectrophotometry for validation of design steps 
Shimadzu UV-1800 spectroscopy was initially adopted for the identification of the 
solutions in order to validate the feasibility of each design step. UV measurements 
provided the absorbance levels for the solutions containing the probe and the target 
(LNA and miRNA) adopted in the experiments, and the residue solutions of magnetic 
beads before/after their functionalisation with the LNA-probe, hybridisation with  the 
target sequence and subjection to heat (or chemical denaturation methods).  
An absorbance peak at around 260 nm is reported in the literature for the representation 
of nucleic acids (Tinoco et al. 1980). Hence, a similar absorbance peak for the final 
solution of target miRNA captured by the magnetic beads would prove the success of 
the methodology for fishing for miRNA from solution. 
Prior to analysis, we have tested the thermal stability of PierceTM Streptavidin 
Magnetic Beads that were modified with biotinylated LNA, under extreme heat 
conditions (95˚C for 10 minutes). Such a study is crucial in order to make sure that the 
stability of streptavidin-biotin binding (between the beads and the LNA-probe) is 
conserved under high temperatures. The application of high temperatures was required 
for the denaturation of the probe LNA-target miRNA helix for the final release of 
target. An inability of the magnetic beads-LNA binding to resist high temperatures 
could result in the release of the LNA probe together with the target miRNA from the 
magnetic beads’ surface, hence lead to false signal in the final solution for captured 
target miRNA. Although the biotin, after binding streptavidin, increases the thermal 
stability of streptavidin significantly (Gonzalez et al. 1999), there are studies that 
reported the reversible breakage of the bond under elevated temperatures (Holmberg 
et al. 2005). Hence, we functionalised the PierceTM Streptavidin Magnetic Beads with 




C h a p t e r  4                                            P a g e  | 116 
 
   
 
Figure 4. 3 A UV absorbance graph for blank buffer (black line), biotinylated LNA 
probe in buffer (red line), and the residue buffer solution after the heating up of LNA 
modified magnetic beads at 95˚C for 10 minutes (blue line). The absorbance levels 
below 230 nm were considered to be noise due to the increased absorbance of the 
quarts cuvette itself, upon being subjected to light at wavelengths lower than 250 nm. 
 
Following the heating of LNA-modified magnetic beads at 95˚C for 10 minutes, UV 
spectrophotometry results in Figure 4.3 for the residue solution (blue line) indicated 
an absorbance peak at 263 nm. This value is very close to the initial absorbance peak, 
at 259 nm, that was obtained for the LNA probe prior to its immobilisation on magnetic 
beads. Such results could be attributed to the fact that under high temperature 
conditions, a disruption is made in streptavidin-biotin binding between the magnetic 
beads and the probe. This results in the discharge of the LNA-probe into solution. 
Additionally, the slight shift of the absorbance peak (Figure 4.3, red peak → blue 
peak), after the heating up of the LNA-modified beads, towards the right end of the 
spectrum could be attributed to the additional discharge of the streptavidin coating of 
the magnetic beads into solution (Stoscheck 1990). This condition was confirmed by 
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a second assay that analysed the residue solution of magnetic beads (without the LNA 
probe) before and after heat was applied. 
 
 






















 buffer  
 magnetic beads washed in buffer 
 magnetic beads washed in buffer and heated up 
         at 95C 
 
 
Figure 4. 4 UV absorbance graph for blank buffer (black line), residue solution of 
magnetic beads after being washed in buffer (red line), residue solution of magnetic 
beads after being washed and heated up at 95˚C for 10 minutes in buffer (blue line). 
The absorbance levels below 230 nm were considered as noise due to the increased 
absorbance of the quarts cuvette itself upon being subjected to light at wavelengths 
lower than 250nm. 
 
The results in Figure 4.4 suggest no significant absorbance peak in the residue solution 
of magnetic beads upon being washed in buffer. This indicates no dissociation of the 
streptavidin coating from the magnetic beads surface upon washing. However, an 
absorbance peak at 280 nm was observed within the residue solution after heating up 
the beads to 95˚C. This could be attributed to the discharge of the streptavidin coating 
of the magnetic beads upon heating, and resulting in the absorbance at 280 nm that 
indicates the presence of proteins (Stoscheck 1990). This also explains the slight shift 
of the absorbance towards 280 nm (blue peak) in Figure 4.3 for the residue solution of 
280 nm 
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LNA-modified magnetic beads upon heating, as the peak corresponds to the 
dissociation of the LNA-probe together with the streptavidin into solution. 
The results indicated the degradation of the streptavidin coating of magnetic beads 
upon heating and the crucial need for an alternative method for the denaturing step of 
the LNA probe-target miRNA duplex that eliminates heat. For this purpose, another 
set of assays were performed which compared the efficiency of denaturation and target 
release using a number of chemical methods. Four different methods were adopted: 
incubation with Milli-Q water (ion-free), 50% (w/w) urea solution, 60% DMSO 
solution and 1 M NaOH (alkaline) solution for 10 minutes at ambient temperature. 
Prior to the assays, the LNA-functionalised magnetic beads were incubated with each 
solution in order to confirm that the biotin-streptavidin bonding between the probe and 
the magnetic beads was not disrupted upon incubation with these solutions. Hence, the 
absorbance peaks observed in the residue solution after denaturation of the LNA probe 
functionalised magnetic beads-target miRNA can be attributed only to target release 
and no interference due to probe dissociation from the magnetic beads surface into 
solution. 
 
    
Figure 4. 5 UV-absorbance graph of the final solution of target miRNA after 
performing dehybridisation in Milli-Q solution (black line), in 50% (w/w) urea 
solution (red line), in 60% DMSO solution (blue line), and in 1 M NaOH solution 






















 LNA-miRNA dehybridization in milli-q
 LNA-miRNA dehybridization in 50% urea 
 LNA-miRNA dehybridization in 60 % DMSO
 LNA-miRNA dehybridization in 1 M NaOH
264 nm
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(green line) for 10 minutes. For each measurement, a baseline measurement was 
carried out within the solution of investigation prior to the UV-analysis. The 
absorbance levels below 230 nm were considered to be noise due to the increased 
absorbance of the quarts cuvette itself upon being subjected to light at wavelengths 
lower than 250nm. 
 
As suggested by the results in Figure 4.5, a distinguishable nucleic acid absorbance 
peak was observed only in two cases: one with the adoption of 1 M NaOH, and one 
with the adoption of 60% DMSO for the denaturation of the LNA capture probe-
miRNA hybrid duplex. The peak is most significant and clear at 260 nm for the case 
of 1 M NaOH where this peak is slightly shifted to 264 nm upon the adoption of 60% 
DMSO which also presented very noisy data upon being measured. Therefore, we have 
decided to pursue the rest of the assays by adopting 1 M NaOH as a chemical 
denaturation method, which presented promising results for the release of target 
miRNA. 
Another assay was carried out for the comparison study of the expected absorbance 
peak of miRNA in solution, with the absorbance peak obtained after its capture and 
then its release into solution. Such a method would prove the presence of captured 
miRNA in the final solution. The results presented in Figure 4.6 revealed an absorption 
peak at 259 nm for the biotinylated LNA probe (Figure 4.6(a), step i), 258 nm for the 
target miRNA in solution before its capture (Figure 4.6(a), step ii), and 259 nm for the 
solution that contains the captured target miRNA that was released by chemical 
denaturation in 1 M NaOH solution (Figure 4.6(a), step 5). The results match closely 
with literature that identifies an absorbance peak at around 260 nm for the 
representation of nucleic acids (Tinoco et al. 1980). The presence of an absorbance 
peak at 259 nm in the final target solution that is very close to the initial absorbance 
peak of the target solution indicates a successful capture by the magnetic beads and 
the subsequent release into final solution. Hence, the final solution of target miRNA 
was utilised for its electrochemical detection with PNA-probes (Section 4.3.2) for the 
approval of our methodology of fishing of miRNA from solution by use of magnetic 
beads. 
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      (a) 
          
     (b) 
          
 
Figure 4.6 (a) Representation of the design steps (i, ii and 5) that were tested by UV 
spectrophotometry measurements. (b) UV absorbance of the biotinylated LNA probe 
(red), target miRNA (blue), and the magnetic beads captured miRNA (pink). Buffer 
was set as the baseline measurement (black line) of the spectrophotometer prior to UV 
analysis. The absorbance levels below 230 nm were considered to be noise due to the 
increased absorbance of the quarts cuvette itself upon being subjected to light at 
wavelengths lower than 250 nm. 
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4.3. 2 Electrochemical Impedance Spectroscopy (EIS) results 
Faradaic EIS was selected for the evaluation of the stability of the fabricated PNA-
probe prior to analysis with target miRNA (Figure 4.7a). PNA-probes are known for 
their high specificity to complementary targets and are expected to perform no 
hybridisation with a non-specific target. This was confirmed by an assay that was 
performed by incubation of PNA-immobilised electrodes with a high concentration of 
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Figure 4. 7 (a) EIS characterisation of the PNA immobilised probe stability in 10 mM 
PB (pH 7.3) buffer followed by hybridisation in 10 mM PB (pH 7.3) that contains 1 
nM non-specific miRNA. (b) Percentage variations of Rct upon hybridisation of PNA 
immobilised probe with a non-specific miRNA target. All measurements were 
performed in 10 mM PB that contains 10 mM of [Fe (CN)6]-3/4- redox couple. Error 
bars represent three separate electrodes. 
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The next two assays were carried out in order to observe the hybridisation of the PNA-
probe with the target miRNA captured by LNA-modified magnetic beads. The 
measurements were performed in 10 mM of [Fe (CN)6]-3/4- redox couple to monitor 
the resistance to charge flow transfer upon target binding events.  The first assay 
adopted the solution of thermally released miRNA from the magnetics beads’ surface 
for its hybridisation on complementary PNA probes. In previous sections we have 
observed that high temperatures lead to the dissociation of the streptavidin coating 
from the magnetic beads surface and the release of probe-LNA. Hence, upon EIS 
measurements no variation of Rct was expected due to the lack of a target in the 
solution. On the other hand, the second assay eliminated the use of high temperatures 
and adopted a chemical denaturation method (incubation of magnetic beads containing 
LNA-miRNA helix in 1 M NaOH) for the release of target from the magnetic beads’ 
surface. Hence, EIS measurements were expected to display an increased value of Rct 
due to the presence of captured miRNA, inside the solution, that is complementary to 
the probe-PNA. Binding of the target to the PNA-probe is expected to increase the 
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                           (a) 
                        
                           (b) 
                            
Figure 4. 8 (a) EIS characterisation of the PNA immobilised probe and its stability in 
blank buffer followed by hybridisation with solution that contains thermally released 
miRNA from magnetic beads surface. (b) EIS characterisation of the PNA 
immobilised probe and its stability in blank buffer followed by hybridisation with 
chemically released miRNA from magnetic beads surface. All measurements were 
performed in 10 mM PB that contains 10 mM of [Fe (CN)6]-3/4- redox couple. For the 
stability measurements, the electrodes were incubated in 10 mM PB for 30 minutes 
prior to measurement in redox couple. 

















 Stability in blank buffer
 Buffer containing thermally released 
         miRNA target



















 Stability in blank buffer
 Buffer containing chemically
         released miRNA target
C h a p t e r  4                                            P a g e  | 125 
 
   
The results given in Figure 4.8 (a) represent the measurements of the assay design that 
used the method of thermal denaturation for the release of target miRNA from the 
magnetic beads’ surface. A PNA/MCH self-assembled layer with a ratio of 1:10 had 
an Rct variation of 2.24% upon stabilisation, which reflects the formation of a stable 
PNA-MCH SAM. Initial incubation with the blank buffer showed no significant 
change of Rct (∆Rct = 3.8%), which demonstrates a strong stability of the probe before 
its incubation with the target. This was followed by incubation with the solution that 
was expected to contain the magnetic beads-captured miRNA, free in solution, upon 
thermal release. However, the EIS results showed almost no variation in Rct, (785.6 Ω 
→765.9 Ω, ∆Rct=6.2%) upon target incubation, as shown in Figure 4.8 (a). This has 
once again proven the poor efficiency of thermal release, with possible disruption of 
the magnetic beads surface, and encourages the application of chemical denaturation 
methods. As a result, the assay was repeated by replacing thermal denaturation with 
the incubation in an alkaline solution (1 M NaOH diluted in Milli-Q). The target 
miRNA that was released into the alkaline solution was in turn re-hybridised with the 
PNA probe for EIS detection. The conditions for the re-hybridisation with the PNA 
probe was achieved by mixing 10 µl of the target solution (in 1 M NaOH solution) 
with 100 µl of 10 mM PB solution (at pH 7.3). This is necessary to represent the 
hybridisation buffer, and reduce the pH of the alkaline solution for the required 
hybridisation efficiency with the complementary PNA probe. The results shown in 
Figure 4.8 (b) once again suggest the strong stability of PNA-MCH SAM prior to 
incubation with target. In this case, a significant Rct variation of 40.1% was observed 
after incubation with the target, which corresponds to successful hybridisation. The 
assay was repeated on three different electrodes in order to approve the reproducibility 
of detection. 
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Figure 4. 9 Percentage variations of Rct upon hybridisation of PNA immobilised probe 
with chemically released target miRNA. Error bars corresponds for the standard 
deviation for three separate electrodes. 
 
The results in Figure 4.9 revealed the reproducibility of the method upon detection on 
three different PNA-immobilised electrodes that suggested an average Rct variation of 
32.4 ± 5.4 % upon hybridisation with the target miRNA. This is significantly higher 
than the blank buffer incubation that had an Rct variation of 2.18 ± 0.78 %.  Hence, our 
methodology of fishing for miRNA from solution by use of LNA-modified magnetic 
beads was proven to successfully separate the target from solution and its direct 
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4. 4 Conclusions 
In this work, we have developed a new method for magnetic beads based 
electrochemical detection of miRNA that involves separation and pre-concentration of 
the target miRNA sample from solution, and its direct electrochemical detection on a 
PNA-immobilised gold electrode. By optimising the various assay steps found in the 
literature, we have developed an improved methodology which offers direct detection 
of target miRNAs with no need for pre-labelling of target sequences or enzymatic 
labelling on the detection probe. In an ideal world, it is crucial to develop technologies 
that provide accurate results without the requirement for many amplification steps. 
Although the literature offers various magnetic beads-based detection methodologies 
with great limits of detection, there is still the need for the elimination of a number of 
the assay steps that are not suitable for real world applications. In the healthcare 
industry there is a need for point-of-care testing that is simple, and offers results in a 
short time after patient contact. For this purpose, we have investigated the feasibility 
of a methodology that eliminates the need for sample preparation, hence the 
requirement for trained labour, or for additional signal enhancement steps. 
Additionally, an important and neglected aspect of miRNA detection is distinguishing 
between the pool of miRNA sequences which can lead to false positives in the results 
of patients. For this purpose, the LNA-probes that were utilised have a special affinity 
for complementary miRNAs, and offer improved hybridisation efficiencies. Such a 
property of LNA-probes was combined with the separation properties of magnetic 
beads so that LNA favoured capturing of target miRNA from solution was achieved. 
Following the capture of the target, we have carried out chemical denaturation of the 
hybridised LNA-miRNA helix for the release of the miRNA from the magnetic beads’ 
surface. Then we utilised PNA-immobilised gold electrodes for the EIS based 
detection of miRNA, which demonstrates a significant variation in Rct (32.4 ± 5.4 %) 
upon target incubation. We believe such a model for detection is a crucial step towards 
the easy fishing of miRNAs from complex solutions, such as blood, and pre-
concentration of the target prior to its direct electrochemical detection for 
quantification. The idea can be easily translated to manufacturing by utilising the 
“Lab-on-chip” technology for diagnostics (Herold & Rasooly 2009; Erickson et al. 
2014), which is further explained and demonstrated in Chapter 6. EIS measurements, 
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by using PNA-probes, revealed a strong specificity by having almost no variation in 
Rct (0.78±0.07%) with a non-specific miRNA solution. Hence, we have demonstrated 
the feasibility of a methodology for the detection of miRNA, that combines the highly 
specific separation properties of LNA-modified magnetic beads with the sensitive and 
specific electrochemical detection properties of PNA-probes. To the best of our 
knowledge, our experimental work is the first PNA-probe based electrochemical 
detection study that utilises LNA-modified magnetic beads for capture and pre-
concentration of miRNA prior to analysis. Up to date, direct electrochemical detection 
of miRNAs from complex solution, such as blood continues to be a challenge. We 
hope our methodology, upon further investigations, will be applicable for the detection 
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Chapter 5 Redox-tagged peptide 




In this chapter, we report on the adoption of a redox-active self-assembled monolayer 
for direct and capacitive based recognition of the target binding. The methodology can 
significantly benefit electrochemical biosensing platforms due to the redox active 
nature of the SAM. Incorporation of a peptide possessing ferrocene moieties that has 
self-assembling capability to metal surfaces, for the recognition of target 
biomolecules, has proven to be a success in previous studies. Hence, our methodology 
modifies the existing method for its use with PNA probes for the detection of DNA 
which can eventually be adapted for miRNA detection. This is mainly due to DNA 
being less vulnerable to RNAse degradation than miRNA, which provides an 
advantage when performing optimisation studies. If successfully implemented, such a 
methodology comes with the major advantage of eliminating the need for the doping 
of the measurement solution with redox active ions, and it offers a direct and sensitive 
capacitive based recognition of the target that is more applicable for real sensor 
devices. The work presented in this chapter has fostered collaboration with the 
Nanobionics Research Group in São Paulo State University, who have synthesised the 
ferrocene-tagged peptide utilised in our studies. The entirety of the experimental work 
presented in this chapter, including the fabrication of the sensor surface, 
electrochemical measurements and the SPR measurements was carried out by the 
author. A specific level of roughness of the electrode surface had been a crucial factor 
for obtaining optimum immobilisation of the peptide. Additional investigations were 
carried out for maintaining it below a certain value in all measurements. Additional 
work is not presented for the sake of clarity, and to ensure we maintain confidentiality 
with our collaborators. 
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5. 1 Background  
Advancing beyond blood glucose analysis, electrochemical biosensors are becoming 
a prominent alternative for point-of-care applications due to being easy to miniaturise 
(Moschou & Tserepi 2017), integrate with mobile devices (Roda et al. 2016; Zhang et 
al. 2016), their low power requirements and ease of use. There is currently an 
increasing interest in the possibility of nucleic acids and protein markers reporting on 
diseases at early stages, before any symptoms arise (Santos et al. 2014). Although a 
wide range of strategies exist for their detection (optical methods such as Colorimetric, 
Surface Plasmon Resonance, Optical Microarray, ELISA, Interferometry and mass 
sensitive platforms such as Quartz Crystal Microbalance) (Haab 2003; Homola 2008; 
Ray et al. 2010; Speight & Cooper 2012; Santos et al. 2014), these methods either 
require target labelling, te utilisation of an appropriate sandwich form, rely on specific 
induced variation in excitable surface plasmons or modification with nanoparticles for 
increased sensitivity. However, electrochemical methods are known for possessing a 
high sensitivity and are readily scalable at a low cost. In addition, there is a 
significantly growing body of work in label free approaches in electrochemical 
platforms that can achieve high levels of selectivity via controlled interfacial chemistry 
(Santos et al. 2014; Santos et al. 2015; Fernandes et al. 2015; Piccoli et al. 2016; Piccoli 
et al. 2018). 
In the past, a vast range of strategies have been suggested for the improvement of 
electrochemical sensor performance for oligonucleotide detection. A few examples 
include label-based methods which involve the adoption of electroactive markers such 
as redox indicators and intercalators, nanoparticles, quantum dots and enzymes 
(Pumera et al. 2005; Pan 2007; Wei et al. 2011; Jolly et al. 2016; Gaiji et al. 2017). 
Along with improving the sensor performance by such methods, self-assembly 
approaches were adopted to modify the surface for advanced detection. As an 
alternative surface, studies were conducted that designed a mixed SAM as a potential 
electroanalytical assay platform for point-of-care applications. The mixed SAM is 
composed of a redox layer with an antibody receptive component that comes on top 
for the purpose of redox capacitive detection for the recognition of target molecules 
(Santos et al. 2015; Fernandes et al. 2015; Piccoli et al. 2018). Our experimental work 
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in this chapter adopts a similar methodology and benefits from the redox properties of 
ferrocene that is integrated within the SAM. Such a strategy aims to eliminate the need 
for labelling the target or for additional steps, such as the use of intercalators for signal 
amplification. A faradaic probe is developed with a molecular layer of ferrocene-
tagged peptides that offers the sensitive label-free recognition of a target in solution. 
It is stated in recent literature that the redox activity of a confined group leads to the 
formation of an interfacial charging signal that is detected by an EIS derived complex 
capacitance (Cr) signal (Santos et al. 2014). Such a signal depends heavily upon its 
electrostatic environment. In this case the Cr of a surface confined electroactive film 
does not depend on its dimensions, but rather on the redox centre energy levels and 
occupancy (Bueno et al. 2012; Bueno et al. 2013). Hence, such a methodology 
eliminates the need for pre-labelling of the target and the need for doping of the 
measurement solution with redox active ions. If the methodology is coupled 
successfully with PNA-probes, it will allow for the label-free and sensitive detection 
of DNA/miRNA targets that is more applicable in the development of point-of-care 
technology. 
 
5.1. 1 Redox active peptide for capacitive diagnostic assays 
This section will introduce the methodology behind the development of a platform that 
contains redox active elements built inside the SAM layer that offers capacitive based 
direct analysis of target binding. In order to obtain such an electrochemically active 
capacitive interface, studies in literature introduced the synthesis of a peptide bearing 
a ferrocene (fc) molecular (redox) group, which comes with the sequence Fc-Glu-Ala-
Ala-Cys, via solid phase peptide synthesis (Piccoli et al. 2018). In order to achieve the 
self-assembling capability together with the electrochemically active capacitive 
response of the peptide, the side chain of cysteine (Cys) was covalently bound to the 
gold electrode (via sulphur groups) and the side chain of glutamic acid (Glu) was used 
to attach the ferrocene in the peptide chain (Piccoli et al. 2018). The redox-tagged 
peptide was immobilised on the gold electrode and a recognition probe was attached 
onto the peptide via the activation of the terminal carboxyl group of the glutamic acid 
side chain of the peptide (Piccoli et al. 2016; Piccoli et al. 2018). Such a methodology 
establishes a Faradaic probe that offers sensitive and label-free recognition of a target 
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in solution (Bueno et al. 2012; Santos et al. 2015; Piccoli et al. 2018). The strategy is 
based upon mapping the perturbations in the interfacial charging of the redox elements 
incorporated in the SAM after the binding of the target. 
The methodology adopts impedance based electrochemical capacitance spectroscopy 
(ECS), that has shown to be a convenient and highly sensitive mode of detection 
among the broad range of label free electronic biomarker assay methodologies 
currently available (Santos et al. 2014; Fernandes et al. 2015; Piccoli et al. 2016). 
The main difference between Faradaic and non-Faradaic impedance approaches is the 
requirement for redox doping of the measurement solution. In non-Faradaic mode, the 
assessment is made not through the changes in the resistance to charge transfer in 
solution, but through the variation of double layer capacitance, Cdl, that is a measurable 
quantity and observed to be very sensitive to interfacial variations. Such a variation is 
observed, for instance, when a target protein attaches to a receptor that is already 
immobilised on an electrode surface and displaces water and ions from the surface 
(Tkac & Davis 2009), or as a result of the conformational change of a protein after the 
binding of an analyte (Berggren et al. 2001). The capacitive behaviour of the 
biorecognition surface in non-Faradaic mode can be described as a combination of two 
capacitances: Cm that refers to an insulating layer comprised of a SAM and double 
layer, and Crec that corresponds to the biorecognition layer. A third layer of Ca is 




Figure 5. 1 Schematic representation of a traditional capacitive biosensor. The 
capacitive behaviour can be explained in three capacitors: the one due to the 
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insulating layer (Cm), the one due to receptive layer (Crec) and the final one due to the 
biorecognition layer (Ca).  
 
Hence, the total capacitance is given as followed:          












                              Equation 5. 1 
 
According to Equation 5.1, the lowest element dominates the total capacitance. This is 
crucial for the sensor design based on capacitive measurements as the capacitance of 
the insulating layer must be as high as possible to allow one to detect changes in the 
system as a result of target binding (Berggren et al. 2001). In addition, the construction 
of an impermeable insulating layer to ions in solution will lead to the prevention of 
signal loss (Berggren et al. 2001). 
The studies adopted capacitive approaches commonly used in aptamers and antibodies 
as recognition elements (Berggren & Johansson 1997; Limbut et al. 2006a; Limbut et 
al. 2006b). For instance, one of the methodologies immobilised a specific antibody 
(MD-2) above SAM on a gold electrode surface for the detection of a biomarker for 
autoinflammatory (and autoimmune) diseases that is called interferon-γ. The study 
revealed a direct detection of the protein interferon-γ at attomolar levels (Dijksma et 
al. 2001). 
Placing a voltage polarised metallic interface, containing a molecular film with a redox 
active entity, into an electrolyte results in two contributions to capacitance. The initial 
contribution is due to the double layer capacitance that results from the contact of the 
metal interface with solution. The second contribution to capacitance is due to the 
presence of an element within the molecular film that can be Faradaically charged 
(redox active) and termed as pseudocapacitance, Cr (Santos et al. 2014). Although the 
magnitudes of these two capacitive elements are sensitive to surface and solution 
composition, pseudocapacitance is known to be considerably higher. Very recent 
studies performed measurement of this capacitance, that can be also referred as redox 
capacitance (Cr) through impedance-derived electrochemical spectroscopy, ECS 
(Santos et al. 2015; Piccoli et al. 2018). 
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 This impedance derived capacitance (Cr) is in fact composed of two distinct 
contributions (Santos et al. 2014): 
 This impedance derived capacitance (Cr) is in fact composed of two distinct 
contributions (Santos et al. 2014): 









                                 Equation 5. 2 
                                                            
Where Ce is attributed to the electrostatic or geometrical capacitance that is a result of 
charge separation in the normal sense and can be simply defined as Ce=dq/dV (where 
q is the net charge and V represents the potential). Cq on the other hand is the quantum 
capacitance that arises specifically from the variations of chemical potential changes 
associated with charging a nanoscale mesoscopic entity. The pseudocapacitance (Cr)  
is associated with surface confined redox events and is a representation of a specific 
manifestation of the general mesoscopic capacitance principles reported by Marcus 
Büttiker (Büttiker et al. 1993). 
The quantum capacitance (Cq) is explicitly defined with the following formula (Bueno 
& Davis 2014): 











 )             Equation 5. 3 
 
Where gm represents the energy density of states in metal and gr represent that of the 
molecular density of states chemically attached over the electron reservoir. The 
quantum capacitance, Cq, arises explicitly from the chemical potential variations 
associated with charging a nanoscale mesoscopic entity (Büttiker et al. 1993). In such 
an approach, since 𝑞𝑚(E) >> 𝑞𝑟(E), as the electronic density states in the metal are 
much higher compared to those associated with the molecular redox states chemically 
attached over the electron reservoir, the formula simplifies to Cq=e
2gr (Bueno & Davis 
2014). We can further define gr by a Gaussian redox density of states: 
 
           gr(µe) = 
1
σ√2π
 exp [− 
(Er−µe
2σ2
 ]                       Equation 5. 4 
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where 𝜎 refers to standard deviation (and 𝜎2 the variance) of the multiple possible 
energetic states. 
The reported studies in literature have shown that the element of Cr is sensitive to the 
local environment (Fernandes et al. 2014) and any variations in redox site occupancy 
should be experimentally reported through Cr. In other words, the hypothesis states 
that any local change in the dielectric constant or electrostatics will result in 
perturbation of the charging fingerprint in a detectable manner (Lehr et al. 2014). 
Hence, if one manages to couple this ability within a selective target-recruiting 
molecular film, then one can generate a feasible sensor that eliminates the need for 
target labelling or solution doping with redox markers. A number of studies were 
recently performed which show the resolved Cr charging element can be effectively 
adopted as a transduction of biological recognition events (Bedatty et al. 2013; 
Fernandes et al. 2014; Lehr et al. 2014). 
The Cr signal is resolved from electrochemical impedance spectroscopy, Z*(ω), which 
is converted to capacitance by using the mathematical relationship C*(ω)=1/jωZ*(ω) 
where ω is the angular frequency and j =√−1  (Goes et al. 2012) (Bueno et al. 2012). 
Any change in the environment of redox tethered sites leads to a change in the storage 
capability of the peptide-SAM layer with a resulting change in Cr. The behaviour was 
demonstrated experimentally in recent studies for the label-free detection of C-reactive 
protein (CRP) (Bedatty et al. 2013), by utilising a mixed SAM that contains a tethered 
redox probe (11-ferrocenyl-undecanethiol) pentadecanethiol on which the receptive 
antibodies were physisorbed. This same methodology was further approved in 
additional studies (Johnson et al. 2012; Bryan et al. 2013). 
Prior to any impedance derived capacitive analysis with such a redox active molecular 
layer, it is required to adopt cyclic voltammetry in order to approve the Faradaic 
activity and identify the potential windows of maximum redox activity (the half wave 
potential E1/2) and redox inactivity (Eout) (Santos et al. 2015; Fernandes et al. 2015; 
Piccoli et al. 2018). This provides one with the analysis of maximal and minimal 
capacitive analysis. Following that, comes the electrochemical impedance 
spectroscopy (EIS) measurement over a range of frequencies (10 mHz – 1 MHz) 
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within the potential windows of redox activity and inactivity. In EIS measurements, a 
modulating potential [V(t) = Vo sin(ωt)] (where Vo is the maximum voltage, t is the 
time, and ω is the angular frequency) is applied and the resulting sinusoidal current 
response of the system is monitored [I(t) = Io sin(ωt+𝜙)] (where Io is the maximum 
current and 𝜙 is the phase shift) which allows one to derive various functions such as 
impedance (Z*). Hence, the impedance can be converted to capacitive data (C* = 
1/jωZ*) (Santos et al. 2014). 
In this chapter we will introduce an experimental study that couples the capacitive 
sensing ability of a ferrocene tagged peptide SAM with highly specific PNA probes 
for the detection of a target DNA sequence that is specific to Human Pathogen 
Clostridium difficile {Formatting Citation} (Joshi et al. 2014). If the successful 
demonstration of the methodology is achieved for DNA detection, then the 
methodology can be further adapted for miRNA detection that will offer a label-free 




Figure 5. 2 (a) Schematic representation of the redox-tagged peptide SAM layer with 
PNA probe immobilised on top that captures the target DNA through hybridisation. 
The schematic of the methodology is recreated for DNA detection by using PNA-
probes (Santos et al. 2015; Piccoli et al. 2016). Zi and Rs represent the interfacial 
impedance and the solution resistance respectively of a generic receptive interface 
used in capacitive biosensing. Supportive SAM contains a tethered redox group that 
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represent the Faradaic branch and able to store charge in the electrode-solution 
interface. Sensing/receptive probe (PNA) is attached on top that is complementary to 
target DNA (specific to C.difficile bacteria). Appropriate equivalent circuit capable 
of modelling electrochemical capacitive biosensors is comprised of two series 
capacitances: that of the monolayer (Cm) and of the double layer (Cdl) where Cdl >> 
Cm which means the domination of Cm in the analysis and is represented in the circuit 
(Bueno et al. 2012; Bueno et al. 2013). The resistive (Rt) and capacitive (Ct) terms 
represent the ideal response of the dipolar layer (since Cm<< Ct , consequently Rt and 
Ct control the monolayer dielectric (ionic) response (Santos et al. 2015). In contrast 
the faradaic response is controlled by Rct (charge transfer resistance) and Cr (redox 
capacitance). (b) Cr can be directly determined from the diameter of the semi-circle 
of the capacitance Nyquist plot. 
 
5. 2 Materials and methods 
5.2. 1 Chemical reagents 
The redox-tagged peptide with the sequence Fc-Glu-Ala-Ala-Cys was synthesised via 
solid phase peptide synthesis by using standard methods provided in literature (Piccoli 
et al. 2018). All solvents and chemicals unless, otherwise stated, were of analytical 
grade and purchased from Sigma Aldrich (UK). 
 
 
                                                 
Figure 5. 3 Chemical structure of the redox (ferrocene) tagged peptide (Piccoli et al. 
2018). The thickness of the peptide SAM was resolved by ellipsometry as 1.80 ± 
0.03 nm. 
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5.2. 2 Oligonucleotides 
The HPLC purified PNA probe sequence was purchased from Cambridge Research 
Biochemicals, UK in lyophilised form. The synthetic DNA sequence that is specific 
to Human Pathogen Clostridium difficile (Joshi et al. 2014) was purchased from 
Sigma Aldrich, UK. The sequences are shown in Table 5.1 below. 
 
Table 5. 1 List of PNA probe and complementary DNA sequence used in this work.  
PNA probe:  
(N term) - NH2 - TTT TTT TTA ATA CTA 
ACA CTG C - (C term) 
DNA sequence (49 bases),  
*specific to C. difficile bacteria 
3’-AAA TTA TGA TTG TGA CGT AAT CCC 





5.2. 3 Electrode surface preparation for CV and EIS measurements 
A gold working electrode was first mechanically polished on a polishing pad for at 
least 5 minutes with aluminium oxide with decreasing particle size (starting with 1μm, 
then 0.3 μm and finishing with 0.05 μm). Between each step, the electrode was rinsed 
with Milli-Q water and sonicated in Milli-Q for 2 minutes in order to remove adhered 
particles. Cyclic voltammetry was then carried out on the electrode surface for the 
reduction of surface oxides, by using 0.5 M KOH solution (-0.3 V to -1.6 V at a scan 
rate of 100 mV s-1) for 75 scans, which was followed by electrochemical cleaning in 
0.5 M H2SO4 (-0.2v to 1.5 V at 100 mV·s-1) until stabilisation of the gold reduction 
peak in CV was obtained (25 scans). Additional CV was carried out in 0.5 M H2SO4 
by setting the potential from 0.2 to 0.6 V at 100 mV·s-1 for 10 scans. This final CV 
was performed in order to assure a capacitive current that is not higher than 0.6 µA at 
0.3 V vs. Ag|AgCl. Following the electrochemical cleaning, the electroactive areas 
were evaluated by mathematical integration of the cathodic peak with the potential 
from voltammograms for electrode cleaning, by using a conversion factor of 410 
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µC.cm-2 (Santos et al. 2015). The roughness factor was controlled by maintaining it 
below 1.7 in all measurements. 
The biosensor was prepared by the immersion of a clean gold electrode in a solution 
containing 2 mM of redox-tagged peptide in H2O/ACN (1:1) for 16 h (at 4˚C). After 
being thoroughly rinsed with Milli-Q water, the carboxyl groups of the glutamic acid 
side chain were activated with an aqueous solution of 0.4 M N-(3-(dimethylamino)-
propyl)-N’-ethylcarbodiimide (EDC)/ 0.1 M N-hydroxysuccinimide (NHS) for 30 
minutes. The activated electrodes were then rinsed with Milli-Q water followed by a 
second rinse in 50% DMSO and then immediate incubation with 1 µM of PNA probes 
(prepared in 50% DMSO) for 2 hours at room temperature. At the end of the PNA-
probe immobilisation (via covalent bonding between the amino group terminated PNA 
and the activated carboxyl group of the peptide glutamic acid side chain), the electrode 
was rinsed with Milli-Q followed by measurement buffer. Then CV and EIS were 
performed to confirm the successful immobilisation. This was followed by 0.1% BSA 
(bovine serum albumin) solution incubation for 1 hour at room temperature to 
eliminate any active carboxyl groups. 
 
5.2. 4 Electrochemical measurements 
Electrochemical measurements were conducted in a cell that contains 20 mM 
tetrabutylammonium perchlorate (TBAClO4) as a supporting electrolyte dissolved in 
acetonitrile and water (1:4 (v/v)). The supporting analyte was replaced with 10 mM of 
PB (pH 7.3) for only the final set of EIS experiments as required. CV was performed 
at a scan rate of 100 mV·s-1 between -0.2 V and 0.7 V relative to Ag|AgCl. 
Electrochemical impedance spectroscopy measurements were carried out in the ac 
frequency range of 100 kHz to 0.1 Hz with a 10 mV amplitude (peak to peak). The dc 
bias was set to the formal potential of the ferrocene redox-tagged peptide determined 
by CV prior to running EIS measurements (i.e. 0.363 V relative to Ag|AgCl). 
Impedance derived capacitance analysis adopted the mathematical relationship C(ω)* 
= 1/jωZ(ω)*, where ω is the angular frequency (Bueno et al. 2012). 
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5.2. 5 Preparation of gold sensor chip for SPR measurements 
The gold sensor chip was sonicated in acetone, ethanol and Milli-Q water respectively 
for 3 minutes. Following the sonication, the chip was dried under a nitrogen pump 
followed by UV/Ozone cleaning for 30 minutes. Then the clean gold surface was 
covered completely with 2 mM of redox-tagged peptide in H2O/ACN (1:1) and placed 
inside a chamber in order to prevent evaporation of the sample. The incubation was 
carried out for 16 h. In the end, the chip was rinsed thoroughly with H2O/ACN (1:1) 
followed by a rinse with Milli-Q water. The carboxyl groups of the glutamic acid side 
chain were activated by incubating the chip with an aqueous solution of 0.4 M N-(3-
(dimethylamino)-propyl)-N’-ethylcarbodiimide (EDC)/0.1 M N-hydroxysuccinimide 
(NHS) for 30 minutes. Then the chip was rinsed thoroughly with Milli-Q water and 
dried under nitrogen for SPR measurements. 
 
5.2. 6 SPR measurements 
SPR measurements were carried out using a Reichert SPR 7000DC dual channel flow 
spectrometer at 25°C. The measurement buffer, 10 mM PB (pH 7.3), was filtered 
through 0.2 μm filters, and degassed for 2 h by sonication before the measurements. 
500 µl of 1 µM PNA probe, 0.1% BSA and 100 nM DNA target were prepared 
separately in 10 mM PB (pH 7.3). These incubation samples were degassed prior to 
injecting into the SPR in order to avoid the formation of any bubbles within the system. 
The peptide-SAM modified chip was placed under the SPR module for the 
measurements and was injected with 1 µM PNA probe for 30 minutes under a flow 
rate of 8 μL/min. Then the chip was washed with buffer, 10 mM PB (pH 7.3), under a 
flow rate of 25 μL/min for 10 minutes for the dissociation of any unbound molecules 
and until a stable baseline was achieved. This was followed by the injection of 0.1% 
BSA for 7 minutes and then a wash under buffer until reaching stabilisation again. 
After stability was achieved, the chip was injected with three rounds of blank samples 
followed by a target concentration, where each incubation was carried out for 7 
minutes under a flow rate of 25 μL/min. A wash under buffer was carried out for 10 
minutes after each incubation for the dissociation of any unbound molecules. 
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5. 3 Results and discussion 
5.3. 1 Cyclic voltammetry (CV) analysis of electrochemical activity 
of peptide SAM 
The electrochemical characterisation of the redox-tagged peptide was performed by 
the self-assembly of the peptide to the gold electrode and measuring cyclic 
voltammetry responses in the presence and absence of the peptide. The ability of the 
synthesised peptide to attach on gold is expected to occur due to the presence of a thiol 
group in the Cys residue. Figure 5.4 displays the comparison of cyclic voltammetry 
results for the bare gold electrode surface and the electrode surface when immobilised 
with redox-tagged peptide overnight. There is a clear appearance of oxidation and 
reduction peaks associated with the ferrocene/ferrocenium (Fc/Fc1) redox coupling 
activity. The CV response resulted in an associated half-wave potential (Ein or E1/2) of 
0.363 V relative to the Ag|AgCl reference electrode, that agrees closely with the value 
reported in literature (Piccoli et al. 2018). The difference between the oxidation and 
reduction potential peaks is 22 mV and the ratio between anodic (jpa) and cathodic (jpc) 
current is almost a unit ratio. Such results can be attributed to the successful attachment 
of redox-tagged peptide onto the gold electrode surface and performing typical redox 
reversible processes (Piccoli et al. 2018). 
 
      


























Figure 5. 4 Cyclic Voltammetry response of redox-charging peptide-aptamer SAM 
and its comparison to bare gold electrode. Dashed lines placed on the graph represent 
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the potentials for non-faradaic (0.1V) and faradaic (0.363 V) outputs. CV 
measurements were carried out in 20 mM TBAClO4 in ACN/H2O 1:4 at a scan rate of 
100 mV·s-1. 
 














Figure 5. 5 Additional CV measurements at different scan rates where anodic and 
cathodic peak currents were observed for further approval of reversibility of the 
peptide SAM system (a) Cyclic voltammetry graph of the peptide SAM at various scan 
rates (b) Anodic and cathodic peak currents for peptide SAM at various scan rates. 
 
 
The reversibility of the redox activity of the peptide SAM was further approved by 
repetitions of the cyclic voltammetry measurements upon using various scan rates 
(Figure 5.4). The resulting anodic and cathodic peak currents for each scan rate were 
compared in a graph displayed in Figure 5.5 (b) which put the ratio between anodic 
(jpa) and cathodic (jpc) current close to a unit ratio for each scan rate. 
The molecular surface density can be quantified from cyclic voltammetry by 
measuring the oxidative charge associated with ferrocene oxidation (Piccoli et al. 
2018). The positive peak area in Figure 5.3 divided by the scan rate of 100 mV s-1 
corresponds to the oxidative charge (Trasatti & Petrii 1991): 
              Oxidative Charge, Q =  
1
s
∫ i. V′ dV′                           Equation 5. 5 
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Electrochemical surface area (ESA), Ae in cm2, is then (Trasatti & Petrii 1991) (Santos 
et al. 2015) : 
                      ESA, Ae =  
Q
410 X 10−6
                                Equation 5. 6 
 
The molecular surface coverage is then evaluated (ᴦ, mol cm-2) as: 
                                      ᴦ = 
Q
F x Ae
                      Equation 5. 7 
 
Where, F is Faraday’s constant (9.649 x 104 Cmol-1) and Ae is the electrochemical 
surface area. 
Hence, the molecular surface density was evaluated to have a value of 1.33 x 10-10 
mol.cm-2 which is in agreement with the prior reports for peptide SAM on a gold 
surface (Gatto et al. 2012; Piccoli et al. 2018). The slightly lower value in comparison 
with the expected theoretical values reported in literature for cysteine-anchored 
peptide SAMs could be attributed to the fact that the theoretical values for the surface 
molecular coverage are usually higher due to the assumption of vertical orientation 
and a close hexagonal packing of helical peptides (Gatto et al. 2008). However, in 
reality peptide SAMs are never perpendicularly oriented and their axis has a tilt angle 
of 30−60° with respect to the surface (Kai et al. 2008; Okamoto et al. 2009; Piccoli et 
al. 2018). 
 
5.3. 2 Electrochemical impedance spectroscopy analysis of 
immobilisation of peptide SAM and its stability 
Following the studies of the peptide SAM on gold using cyclic voltammetry, further 
investigation of the SAM immobilisation was made using electrochemical impedance 
spectroscopy. The hypothesis of this study is that the redox properties of the peptide 
SAM, when resolved by impedance derived capacitance techniques, is capable of the 
sensitive reporting of the binding of biological targets (Santos et al. 2014; Santos et al. 
2015; Fernandes et al. 2015; Piccoli et al. 2016; Piccoli et al. 2018). This analytical 
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methodology is distinctive from what is offered by traditional impedance 
methodologies in that it reports the charge transfer resistance upon data fitting. A redox 
capacitance signal originates from the charging capability of the ferrocenyl redox-
tagged peptide. As a result, the “charging identity” can be provided by converting the 
impedance data to capacitance. The signal measured in this case is not based on charge 
transfer resistance but on non-Faradaic capacitive charging. As a result, the interfacial 
recognition is detected by converting the same raw data into a complex capacitance 
Nyquist diagram as shown in Figure 5.6. 
 
 












Figure 5. 6 (a) Nyquist impedimetric plot of Z” versus Z’ for electroactive peptide-
SAM immobilised on gold electrode surface at electrode potential corresponding to 
half-wave potential (b) The analogous capacitive response of C” versus C’, Cr itself is 




Figure 5.6 (a) displays a resolved Cr value of 176.3 μF cm
−2 at half-wave potential 
(E1/2) that is markedly greater than either the capacitance of bare gold (11.52 μF cm
−2) 
or the SAM at redox out potentials (Eout), which is the potential where no Faradaic 
redox activity is observed (6.8 μF cm−2). Although the measured Cr value is smaller 
than the reported value in literature, 267.0 ± 7.1 μF cm−2 (Piccoli et al. 2018), it is 
worth mentioning the variable factors such as electrode quality, different 
electrochemical apparatus, and measurement solution quality that could lead to slightly 
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different values to what is reported by other groups. However, the significant variation 
of the Nyquist derived capacitance at E1/2 in comparison to redox out potential and the 
bare electrode case, indicates the successful immobilisation of the peptide-SAM and 
the adoption of its redox properties. 
                                     
                     







    
 
 
                                                                                   
            
 
          
                                                                                                          












Figure 5. 7 (a) Capacitive Cole-Cole plot after immobilisation of the electroactive 
peptide-SAM, measurements carried out at electrode potentials corresponding to half-
wave potential (E1/2, evaluated as 0.363 V from Figure 5.4) and redox-out (Eout, 
evaluated as 0.1 V from Figure 5.4) vs. Ag|AgCl potentials. (b) The real part of the 
capacitance of the ferrocene-tagged peptide SAM at both electrode potentials (half-
wave and redox out). (c) The imaginary part of the capacitance of the ferrocene-tagged 
peptide SAM at both electrode potentials (half wave and redox out). 
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Prior to any covalent immobilisation of PNA-probe, it is imperative to assess the 
stability of the SAM. Nyquist resolved capacitive response in Figure 5.8 displays the 
signal output change during five rounds of incubations in the absence of target. A 
significant drop, 24.49%, was observed on the initial Cr value of the peptide SAM by 
the end of three incubations. A well stable SAM was reported only after four 
incubations where 3.49% fluctuation was observed between the last two incubations 
(Figure 5.7, Stability 4 & 5) that indicates for good stability of the platform. This once 
again demonstrates the critical requirement for sufficient number of blank incubations 
for complete stability before any further investigation. 
 




























Figure 5. 8 EIS measurements taken in 20 mM TBAClO4 ACN/H2O 1:4, for blank 
electrode surface followed by measurement after its immobilisation with the peptide 
SAM. Then 5 rounds of stability measurements were carried out for the electrode 
surface immobilised with the peptide SAM. For or each stability measurement the 
electrode surface was incubated in 10 mM PB, pH 7.0 for 30 minutes and rinsed with 
Milli-Q water before measuring. 
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5.3. 3 Surface Plasmon Resonance (SPR) Analysis for the Validation 
of Attachment of PNA-Probe on peptide-SAM 
Following the CV and EIS characterisation of the peptide-SAM, and prior to the 
further investigation of the attachment of the PNA-probe on the redox-tagged SAM by 
EIS, a constructive step provides validation of the methodology on a different 
measurement platform. The real time monitoring of the immobilisation of the PNA-
probe on the redox-tagged peptide was carried out by using surface plasmon 
resonance. A gold planar SPR chip was functionalised with redox-tagged peptide for 
this purpose. SPR is an optical technique that detects the molecular binding on a thin 
metal (e.g. gold) film in terms of variations of refractive index. The measured signals 
reflect the molecular weight of the adsorbed biomolecules and can be used for the 
quantification of the number density of different types of adsorption. The plot given in 
Figure 5.8 (black line) corresponds to the real-time monitoring of the injection of the 
PNA probe under the flow of measurement buffer (10mM PB, pH 7.3) for its capture 
by the SPR chip that was previously immobilised by the ferrocene-tagged peptide. A 
control measurement was carried out at the same time where the other half of the same 
chip was incubated with a blank buffer instead of PNA-probe (red line). The shift in 
the reflectivity curve indicates the molecular binding taking place on half of the gold 
film, where no shift (hence no binding) was observed for the control (Bhalla et al. 
2015). PNA upon binding on the surface of the gold is functionalised with redox 
peptide-SAM and revealed a change of 467.7 µRIU, whereas the incubation with the 
control revealed no change. The SPR chip was washed under flow of measurement 
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Figure 5. 9 Real time SPR response for PNA-probe attachment on ferrocene-tagged 
peptide immobilised SPR chip (black line). Red line corresponds to control (blank 
buffer) incubation. All measurements were carried out under flow, in 10 mM PB (pH 
7.3). 
 
           























Figure 5. 10 Evaluation of change in µRIU after the PNA probe immobilisation upon 
using SPR real time response and its control (Figure 5.9). The error bar represents the 
standard deviation for three different chips.  
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Following the confirmation of immobilisation of the PNA-probe by SPR 
measurements, further analysis was carried out in order to test the stability of the 
designed redox tagged PNA-probe. Following the probe injection, the chip was 
injected with 0.1% BSA (prepared in 10 mM PB, pH 7.3) for the complete coverage 
of the gold surface for the elimination of non-specific binding. This was then followed 
by three consecutive blank buffer incubations (each for half hour). The evaluated %∆ 
µRIU results are displayed in Figure 5.10 and are found to be in good agreement with 
a stable system. 
 
   



















Figure 5. 11 Evaluation of % variation of µRIU upon using SPR real time response. 
All measurements were carried out under flow, in 10 mM PB, pH 7.3. Error bars 
represent the standard deviation for repetitions (n=2). 
 
 
Following the approval of a stable system, the redox probe was investigated for its 
ability to capture the target DNA sequence. The SPR chip that was functionalised with 
redox probe was injected with 100 nM target DNA (specific to C.difficile) under flow. 
Control measurement was carried out with blank buffer incubation. 
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Upon incubation with the DNA target, a shift of 70 µRIU was observed on the 
reflectivity curve (Figure 5.12) where no shift was observed for the case of the blank 
buffer. Hence, the SPR responses, upon RIU variations, successfully demonstrated the 
phases of PNA-probe immobilisation, stability of probe, and molecular binding upon 
incubation with target DNA. 
  



















 Peptide SAM + PNA + DNA




















Figure 5. 12 Real time SPR response for attachment of PNA-probe followed by its 
surface blocking, stability measurements and incubation with 100 nM target DNA 
(black line). Red line corresponds to control where the fabricated probe was 










C h a p t e r  6                                            P a g e  | 155 
 
   
5.3. 4 Electrochemical Impedance Spectroscopy Analysis for the 
Attachment of PNA-Probe on Peptide-SAM 
Following the SPR validation of the successful attachment of PNA-probe to the redox 
tagged SAM, the same process was repeated for DNA detection on the EIS platform. 
Upon covalent immobilisation of the Peptide Nucleic Acid (PNA) probe, the redox 
capacitance, Cr, (at Ein) is expected to change (decrease), indicating the successful 
covalent bonding of the probe with peptide (Santos et al. 2015; Piccoli et al. 2018). 
The results in Figure 5.13 show a 13% decrease in the Cr (109 µF cm
-2 →94.08 µF cm-
2) upon the immobilisation of the PNA probe on the peptide SAM. The previous 
studies reported a significant reduction of Cr (54%) for the case of immobilisation of 
CRP aptamer on the developed SAM (Piccoli et al. 2018). However, there are no 
published studies for PNA immobilisation on the electroactive peptide SAM and how 
it affects the electrostatic environment of the SAM. This leaves one with the question 
if the lower Cr drop indicates insufficient probe immobilisation on the SAM or if this 
is due to the neutrally charged nature of PNA. Previous attempts to detect CRP aptamer 
benefits the negative charges of the CRP bound for electrochemical impedance-based 
detection platform and its negative influence on the impedance derived capacitance 
measurements with peptide-SAM. However, due to its neutrally charged nature it 
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Figure 5. 13 EIS measurements taken in 20 Mm TBAClO4 ACN/H2O 1:4, for 
peptide-SAM (black curve) followed by covalent immobilisation of PNA-probe (red 
curve) and 0.1% BSA blocking for complete coverage of the surface (blue curve). 
 
 
In order to benefit fully from the electrochemical activities of the redox peptide, 20 
mM TBAClO4 ACN/H2O (1:4) has been adopted as this is the measurement buffer that 
is reported in literature (Piccoli et al. 2018). However, certain buffer conditions are 
essential when it comes to the hybridisation of PNA-probes with DNA. Due to the 
neutral backbone of PNA, the hybridisation of PNA oligomers to complementary DNA 
are known to be essentially independent of the ionic strength of the solution. Detection 
limits as low as fM levels have been obtained previously in our group, using different 
methods, by adopting 10 mM PB (pH 7.3) (Jolly et al. 2016) as both the measurement 
and hybridisation buffer. Additionally, SPR results performed successful binding of 
the target DNA, under a flow of 10 mM PB, pH 7.3. 
Hence, the behaviour of the hybridised PNA-DNA duplex is not known in 20 mM 
TBAClO4 ACN/H2O 1:4 when used as the measurement buffer. Although the method 
has given stable measurements for the peptide-SAM and covalent attachment of PNA-
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probe, the investigation of binding has not shown any significant variations on the Cr 
value (Figure 5.14). The results required further investigation of the measurements by 
replacing the measurement buffer with 10 mM PB (pH 7.3). 
 
    























 Peptide-SAM + PNA
 Peptide-SAM + PNA + BSA blocking
 Blank incubation 
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 100 nM DNA
 
 
Figure 5. 14 EIS measurements taken in 20 mM TBAClO4 ACN/H2O 1:4, for peptide-
SAM (red curve) followed by covalent immobilisation of PNA-probe (blue curve) and 
0.1% BSA blocking for complete coverage of the surface (pink curve), three 




In order to encourage better hybridisation of probe PNA with target DNA, the 
measurement buffer was replaced with 10 mM PB (pH 7.3). The assay was repeated 
by keeping all the other factors the same as previously. The Cr response upon 
incubation with various concentrations of C.difficile specific DNA performed 
increased variation upon increasing target concentrations (Figure 5.15) when the 
measurement buffer was replaced with 10 mM PB (pH 7.3). Good reproducibility was 
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observed upon repetition of the assay on three different electrodes. A second assay was 
designed as control measurement by replacing the target incubations with blanks. This 
was done in order to observe if the capacitive shift (Cr) that is displayed in Figure 5.15 
is due to binding of the target and does not correspond to any fluctuation/instability of 
the capacitance of the system over time. 
 
           



























Figure 5. 15 Evaluation of change in %Cr upon incubation of the peptide SAM-PNA 
probe functionalised electrode with various concentrations of target DNA. Target 
incubations were carried out after stabilisation of the platform with blank incubations. 
The measurements and incubations were carried out in 10 mM PB (pH 7.3). The error 
bars represent the standard deviation between three different electrodes. 
 
Unfortunately, the results for the control measurements in Figure 5.16, showed a 
variation of the resolved capacitance (Cr) upon consecutive blank incubations. 
However, the Cr values were observed to be even more variable for the case of blank 
measurements compared to target incubations which leaves one in doubt if the result 
were due to a fault in the assay. Therefore, this has revealed the further need for the 
repetition of control measurements for the approval of target binding. The assays could 
not be taken any further due to limited supply of the peptide. 
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Figure 5. 16 Evaluation of change in %Cr upon incubation of the peptide SAM-PNA 
probe functionalised electrode with control (blank). The measurements and 
incubations were carried out in 10 mM PB (pH 7.3).  
 
 
5. 4 Conclusions 
A diverse range of interfacial strategies that adopt redox active elements exist for the 
detection of nucleic acids. Of the methods which are quantifiable and sensitive, those 
which do not require pre-labelling of the target analyte and the measurement solution 
are the most flexible in format and capability. In addition, elimination of redox 
labelling will drop the cost and help with scalability. 
We have introduced a new analytical methodology based on the adoption of redox 
active SAM as surface tethered redox reporters in establishing a sensitive and label-
free capacitive based detection of target DNA specific to C.difficile. The design steps 
for the immobilisation of the peptide-SAM on the gold electrode, stability of the SAM, 
attachment of PNA-probes onto the SAM, and detection of DNA were initially 
approved by using surface plasmon resonance. Then the steps were repeated for 
detection by electrochemical impedance derived capacitance spectroscopy. A few 
obstacles were encountered during the electrochemical measurements. The control 
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assays indicated a shift in the impedance derived capacitance (Cr) of the system over 
time. There could be possible explanations for such results. Such results and the poor 
stability of the peptide-SAM was observed only after utilising a new batch of the 
synthesised redox tagged peptide. Although we expect the quality of the synthesised 
peptide to be the same all the time, the observed results could be due to a fault in the 
batch under use. Due to limited synthesis of the peptide by suppliers and limited time, 
the control experiments could not be taken any further. As a result, future improvement 
would be the repeat of control measurements for the further approval of the results 
obtained for target detection. On the other hand, if the results are not due to the 
instability of the peptide, then another factor to look into would be the decision of 
using a different buffer for the measurements. A buffer is required that makes best use 
of the capacitive properties of the peptide as stated in the literature (Piccoli et al. 2018). 
However, it should at the same time encourage the hybridisation efficiency between 
PNA-DNA for the case of our study. The SPR results revealed successful 
immobilisation of the peptide-SAM on the gold electrode, and attachment of the PNA-
probe on the SAM followed by DNA target detection. This is attributed to the fact that 
the buffer (10 mM PB, pH 7.3) adopted for the SPR analysis provided the required 
conditions for the hybridisation to take place (Jolly et al. 2016), and was sufficient 
enough for SPR analysis that it did not require the enhancement of the capacitive 
properties of the peptide-SAM. On the other hand, for the case of the electrochemical 
measurements there is the requirement for a buffer that will both enhance the 
capacitance value of the peptide-SAM and provide a sufficient environment for the 
hybridisation of the probe PNA with the target DNA. As a result, further research is 
required into finding the best buffer that will offer a good trade off between these two 
factors. 
Overall, our experimental study introduced the design of a sensitive capacitive 
biosensor using a redox-tagged peptide supported SAM. The methodology proved its 
application in literature for the detection of C-reactive protein with a sensitivity that 
significantly exceeds that attainable with an analogous antibody interface (Piccoli et 
al. 2018).  Therefore, redox active self-assembled monolayers are predicted to be 
useful in the development of biosensor devices to precisely detect biomarkers of 
clinical relevance, in a label-free form. In the case of our study, there is still the 
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requirement for a better modification of the method for enhancing the hybridisation 
efficiency of PNA with DNA. However, the design methodology proved its capability 
to detect target DNA after monitoring the fabrication steps of SPR. Hence, a 
constructive future plan would be the optimisation of the buffer and a repeat of the 
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Chapter 6 Summary and Outlook 
 
With the main objective of improving the early diagnosis of cancer, the work in this 
thesis is a step forward towards the development of point-of-care technologies for the 
electrochemical based detection of circulating miRNAs. The breakthrough of a broad 
range of studies proving the relationship of circulating miRNAs to early states of 
cancer, and the lack of blood-based biomarkers currently in clinical diagnosis, has been 
the major motivation of this thesis. The main focus has been given to the adoption of 
oligonucleotide-based probes for the capture of target miRNAs from solution. A 
highly-sensitive PNA-based capture probe was demonstrated in the first experimental 
study for direct detection of miRNA. A new method was developed within the second 
experimental study, which was for the direct detection of miRNA in a serum 
environment, in order to overcome the difficulties that were encountered during second 
study. Hence, the second study examined the efficient separation and pre-
concentration of miRNA from solution prior to detection.  In the last experimental 
study, a redox active self- assembled monolayer was investigated for label-free and 
capacitive based detection. If successfully implemented, such a biosensor eliminates 
the need for doping of the measurement solution used within the first and second 
experimental work, further simplifying the detection. The strategies that have been 
experimented with in these studies are; label-free and amplification-free detection of 
low concentrations of miRNAs using PNA probes, the separation of target miRNA 
from complex solutions with LNA modified magnetic beads, pre-concentration of the 
target prior to detection, and the coupling of redox active SAMs with PNA probes for 
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6. 1 Summary  
The main focus has been given to the adoption of oligonucleotide-based probes for the 
capture of target miRNAs from solution. The key reasons for such an adoption in the 
development of biosensor devices are; their binding affinity for the target, their ease 
of chemical modification, the ability to create controlled surface chemistry for 
reproducible results, and their excellent stability as probes. Due to natural DNA not 
being free from limitations, which prevents their use in electrochemical biosensors, we 
have investigated the adoption of novel classes of synthetic DNA analogues (PNA and 
LNA). In these analogues, the backbone phosphate groups of DNA are subjected to a 
variety of chemical modifications for improved specificity and affinity of 
hybridisation with natural DNA and RNA/miRNA targets. The fine-tuning of these 
synthetic probes with various detection methodologies have been investigated. 
In Chapter 3, our work in the development of a PNA-probe based biosensor for the 
detection of miR-21-5p revealed the crucial role of the optimisation of PNA-probe 
coverage density on the electrode surface for the enhancement of hybridisation 
efficiency. This was achieved with the incorporation of a spacer molecule, MCH, 
which was adopted as a surface blocker that is crucial for the prevention of non-
specific binding. Upon the investigation of various ratios of PNA-probe to MCH on 
the electrode surface, the ratio of 1:15 (PNA:MCH) resulted in the maximum Rct 
change of 32.2 % ± 3.7% upon hybridisation with the target miRNA, measured by 
means of Faradaic EIS. Although one might expect a better hybridisation with higher 
densities of probe on the surface, the Rct change was observed to drop significantly 
upon adopting a larger probe density on the electrode surface (1:2 ratio of PNA:MCH). 
Hence, such results reveal the fact that high probe density does not necessarily lead to 
better hybridisation with a target, and the surface chemistry optimisation is a crucial 
step prior to the fabrication of a successful biosensor. These results are due to the 
combination of two effects: steric hindrance that leads to reduced hybridisation, and 
the large initial Rct that leads to less apparent variation in Rct after hybridisation. Such 
a methodology was reinforced with an additional study presented in the same chapter 
where similar surface chemistry optimisations were carried out for the detection of a 
C.difficile specific DNA (49 bases long) using PNA-probes. For the detection of such 
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a long sequence, there is a need for better spacing of the PNA-probe, and the optimised 
ratio is not expected to be the same as cases that use a shorter sequence, such as for 
miRNA. Hence, the results supported our methodology and the optimised detection 
was achieved with a lower probe density of 1:29 (PNA:MCH) on the electrode surface. 
This strategy can be easily translated to any other oligonucleotide probes (DNA/LNA) 
for the detection of nucleic acids. We have achieved a detection level as low as 0.77 
fM for miRNA detection with no additional steps, which was previously achieved in 
literature only with the adoption of amplifications steps. However, the complex sample 
composition of blood makes it difficult to detect blood biomarkers such as miRNA. 
Our experimental efforts revealed a quantification limit of 10 pM when target miRNA 
was prepared in the serum environment. Upon replacing the solution with 100% serum, 
the increased interference of non-specific interactions lead to a negative variation of 
Rct, and the electrochemical readings for target concentrations were disrupted. 
In order to address the major issue of non-specific binding, we have developed a new 
assay in Chapter 4, for the magnetic beads based separation of target miRNA from 
complex solutions. The methodology is well established in literature for the pre-
concentration of miRNA from biological samples. In general, magnetic beads offer an 
easy, effective option for sample preparation and separation of target miRNA. If 
developing a biosensor device for PoC purposes, the coupling of such effective 
separation methodologies with oligonucleotide-based electrochemical detection 
probes, would create very powerful biosensors. In this study, we have modified the 
magnetic beads with locked nucleic acid (LNA) probes which are known for their high 
affinity to complementary miRNA. As a result, the capture of the target was 
encouraged further. The captured miRNA was then brought to the sensor surface that 
was immobilised with PNA probes and recognised through hybridisation with 
complementary PNA. PNA probes are adopted due to their excellent stability for 
electrochemical detection studies, and their ability to produce low limits of detection 
for miRNA sensing, which was proved earlier in Chapter 3. 
Our final experimental study in Chapter 5, demonstrates a new detection methodology, 
in collaboration with the Nanobionics group in São Paulo State University, for the 
development of label-free diagnostic assays. The successful implementation of the 
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methodology will offer the elimination of the need for redox markers in measurement 
solutions, and provide one with the capability to carry out direct electrochemical 
measurements, which is crucial for real case PoC devices for clinical applications. In 
this study we have introduced a new analytical methodology based on the adoption of 
redox active SAMs as surface tethered redox reporters in establishing a sensitive and 
label free capacitive based detection of the target. The study aimed to adopt the 
capacitive sensing ability of a ferrocene-tagged peptide SAM that is fairly sensitive to 
any electrostatic and chemical potential variations in its environment. Hence, if the 
SAM is coupled with a selective probe that captures the target, one can generate a 
feasible sensor that monitors the capture process by depending on the capacitive 
variations on the SAM due to binding processes. 
 
6. 2 Future Work 
Part of the work presented in this dissertation has fostered collaboration with another 
research group for label-free detection of circulating miRNAs (or any other disease 
specific nucleic acids). The future work of this collaborative study that is presented in 
Chapter 5, will be taken further with the continued collaboration between our group 
and the Nanobionics group in São Paulo State University. 
On the other hand, some research that has been performed, but not presented in this 
dissertation, on transferring the methodologies from Chapters 3 & 4 to manufacturing 
are as follows: 
6.2. 1 Lab-on-a-chip  
The rapid expansion of mobile technology is also leading to a transformation in 
healthcare applications. The methodology of lab-on-a-chip (LOC) diagnostics 
(Moschou & Tserepi 2017) is now offering informative molecular diagnostics tests 
directly to the user with a smartphone, allowing them to take better control of their 
own health (Li Shen et al. 2012; Stemple et al. 2014; Chen et al. 2014). A lab-on-a-
chip device integrates one or several laboratory functions down to a single chip. Hence, 
the laboratory functions are reduced to the size of a chip that it at most centimetres in 
size, in order to achieve automation and high-throughput (Hwang et al. 2006; Alyassin 
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et al. 2009; Moschou & Tserepi 2017). An ideal POC test requires the following: high 
sensitivity and specificity, affordability, rapid evaluation of results, ease of use (no 
need for trained labour), and functioning without the need for additional apparatus 
(Yetisen et al. 2013; Jolly, Rainbow, et al. 2019). As a result, LOC takes up the 
challenge by offering integrated sensors for specificity and sensitivity, rapid analysis 
by a miniaturised design, ease of use due to sample-in-answer-out microsystems, 
minimised reagent volumes for affordability and fabrication of cost-effective devices, 
and the elimination of additional equipment by implementing autonomous systems 
(e.g. integration of sample handling, sample pre-treatment and sensor read-outs). Upon 
using microfluidics the technology reveals the fact that, under flow, a biosensor 
saturates with much lower concentrations of nucleic acids (Jolly, Rainbow, et al. 
2019). This discipline has its origins in the early 1990’s and has grown exponentially. 
The technology is gaining the attention of both industry and academic researchers as 
an essential tool for life science research. 
The methodologies developed in Chapters 3 & 4 can be incorporated for the fabrication 
of a strong biosensor for miRNA separation and detection. The idea can be easily 
translated to manufacturing by utilising the “lab-on-a-chip” technology for diagnostics 
(Herold & Rasooly 2009; Erickson et al. 2014). In a miniaturised microfluidic system, 
we can integrate the various functional units that are required for our design 
methodology that initially involves the separation of miRNAs from solution followed 
by their detection on an electrode surface. An increase in speed and automation can be 
achieved by performing these processes with microfluidics. To provide one with the 
preliminary idea of the implementation of our methodology on a miniaturised 
platform, we have created the flow diagram in Figure 6.1. The diagram presents how 
the methodology can be transformed to a LOC design that integrates all the functional 
units required for the functioning of our detection methods on a POC device. The 
complex sample composition of blood usually makes it harder to detect biomarkers 
directly from blood. For this purpose, the research into miniaturised systems for blood 
plasma separation has been thriving over the last 14 years (2005-2019) (Crowley & 
Pizziconi 2005; Browne et al. 2011). With further investigation of available 
miniaturised technologies for efficient separation of blood plasma, an appropriate filter 
can be coupled with our design. The first inlet of the mixer in Figure 6.1 (or 
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micromixer) receives blood plasma/serum that is separated from blood upon 
collection, by use of an appropriate filter system. Then the blood plasma/serum will 
be mixed with a solution that contains magnetic beads modified with LNA probes that 
are complementary to the target miRNA. The beads will separate the target miRNA 
from the blood plasma/serum under flow. Then the beads that hold the target miRNA 
will be separated from the solution by use of magnetism. The remaining blood 
plasma/serum will be discarded and the solution that holds the magnetic beads will be 
diverted to the inlet of a mixer that allows in an alkaline solution from its second inlet. 
The alkaline solution will be mixed, under flow, with the magnetic beads that hold the 
target miRNAs and lead to the release of target miRNA from the surface of the 
magnetic beads due to the denaturation of the LNA-target miRNA duplexes. Following 
this will be the separation of the magnetic beads waste, by use of a second magnetic 
separation module. In the end we will be left with a solution that holds only the target 
miRNA. Appropriate pH adjustment will be made in the target solution in order to 
bring the high alkaline nature of the solution down to pH 7. This is an essential step 
for the hybridisation with the PNA capture probe. After providing the required pH 
environment, the solution that contains the target miRNA will be sent for its 
electrochemical analysis on a PNA-probe immobilised on a gold-plated sensing 
electrode layer on a commercial printed circuit board (PCB). 
A maximum volume of 400 μL serum or plasma has proven to be enough for the 
detection of cancer-derived circulating miRNA biomarkers whereas even smaller 
volumes (i.e. 25 μL) would be sufficient if highly abundant circulating miRNAs are 
being measured (Kroh et al. 2010; Murray et al. 2018). Hence, the development of 
miniaturised LOC technology that is capable of working with such volumes requires 
the active handling of small volumes of fluid (active microfluidics) by components 
such as microfluidic pumps or microfluidic valves (Haeberle & Zengerle 2007; Suzuki 
& Yoneyama 2003). For the development of micro-fluidic based POC diagnostic 
devices, the handling of such small volumes of fluid by external pumps is not ideal as 
they will require trained persons to handle them. In order to facilitate the easy handling 
of the device for untrained people, many strategies have been developed for on-chip 
fluid manipulation (Lei 2012). Microfluidic pumps are adopted for supplying the fluids 
in a continuous way whereas microfluidic valves are used for injecting precise volumes 
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of samples and buffers. This not only reduces the handling faults but also standardises 
the analytical conditions for each measurement. In future, for an ideal automated 
diagnosis and prognosis of cancer using such a methodology, initially a small volume 
of blood will be collected from the patient by a nurse. The nurse will insert the sample 
into the hand-held LOC device and the rest of the analysis will be carried out by the 
device and require no additional technical handling by the nurse. The information of 
the results will right away be sent to a computer or a smart device for further 
investigation by a doctor. Such an automation will not only speed up the detection but 
it also offers a straightforward monitoring process of patient recovery during the 
course of their treatment. Upon further investigation, the studies can be extended for 
the development of multiplexed platforms for parallel sensing of groups of miRNAs 
which would provide one with more complete information about the state of cancer 
development. As stated in our literature review, the detection of multiple miRNAs 
gives a better idea of the progress of the disease, and the development of multiplexed 
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All in all, the development of a successful oligonucleotide-based biosensor is an 
interdisciplinary subject and relies on a broad knowledge base in; the characterisation 
of bio-recognition probes with their respective analytes, the immobilisation of bio-
recognition probes onto electrode surfaces, the optimisation of surface chemistry, 
sensor design, microfluidics and fabrication. We have exploited the probe/target 
methodologies for analysing the practical applications of the detection of circulating 
miRNAs. Our studies demonstrated the great potential of effective and low-cost 
oligonucleotide-based sensors upon adopting strategic approaches for the integration 
of functional units for the effective separation of targets, and their detection. The 
studies can be extended to the development of multiplexed platforms for the parallel 
sensing of groups of miRNAs. If developed successfully, such a device could offer 
the easy and fast assessment of patient’s states, and the detection of cancer at early 
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Appendix 
Appendix I. miRNA detection in serum using EIS technique 
        
Figure I. 1 Rct variations upon incubations with 100% serum only (red bars) and target 
miRNA concentrations spiked in 100% serum (black bars). Error bars represent the 
standard deviation for three separate electrodes. 
 
Appendix II. Quartz crystal microbalance with dissipation signals 
(QCM-D) 
 
Prior to assays, Q-sense analyser (Biolin Scientific, Sweden) was cleaned by using 2% 
Hellmanex solution (in ultrapure water). This was carried out by injecting the solution 
through the instrument for an hour at a flow rate of 1100 µl/min. Following that, the 
instrument was washed with ultrapure water for an extra hour. Prior to modification 
and subsequent testing, the 5 MHz gold-coated quartz crystals (Biolin Scientific, 
Sweden) were cleaned by immersing in freshly prepared piranha solution for 1 minute, 
prepared with 3:1 ratio of H2SO4:H2O2. Then, the crystals were rinsed with Milli-q 
water in order to remove any residues. After rinsing, gold-coated quartz crystals were 
placed separately in four sensor chambers. The chamber temperatures were set to room 
temperature (24°C). The quartz crystals were washed with immobilisation buffer till 



















miRNA concentrations in 100% serum
 miRNA spiked in 100% serum
 Control (100% serum only)
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stabilisation. 10 mM PB pH 7.0 was adopted for the immobilisation of PNA-probes 
on quartz crystal surface. 1000 µL of probe immobilisation solution was injected 
through the instrument at a flow rate of 1100 µl/min in order to assure the complete 




   
 
 
Figure I.2 Q-Sense Analyser consisting of a flow module with pump (First picture, 
white module on the left) and the 4-sensor chambers (First picture, blue module on the 
right). The handling of the gold-coated quartz crystals and their standing in the sensor 
chambers is shown by the two pictures on right. 
 
The next morning following the incubation overnight (~16hr), the crystals were 
washed with the immobilisation buffer until stability (~1hr). This was followed by 
MCH backfilling by injecting 1000 µl of 1 mM MCH prepared in measurement buffer, 
at a flow rate of 1100 µl /min and stopping the pump for an hour right after injection. 
This was done in order to make sure of the complete coverage of the crystals and allow 
time for the backfilling process to take place. The crystals were then washed with the 
measurement buffer by injecting the buffer solution at a rate of 1100 µl/min. After 
stabilisation with buffer, 1000 µl of the first DNA concentration was injected into 
system and the pump was stopped for half hour following the complete injection of 
the concentration. This assured the complete cover of the crystals with target DNA 
solution and let the hybridization process to take place for half hour. Then, the crystals 
were washed with measurement buffer for another half hour in order to allow 
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stabilisation of the response prior to next incubation. Same process was repeated for 
each incubation. The stabilisation could be ideally carried out by injecting the buffer 
for 15 minutes followed by stopping the pump for 15 minutes.  
 
      
 
Figure I.3 Kinetic curve of frequency for the limit of detection study of gold quartz 
crystal immobilised with 1:4 ratio of PNA:MCH. Target DNA concentration was 
raised in seven steps, starting from 1 fM until 100 nM. Crystal was washed with 10 
mM PB (pH 7.0) prior to each incubation.  
 
 
Appendix III. Field-effect transistor-based biosensor (Bio-FET) 
Biologically sensitive field-effect based transistor design was composed of two parts: 
(i) gold electrode where the PNA complementary sequence captures the target DNA, 
and (ii) the FET structure, which transduces the binding events taking place at the 
surface of the electrode into electrical signals. The gate of the transistor design was 
extended (Figure I.4), connecting the gold electrodes that are placed in a reaction cell 
to the n-type MOSFET, by using a metal wire. B1500A HR CMU Semiconductor 
Device Analyser was used on taking the MOSFET readings. 
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Figure I.4 Measurement circuit of the field-effect based transistor. The micro-
electrodes with gold working electrode were placed in a reaction cell that is connected 
to the gate of a MOSFET. The gate voltage is applied through the connection to 
platinum reference electrode of the micro-chips. 
 
 
For detection, a voltage of 50 mV was applied across the drain to source terminals and 
the gate-voltage was swept from 0 – 3V. These settings limited the current to be less 
than 75 μA in order to avoid any changes inside the transistor due to overheating. 
When a voltage is applied between the drain and the source, Vds> 0, it activates the 
current flow (Id) through the induced channel under the gate dielectric. Hence, the 
device enters turn-on state. The conducting channel between the source and the drain 
is created when the applied potential is above the threshold voltage of the device 
(Vgs >Vth) (Aliakbarinodehi et al. 2017). The gate of the transistor is extended to 
connect to an external gold electrode which is functionalized with oligonucleotides 
specific to a pathogenic DNA and exposed to measurement samples. If molecular 
interactions take place at the gate of the transistor, such as negatively charged target 
ssDNA hybridizing with the complementary probe ssPNA and binding on the surface, 
this will in turn modulate the Vgs and alter Id value. This is due to the increased 
negativity of the gate that leads to a raise of the minimum Vgs that is required to 
bring the n-MOSFET to the turn-on state. Hence, these variations are used to 
quantify the binding events taking place at the surface of the gold electrodes. The 
A p p e n d i x                                             P a g e  | 180 
 
   
variations are monitored in terms of shifts on the transfer characteristics 
(Id vs Vgs curve) of the transistor (Chi et al. 2000; Estrela et al. 2010). 
 
                       
 
Figure I.5 Vgs changes vs. target DNA concentration bar graphs (Blank & 20 nM) 
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